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 To my wife, 
Eli 
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“ If you cannot calculate something accurately, you probably 
don’ t understand it very well. ” 
Lord Kelvin (1824-1907) 
4
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Summary 
Biosynthesis of secondary metabolites occurs by concerted multistep reactions in a biological 
(chiral) environment. Therefore, many natural products (NPs) are chiral molecules having one or 
several stereocenters. The biological activity of NPs and drug like molecules is generally 
dependent on the stereochemistry of a molecule. Thus NPs are uniquely predestined to interact 
with biomacromolecules, and this explains their importance as drug leads.  
The complete structure elucidation of a new secondary metabolite involves determination of 
constitution, assignment of relative and, finally, absolute configuration. Constitution and relative 
stereochemistry of molecules can be typically derived from UV-Vis, MS and NMR spectral data. 
The J-based configurational analysis uses proton-proton couplings (
3
JHH) to assign the relative 
configuration of adjacent stereogenic centers in conformationally flexible molecules. The nuclear 
Overhauser effect (NOE) experiment is also extensively used, primarily, to define the 
stereochemistry within a molecule. Assignment of the absolute configuration of these chiral 
carbons is crucial to define the 3D structure of a molecule, and this can be a significant challenge 
in the structural elucidation of new metabolites. 
Chiroptical methods such as electronic circular dichroism (ECD) have been used for assignment 
of absolute configuration since several decades, but were limited in their applicability. The 
rapidly developing computer technologies and a broad diversity of quantum chemical methods 
available now permit to study virtually any molecule by selecting the most appropriate method 
for each particular case, with regard to the desired accuracy, time consumption, and available 
computer resources. The progress in the areas of conformational analysis and quantum chemical 
calculation of molecular properties has widened the applicability of ECD in unambiguous 
determination of chiral molecules. This is especially valuable for the analysis of new molecular 
entities when chemical synthesis of the compound is not an option. The good agreements 
between the experimental and simulated ECD curves of these compounds provided the 
unambiguous configurational establishment.  
The aim of the present work was phytochemical investigation of Iranian medicinal plants, in 
order to identify bioactive compounds responsible for inhibition of Plasmodium falciparum. 
About 120 plant extracts were prepared from 40 plants traditionally used in Iranian traditional 
medicine (ITM) to treat malaria and screened for in vitro activity against P. falciparum.  
In a preliminary screen, the lipophilic extracts of Artemisia persica, Salvia hydrangea, and 
Salvia sahendica roots potently inhibited the growth of P. falciparum K1 strain. HPLC-based 
activity profiling led to localizing and identification of the active constituents of these plant 
extracts. Their structures were elucidated by a combination of powerful analytical methods such 
as HPLC-PDA-TOF-MS, and microprobe NMR. In order to determine the absolute 
configurations of isolated chiral compounds, quantum chemical calculation of ECD spectra in 
combination with experimental ECD studies were used. This methodology successfully applied 
to establish the ACs of structurally diverse and conformationally rigid or flexible molecules 
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including sesquiterpene coumarins, bisabolol sesquiterpenes, diterpenoids and complex 
isoprenoids with novel scaffolds. 
Activity profiling of the active n-hexane extract from the roots of Salvia sahendica against 
malaria resulted in the identification of eight abietane-type diterpenoids. In vitro biological 
activities of isolated pure compounds were determined against P. falciparum L& strain and 
Trypanosoma brucei rhodesiense STIB 900 strain, and cytotoxicity in rat myoblast (L6) cells 
was determined. The IC50 values of the compounds ranged from 0.8 µM to over 8.8 µM against 
P. falciparum, and from 1.8 µM to over 32.3 µM against T. brucei rhodesiense. The cytotoxic 
IC50 values ranged from 0.5-15.5 µM. Selectivity indices for P. falciparum were from 0.1 to 
18.2, and 0.1 to 1.2 for T. brucei rhodesiense. The absolute configuration of sahandol (3) and 
sahandone (4) were assigned by comparison of experimental and calculated ECD spectra and 
optical rotation values. 
HPLC based activity profiling of the EtOAc extract of the aerial parts of Artemisia persica 
resulted in the isolation of a series of bisabolol oxide esters. Relative configurations of 
cyclohexenone/cyclohexene and tetrahydropyran moieties of 5–9 were established on the basis 
of 
3
JH–H coupling constants and NOE difference spectra. Absolute configurations of 5–9 were 
established by comparison of experimental ECD spectra with simulated ECD data for possible 
stereoisomers, by TDDFT. Assignment of AC by ECD calculation is possible even though 
relative stereochemistry cannot establish by NMR techniques due to the flexibility of the 
molecule. Bisaboloids 5–8 exhibited in vitro antimalarial activity against Plasmodium 
falciparum, with IC50 values ranging from 2.8 to 20.1 μM, and selectivity indices (SI) in L-6 
cells of 3.7–11.9. 
Hydrangenone (15), perovskone (16) and salvadione (17) three new triterpenoids with rare 
carbon skeletons were isolated from aerial parts and flowers of Salvia hydrangea endemic plant 
to Iran. These compounds indicated significance in vitro activity against P. falciparum with IC50 
values 1.40, 0.18 and 1.43 μM, respectively and acceptable selectivity index in rat myoblast L-6 
cells. 
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Zusammenfassung 
Die Biosynthese von Sekundärmetaboliten findet innerhalb von konzentrierten, mehrstufigen 
Reaktionen in einer biologischen (chiralen) Umgebung statt. Aus diesem Grund, sind viele 
Naturstoffe (NPs) chirale Moleküle, die ein oder mehrere chirale Zentren aufweisen. Die 
biologische Aktivität von Naturstoffen und wirkstoffähnlichen Molekülen ist normalerweise 
abhängig von der Stereochemie des Moleküls. Deshalb sind Naturstoffe besonders prädestiniert 
mit Biomakromolekülen zu interagieren, das erklärt ihre Bedeutung als Wirkstoffe. 
Eine vollständige Strukturaufklärung von Sekundärmetaboliten beinhaltet die Bestimmung des 
Aufbaus, die Bestimmung der relativen und schlussendlich der absoluten Molekülkonfiguration. 
Den Molekülaufbau und seine relative Stereochemie kann man üblicherweise mittels UV-Vis, 
MS und NMR Spektraldaten ableiten. Die J-basierte konfigurative Analyse nutzt Proton-Proton 
Kopplung (
3
JHH), um die relative Konfiguration von angrenzenden stereogenen Zentren in 
konformativ flexiblen Molekülen zu bestimmen. Das Kern-Overhauser-Effekt Experiment 
(NOE) wird in erster Linie umfangreich angewendet um die Stereochemie innerhalb der 
Moleküle zu definieren. Die Bestimmung der absoluten Konfiguration dieser chiralen 
Kohlenstoffe ist entscheidend für die molekulare dreidimensionale Strukturaufklärung, dies kann 
eine echte Herausforderung sein besonders bei der Strukturaufklärung von neuen Metaboliten. 
Chiroptische Methoden wie elektronischer zirkularer Dichroismus (ECD) wurden schon vor 
Jahrzehnten für die absolute Konfiguration angewandt, sind aber in ihrer Anwendbarkeit 
limitiert. Die sich schnell entwickelnden computerunterstützten Technologien und eine 
umfassende Vielfalt von quantenchemischen Methoden erlauben virtuelle Studien eigentlich 
aller Moleküle unter Nutzung der geeigneten Methoden je nach Struktur die man untersucht, 
betreffend der erwünschten Präzision, Zeitverbrauch und verfügbaren Computerressourcen. Der 
Fortschritt in den Bereichen der Konfomationsanalyse und quantenchemische Berechnungen von 
molekularen Eigenschaften hat die Anwendbarkeit für ECD für die eindeutige Aufklärung von 
chiralen Strukturen erweitert. Das ist besonders wertvoll für die Analyse von neuen molekularen 
Einheiten, wenn die chemische Synthese des Stoffes keine Option darstellt. Die gute 
Übereinstimmung zwischen experimentellen und simulierten ECD-Kurven dieser Verbindungen 
führte zu der eindeutigen Strukturdarstellung. 
Das Ziel der vorliegenden Arbeit ist die phytochemische Untersuchung von iranischen 
Medizinalpflanzen um bioaktive Verbindungen zu identifizieren die für die Hemmung von 
Plasmodium falciparum verantwortlich sind. Es wurden 120 Pflanzenextrakte aus 40 Pflanzen, 
die man in der iranischen traditionellen Medizin (ITM) gegen Malaria einsetzt, vorbereitet und 
für die in vitro Aktivität gegen P. falciparum gescreent. 
In einem einführenden Screen hemmten die lipophilen Extrakte aus Artemisia persica, Salvia 
hydrangea und Salvia sahendica Wurzeln das Wachstum des P. falciparum K1-Stamms. Die 
HPLC-basierte Aktivitätsprofiling führte zur Lokalisierung und Identifizierung von aktiven 
Komponenten aus diesen Pflanzenextrakten. Ihre molekularen Strukturen wurden mittels 
analytischer Methoden wie HPLC-PDA-TOF-MS und NMR aufgeklärt. Um die absolute 
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Konfiguration (ACs) von isolierten chiralen Verbindungen zu bestimmen, wurden 
quantenchemische Berechnungen von ECD Spektren in Kombination mit experimentellen ECD 
Studien angewandt. Diese Methode wurde erfolgreich angewandt um die absoluten 
Konfigurationen von strukturell verschiedenen und konformativ starren oder flexiblen 
Molekülen zu ernitteln, einschliesslich Sesquiterpen Cumarine, Bisabolol-Sesquiterpene, 
Diterpenoide und komplexen Isoprenoiden mit neuartigen Baugerüsten. 
Die Aktivitätsprofile der aktiven n-Hexan Extrakte aus Wurzeln von Salvia sahendica gegen 
Malaria zeigten acht abietane-typ Diterpenoide. Biologische in vitro Aktivität von isolierten 
reinen Verbindungen wurden gegen P. falciparum L& Stamm und Trypanosoma brucei 
rhodesiense STIB 900 Stamm bestimmt, ebenso wurde die Zytotoxizität in Myoblasten der Ratte 
(L6) bestimmt. Die IC50 Werte der Verbindungen reichten von 0.8 µM bis über 8.8 µM gegen P. 
falciparum und von 1.8 µM bis über 32.3 µM gegen T. brucei rhodesiense. Die zytotoxischen 
IC50 Werte reichten von 0.5-15.5 µM. Der Selektivitätsindex für P. falciparum war zwischen 0.1 
und 18.2, und zwischen 0.1 und 1.2 für T. brucei rhodesiense. Die absolute Konfiguration von 
Sahandol (3) und Sahandone (4) wurde bestimmt durch den Vergleich von experimentellen und 
berechneten ECD Spektren und optischen Rotationswerten. 
HPLC-basierte Aktivitätsprofile des EtOAc Extrakts der oberirdischen Teile der Artemisia 
persica führten zur Isolierung einer Reihe von Bisabololoxidestern. Die relative Konfiguration 
von Cyclohexenone/Cyclohexene und Tetrahydropyran Resten von 5-9 wurden ermittelt durch 
3
JH–H Kopplungkonstanten und NOE Differenzspektren. Die absolute Konfiguration von 5-9 
wurden mittels TDDFT durch den Vergleich von experimentellen ECD Spektren mit simulierten 
ECD Daten für möglichen Stereoisomere ermittelt. Die Zuordnung der absoluten Konfiguration 
mittels ECD Berechnungen ist möglich obwohl die relative Stereochemie aufgrund der 
Flexibilität der Moleküle nicht per NMR ermittelt werden kann. Bisaboloide 5-8 zeigten in vitro 
Antimalaria-Aktivität gegen Plasmodium falciparum - die IC50 Werten reichten von 2.8 und 20.1 
μM und der Selektivitätsindex (SI) in L-6 Zellen von 3.7-11.9. 
Hydrangenone (15), Peroyskone (16) und Salvadione (17) sind drei neue Triterpenoide mit 
einem seltenen Kohlenstoffgerüst die aus den oberirdischen Teilen und Blüten von Salvia 
hydrangea, einer endemischen Pflanze im Iran, isoliert wurden. Diese Verbindungen zeigten 
signifikante in vitro Aktivität gegen P. falciparum mit IC50 Werten von 1.40, 0.18 and 1.43 μM, 
und einen akzeptablen Selektivitätindex in Myoblasten der Ratte (L-6). 
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1. Aim of the work 
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A large number of drugs are directly or indirectly derived from natural products, and the search 
for lead structures, notably for anticancer drugs, still heavily depends on natural product 
chemistry.
1, 2
 NPs are uniquely predestined to interact with biomacromolecules, and this explains 
their importance as drugs leads. It is well known that the absolute configuration of natural or 
synthetic chiral substances has a remarkable role on their biological activity.
3
 Actually, the 
building blocks of biological molecules (enzymes, proteins, carbohydrates, amino acids, etc.) and 
many secondary metabolites exist in nature in a single enantiomeric form. Due to different 
interactions between a chiral drug and its binding site, two enantiomers of a drug may have 
different effects. In this case, one enantiomer appear as pharmacologically active (e.g. R-
salbutamol), whereas the other enantiomer is pharmacologically inactive (e.g. S-salbutamol),
4
 
and in the worst case some enantiomers are even toxic (e.g. Thalidomide). Since ligand-receptor 
interactions play a central role in life processes, a better understanding of chiroptical properties is 
critical for a complete study of biological activity on molecular basis.  
The complete structure elucidation of a new secondary metabolite involves determination of 
constitution, assignment of relative and, finally, absolute configuration. Constitution and relative 
stereochemistry can be typically derived from UV-Vis, MS and NMR spectral data.
5
 
Determination of relative configuration of chiral elements is strictly related to determination of 
overall the molecular conformation. These features are determined by aid of NMR, by recording 
of three dimensional sensitive data like scalar J-coupling (
3
JHH and 
3
JCH), and NOE effects. 
However; NMR is unable to discriminate between two enantiomers. In order to solve this 
problem several methods have been proposed, chemical methods (total synthesis, derivatization, 
degradation) and X-Ray diffraction analysis being the most reliable ones. The first approach 
requires a long process for transforming the compound under study into one with a known 
absolute configuration. The diffraction technique, on the other hand, has strong limitations: the 
necessity of having single crystals, and the availability of expensive and complex equipment. 
Chiroptical methods such as optical rotation (OR), electronic circular dichroism (ECD) have 
been used for assignment of absolute configuration since several decades, but were limited in 
their applicability.
6, 7
 Recent progress in computer technologies, the areas of conformational 
analysis and quantum chemical calculation has widened the applicability of chiroptical methods. 
Quantum chemical calculation of chiroptical methods like optical rotation ([α]D),
8
 optical 
rotation dispersion (ORD),
8, 9
 electronic circular dichroism (ECD)
10-13
 and vibration circular 
dichroism (VCD)
14-16
 represented a valuable tool to interpret experimental data and assignment 
of the absolute configuration of diverse structures of natural or synthetic compounds.  
In our research group, HPLC-based activity profiling has been used as successful method for the 
rapid localization, dereplication, and characterization of bioactive NPs in extracts. This approach 
was successfully applied for the identification of new antiprotozoal substances, positive 
GABA(A) receptor modulators, and anti-HIV compounds.
17-24
 The work shown here is an 
expansion of our group's plants screening, by exploring Iranian medicinal plants for the 
discovery of new antiprotozoal NPs with new scaffolds for the target. In this project over 120 
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plant extracts mainly from Lamiaceae and Asteraceae family from the Iranian flora were 
screened against Plasmodium falciparum K1 strain. These plants were selected based on 
ethnobotanical studies and taxonomical considerations. Promising extracts (threshold > 70% 
inhibition at 4.6 µg/ml) were separated by analytical scale HPLC. Whilst UV and MS data were 
recorded on-line, time-based microfractions for bioassay were collected via a T-splitter. LC-MS 
with an ion trap mass spectrometer was used for efficient dereplication of active compounds in 
the extracts. In a next step, constituents responsible for the activity within active extracts were 
identified and evaluated according to their lead potential. The aim was to isolate the most 
interesting molecules with the aid of diverse chromatographic methods and to fully elucidate 
their structure by means of spectrometric and spectroscopic methods. Structure elucidation was 
achieved by 1D and 2D NMR experiments. Relative configuration was established on the basis 
of 
3
JH–H coupling constants and NOE difference spectra. Finally, full assignment of isolated 
compounds were done by applying theoretical simulation of ECD spectra for attribution of the 
absolute configuration by applying ab initio approaches based on a time-dependent density 
functional theory (TDDFT).  
The aim of thesis is to apply theoretical CD predictions to the assignment of the absolute 
configurations of optically active compounds. The necessity of the methods appeared when 
conventional empirical methods could not be applied for any of isolated new or known natural 
compounds. This approach was successfully applied for the assignment of the absolute 
configuration of structurally flexible molecules like the bisabololoxide derivatives (5-9), 
disesquiterpene and sesquiterpene coumarins (10-12) along with structurally rigid isoprenoids 
(15-17) with rare carbon skeleton. The AC of sahandone (4) was established by comparing of 
theoretical ECD and optical rotation with experimental values. The work presents a fast and 
smooth approach in the assignment of absolute configurations of chiral compounds isolated from 
natural sources (Figure 1).  
In addition this method successfully applied for establishing AC of some other new NPs such as: 
terpenoids (mono, sesqui-, di-, sester, and triterpenes), abruquinones, alkaloids, and some 
phenolic compounds which will not be presented here.  
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Figure 1. Overview of selected compounds that have been investigated during this work by quantum chemical calculations. 
17
  
 
 
 
 
 
 
 
 
2. Introduction 
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2.1. Discovery of novel leads from natural sources 
From ancient times, nature has inspired man to discover drugs to treat diseases. People in all over 
the world have been using herbal medicine for treating their illnesses and diseases. NPs have 
prepared the way for modern pharmacotherapy over last two centuries, and it is not surprising 
that 80 % of the world's populations is using plant derived medicines for basic health care.
2
 
Historically, nature has provided many ground-breaking drugs such as: penicillin from the 
fungus Penicillium notatum, morphine from the opium poppy (Papaver somniferum), or digoxin 
from the foxglove (Digitalis purpurea), paclitaxel from yew (Taxus brevifolia), artemisinin from 
sweet wormwood (Artemisia annua), and vinblastine from Madagascar periwinkle 
(Catharanthus roseus). A significant number of natural product derived molecules are currently 
in clinical trials in therapeutic areas such as infectious, neurological, cardiovascular, metabolic, 
inflammatory, and cancer.
25
 
In the last decades pharmaceutical drug discovery has moved from NPs to synthetic approaches. 
Combinatorial chemistry by aid of high throughput screening (HTS) techniques provides a rapid 
identification of a lead molecule against a given target. However NPs are differed from synthetic 
compounds. They are structurally more diverse and often exhibit specific biological activity 
because of spatial and structural complexity.
26
 The abundance of synthetic compounds with 
limited chemical and functional diversity has refreshed interest in nature as excellent resource for 
the discovery of new hits to apply to the design of the next generation of drugs. Thus, NPs are 
still unique as both direct and indirect sources of leads to drugs against all classes of disease.
27-29
 
Isolation of bioactive natural products 
Natural extracts are highly complex mixtures containing hundreds to thousands of constituents. 
Within this mixture one or several compounds are responsible for pharmacological properties. 
Definitely the most challenging job in this context is localizing activity in the extract by bringing 
together biological data and chemo-analytical information in order to identify the active 
principles at an early stage.
26
 This step is important in the discovery of bioactive constituents 
from natural sources due to inherent complexity of natural extracts. The identification of 
bioactive principles of natural extracts often failed, as the biological activity could not be 
enriched.
30
 However, there are numerous examples like morphine, quinine, salicylic acid, 
physostigmine, digitalis glycosides, reserpine, or artemisinin, where the correlation between 
traditional use of a plant and  therapeutically useful plant derived compounds was successfully 
established.
27
 Recently, HPLC-based activity profiling has been used as one of the most 
successful approaches for tracking bioactive compounds in crude mixtures.
26, 31-35
 It consists of 
fractionating bioactive extracts in 96-deep well plates (96-DWP) by means of analytical or 
semipreparative scale HPLC and subsequent assessment of the bioactivity in each fraction. In 
this manner, the activity can be assigned to chromatographic peaks and correlated with the 
spectroscopic information available on-line. Briefly, a minute amount of a bioactive extract is 
separated over analytical or semi-preparative HPLC and divided into microfractions which are to 
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be tested in the particular bioassay (Figure 2). Simultaneously, on-line or off-line chemical 
analysis allows direct allocation of the activity to single constituents. This is in contrast to the 
classical preparative approach of bioassay-guided isolation.
36, 37
 An on-line HPLC-UV-MS 
system is the basic equipment for HPLC-based activity profiling since it provides UV-Vis 
absorbance spectrum, mass abundance, molecular mass, and even molecular formula in case of 
high resolution mass spectrometry (HR-MS) detectors in a single run.
38
 Semi-quantitative 
information may also be obtained by hyphenated evaporative light scattering detection (ELSD).
36
 
Detailed structural information is achieved by NMR measurements of peak-resolved HPLC-
fractions containing the compounds of interest.
39
 Comparison of combined spectral data with 
natural products databases such as the Dictionary of Natural Products (DNP) allows rapid 
dereplication of interesting constituents. Hence, promising secondary metabolites can be 
distinguished from uninteresting ones. Based on these results, thorough investigations can be 
discontinued or further pursued by a large-scale isolation of compounds of interest.  
 
 
Figure 2. HPLC-based activity profiling approach of bioactive extract.40 
Structure elucidation of natural products 
In the past structure elucidation of NPs was extremely difficult. Nowadays a “standard” set of 1D 
and 2D NMR experiments, such as 
1
H, 
13
C, COSY, HSQC, HMBC, NOESY, on 400-500 MHz 
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spectrometers, in conjunction with high resolution mass spectrometric (HR-MS) data, is a routine 
approach to “small molecule” structure assignment with milligram, and even microgram 
quantities of sample. Hyphenation of HPLC separation with different spectroscopic detection 
methods such as PDA, MS offline- or online microflow NMR offers fast and precise methods for 
identification and structure elucidation of NPs.
41
 A PDA detector provides a spectrum of a given 
compound, which allows relating them to classes of secondary metabolites with characteristic 
chromophores. The molecular formula, which can be deduced on-line using HPLC-MS with a 
time-of-flight (TOF) detector, is one of the most useful pieces of information for searching large 
databases such as CAS Registry and DNP. Ion trap MS analyzers are often coupled to HPLC and 
are suitable for MS
n
 experiments (repeated tandem mass spectrometry) which allows 
dereplication of active compounds at a very early stage of the discovery process, directly from 
crude extracts.
42
  
A broad range of NMR experiments is available for the elucidation of the constitution and 
configuration of isolated molecules. One-dimensional 
1
H-NMR and 
13
C-NMR experiments, and 
two-dimensional homonuclear (
1
H,
1
H-COSY) and heteronuclear (
1
H,
13
C) correlation 
experiments such as HSQC and HMBC are standard in determining the covalent structure of a 
small molecule with limited signal overlap. For more complex structures with several 
overlapping spin systems, additional experiments like e.g. (
1
H,
1
H)-TOCSY or (
1
H,
13
C)-HSQC-
TOCSY are recommended. While these experiments detect scalar couplings between two nuclei, 
NOESY and ROESY experiments provide stereochemical information by displaying through 
space correlations which provide information on the 3D-structure of a molecule. Combination of 
NOE based methods with molecular modeling are nowadays commonly used for assignment of the 
relative configuration of organic compounds. However, these experiments, only disclose the 
relative configuration, and complete spatial arrangements of groups need to be proven by 
methods for the determination absolute configuration. These methods will be addressed in 
chapter 2.4.  
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2.2. Iranian traditional medicine (ITM) 
Plants have been used to alleviate and treat diseases since ancient times. In the history of the 
medicine of the Western world, Greeks contributed substantially to a rational use of herbal drugs. 
In the Middle Ages people from the Middle East took part in preserving the Greco-Roman 
expertise by adding their own resources, together with Chinese and Indian herbs.
43
 They were 
not only responsible for accumulating all the existing information on medicine of the time, but 
also added to this knowledge their own keen observations, experimentation, and skills.
43
 Iran has 
an long history of traditional medicine, and numerous historical references such as medical 
books and manuscripts with valuable information about medicinal plants are available in Iran.
44, 
45
 Iranian scholars played an important role in the conservation, combination, coordination and 
development of ideas and knowledge in ancient civilizations.
46
 One of the main sources of 
medical and herbal knowledge of the ancient inhabitants of Iran is the Avesta (the holy book of 
the Zoroastrians, aka Zarathustrans). Many herbs were recorded in this book for various 
ailments. The Iranian academic centers like Jundishapur University (3rd century AD) were a 
gathering place for great scholars from different civilizations. This center had a large hospital, 
and an academy where the first international medical congress was held.
43
 After appearance of 
Islam (1400 years ago), Iranian medical scientists saw two specific stages in in the advancement 
of medical sciences: a) the translation age, from 750-900 AD, when many graduates of 
Jundishapur University translated the corpus of Galenic and Hippocratic works; b) the golden 
age of creativity (900-1100 AD), which was the era of Iranian leading scholars in pharmacology 
and pharmacy such as Rhazes (850- 932) and Avicenna (980-1037).  
Muhammad ibn Zakariyā Rāzī (Rhazes in Latin) (865-925 CE), a chemist, pharmacist, musician, 
physicist, philosopher, and great clinical physician was a leading figure in the field of medieval 
medicine.
47
 He wrote his famous encyclopedia Al-Hawi fi Tibb (The Continents of Rhazes) in 
about 26 volumes.
45
 Rhazes’ book was based on his clinical approach. However, his writings did 
not make a strong impression on Western medical history as did Ibn Sina’s (Avicenna, 980-
1028) works. Avicenna, a Persian pharmacist and physician, contributed much to the science of 
pharmacy and medicine through a valuable book called “Canon Medicinae” regarded as “The 
final codification of all Greco-Roman medicine”.30 The book was more theoretical in its 
approach. Avicenna dedicated two of the five volumes of this book to pharmacy and 
pharmacology. In these two volumes he also mentioned the application of many drugs, most of 
them herbal.
44
 He was also one of the first persons who introduced the concept of polymedicine 
(using multiple medications by a patient) in humoral theory, and he discussed the different 
effects of drugs from one person to another, which is considered an important factor in 
pharmacokinetics today.
44, 48, 49
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Figure 3. Canon Medicine, Avicenna operating on a woman, operation tools are displayed top-left. His Canon of Medicine was 
long a reference in the field. (picture provided from http://fouman.com)50 
 
In this era numerous recipes of herbal formulations were written by different scientists. The 
oldest preserved Persian text on Materia Medica, Ketāb al-abnīa ʿan ḥaqāʾeq al-adwīa (Book of 
the Foundation of the True Properties of Remedies) was written by Abu-Mansur Mowaffaq 
Heravi around 980-90 CE.
51
 Two popular pharmacopeias in Farsi have been used as main 
sources of traditional remedies by later physicians, traditional healers, and even traditional 
herbalists: (1) Tuhfat al-Mu’minin (The Gift of two Mumins) written by Muhammad Zaman e-
Tunekabuni around 1669, and (2) Makhzan al-adviyah (The Storage of Medicaments) written by 
Muhammad husayn ibn al-Alavi al-Khurasani al-Shirazi in 1771 CE.
47
 
Current situation of ethnomedicine in Iran 
Modern Western medicine was introduced to Iranian in 1851 by establishing modern institutions 
of higher learning called “Dar ul-Funun (polytechnic institutes‎). When Western medicine was 
introduced, traditional medicine gradually lost ground and was finally excluded from the 
mainstream of the Iranian medico-pharmaceutical community. However, traditional medicine 
has survived through medical services rendered by unauthorized healers, sometimes even within 
urban areas that have well-equipped hospitals.
47
 The herbal shop,"Attari", is a place for 
diagnostic, prescription and providing medical services (Figure 4). Some of these people have 
unique instructions on how to prepare herbal drugs. They use traditional experience to prepare 
herbal prescriptions and dispense them. Many Iranian people continue to consult these herbalist 
practitioners.  
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Figure 4. A typical herbal shop in Tehran, photo by Nastaran Dadjou (www.nasimonline.ir) 
In recent years, the attitude of the Iranian population, as well as the medical and pharmaceutical 
authorities towards medicinal plants and herbal products has gradually improved. In this regard 
the Iranian Herbal Pharmacopoeia (IHP) has been published in 2002 by contribution of 
different pharmacy schools.
52
 The IHP contains qualitative and therapeutic monographs for over 
100 medicinal plants, and includes: definitions, scientific and common names, plant morphology, 
and plant parts recommended for use, geographical distribution of the plant in Iran and other 
countries, microscopic characteristics, constituents, medicinal applications, and pharmacological 
and toxicological information. The mission of the IHP is to promote the responsible use of herbal 
medicines, and to ensure that they are used with the highest possible degree of efficacy and 
safety.  
Researches on different aspects of Iranian traditional medicine are increasing. Sixteen faculties 
of pharmacy (all have a department of pharmacognosy), and several research institutes on 
medicinal plant and ethnobotany all over Iran, investigate drugs of natural origin, usually with an 
emphasis on plant-derived drugs, and present various courses on medicinal herbs.
47
 Research on 
medicinal plants plays an important role in education and promotion of herbal knowledge. Over 
the past two decades, in accordance with the new wave of medicinal plant usage, research 
activities have shown significant progress. Ethnobotanical information forms the starting point 
for many of these research activities. The results of these investigations have been published in 
respected international as well as domestic journals. The broad ranges of investigations carried 
out in these centers include phytochemical, pharmacological, and clinical studies on medicinal 
plants. The interests on research on different aspects Iranian herbal medicines are raising (Figure 
5). 
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Figure 5. The number of indexed articles on herbal medicine by Iranian researchers. Source: ISI Web of Knowledge 
Several studies have been published on uses of natural remedies in Iranian traditional 
medicine.
43, 53-55
 One of the earliest ethnobotanical works is by Hopper and Field on useful plants 
and drugs of Iran and Iraq, which was a market survey of medicinal plants in Tehran, Esfahan 
and Baghdad markets.
56
 Shokri and Safaian also presented a list of 210 medicinal plants used in 
Mazandaran province.
57
 Several ethnobotanical surveys have documented uses in different parts 
of Iran such as: documentation of ethnobotanical information in the region of Turkmen Sahra in 
north part of Iran,
58
 herbal remedies traditionally used in Kohghiluyeh va Boyer Ahmad 
province,
59
 botanical drugs and preparations in the traditional medicine of west Azerbaijan.
60
 
Adhami investigated selected medicinal plants which have been used in Iranian traditional 
medicine for acetylcholinesterase inhibitory activity.
61
 In other studies Sairafianpour 
62
and 
Naghibi et al.
63
 investigated ethnobotany and ethnopharmacology uses of plants with potential 
antiplasmodial properties.
62
 
 
Biodiversity of the Iranian flora 
Iran has a total surface area of 1.6 million km
2
. The country is divided into five major climates 
including Mediterranean, Desert, Half-desert, Warm-Humid, Warm-Dry, and Mountainous 
climate regions. Except for the inland deserts and the lowlands along the Caspian Sea, Persian 
Gulf, and Gulf of Oman, about half of Iran is composed of high mountains. The main mountain 
chains are Alborz, Zagros, Kopet Dagh, Khorassan and Makran (Figure 6). Iran forms part of 
two biodiversity hotspots: the Caucasus and the Irano-Anatolian. Important terrestrial ecoregions 
for endemic species include the Zagros Mountains Forest Steppe and the Elburz Range Forest 
Steppe. The specific geographical situation of Iran, with its variable climates, makes it a unique 
25
  
place with different ecosystems. Iran is a large country and - after Turkey- has the highest plant 
biodiversity in the Middle East. 
64
  
 
 
Figure 6. Topography map of Iran, main mountain ranges: the Alborz in central N, The Zagros from NW to SE. 
(Source: Wikipedia) 
Due to the great number of its ecosystems and special climates, the Iranian flora consists of over 
8000 spermatophytes plant species belonging to 167 families and 1200 genera. Of these, about 
22% are endemic species belonging to 85 families. In total there are over 1700 endemic taxa in 
the country.
47, 65
 Nearly 60% of the endemic species of Iran belong to the four families Fabaceae 
(394 species), Asteraceae (393 species), Lamiaceae (129 species) and Apiaceae (100 species). 
Genera with high number of endemic species within the Iranian flora are: Astragalus, Cousinia, 
Nepeta, Onosma, Acantholimon, and Dionysia.
66
  
About 20 % of the Iranian flora consists of annual plant species. According to Raunkiær,
67
 this 
figure for world's flora is 13%. When compared with the world flora, the Iranian flora is rich in 
annuals. Despite this, only 6.7% of Iran’s endemic plant species are annuals. There is similar 
picture for tree, shrub, and sub-shrub species. Although 7.5% of the whole country is covered by 
forests, Iran has only seven endemic tree species. Six of these are from the Rosaceae, and one 
from the Ulmaceae families. With the exception of two species of the Pyrus genus which occur 
in the Euxino-Hyrcanian province, the remaining five species evolved within Irano-Turanian 
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boundaries. From a physiognomic view point, the vegetation of Iran is dominated by shrub and 
sub-shrub life forms, but only 6.9% of endemic species are shrubby plants. By contrast, 85 % of 
endemic species in Iran are herbaceous perennials (including 11% caespitose perennials).
65
 
Selection and collection of plant material 
The aim of this project was to screen medicinal plants from Iran for the discovery of new 
antiparasitic NPs with scaffolds new for the target. In this study different strategies were used to 
assemble extract libraries from the Iranian flora. The criteria for selecting plant species were 
based on folk medicinal uses, and indications of the presence of bioactive compounds with anti-
fever properties. Some of the plant material was collected randomly, or in a targeted manner with 
a focus on chemotaxonomic considerations. A total of 40 different plants were selected from the 
Iranian flora, mainly from the Lamiaceae and Asteraceae families (Table 1). 
The plant material was identified by Dr. Ali Sonboli from Department of Biology, Medicinal 
Plants and Drugs Research Institute, Shahid Beheshti University, Tehran, Iran. Voucher 
specimens had been deposited in Herbarium of Medicinal Plants and Drugs Research Institute 
(MPH). Dr. Sonboli also substantially contributed to the selection and collection of plant 
material.   
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Table 1. Plants collected for the screening against Plasmodium falciparum 
Plant name Family  Part 
Heracleum persicum Desf. Apiaceae Fruits 
Artemisia incana (L.) Druce   Asteraceae Aerial parts 
Artemisia persica Boiss. Asteraceae Aerial parts 
Tanacetum balsamita subsp. balsamitoides (Sch.Bip.) Grierson Asteraceae Aerial parts 
Tanacetum chiliophyllum (Fisch. & Mey.) Asteraceae Aerial parts 
Tanacetum dumosum Boiss. Asteraceae Aerial parts 
Tanacetum kotschyi Boiss. Asteraceae Aerial parts 
Tanacetum pinnatum Boiss. Asteraceae Aerial parts 
Tanacetum polycephalum Sch. Bip. Asteraceae Aerial parts 
Tanacetum polycephalum subsp. argyrophyllum (K.Koch) Podlech Asteraceae Aerial parts 
Tanacetum polycephalum subsp. Azerba Asteraceae Aerial parts 
Tanacetum sonboli Mozaff. Asteraceae Aerial parts 
Tanacetum stapfianum (Rech.f.) Podlech Asteraceae Aerial parts 
Tanacetum tabrisianum (Boiss.) Sosn. & Takht. Asteraceae Aerial parts 
Tanacetum tenuisectum (Boiss.) Podlech  Asteraceae Aerial parts 
Berberis vulgaris L. Berberidaceae Fruits 
Buxus hyrcana Pojark. Buxaceae Leafs 
Citrullus colocynthis (L.) Schrad. Cucurbitaceae Bark 
Citrullus colocynthis (L.) Schrad. Cucurbitaceae Seeds 
Hymenocrater elegans Bunge Lamiaceae  Aerial parts 
Hymenocrater bituminosus Fisch. & C.A.Mey. Lamiaceae  Aerial parts 
Lamium album L.  Lamiaceae  Aerial parts 
Micromeria persica Boiss. Lamiaceae  Aerial parts 
Nepeta crispa Willd. Lamiaceae  Aerial parts 
Nepeta denudate Benth Lamiaceae  Aerial parts 
Nepeta hormozganica Jamzad Lamiaceae  Aerial parts 
Salvia aegyptiaca L. Lamiaceae  Aerial parts 
Salvia atropatana Bunge Lamiaceae  Aerial parts 
Salvia brachyantha (Bordz.) Pobed. Lamiaceae  Aerial parts 
Salvia ceratophylla L Lamiaceae  Aerial parts 
Salvia chloroleuca Rech.f. & Aellen Lamiaceae  Aerial parts 
Salvia hydrangea DC. ex Benth. Lamiaceae  Aerial parts 
Salvia sahendica Boiss. & Buhse Lamiaceae  Aerial parts 
Salvia sahendica Boiss. & Buhse Lamiaceae  Roots 
Stachys pilifera Benth. Lamiaceae  Leafs 
Otostegia persica (Burm.f.) Boiss. Lamiaceae  Leafs 
Stachys schtschegleevii Sosn. ex Grossh. Lamiaceae  Leafs 
Satureja khuzistanica Jamzad Lamiaceae  Aerial parts 
Satureja rechingeri Jamzad Lamiaceae  Aerial parts 
Nigella sativa L. Ranunculaceae Seeds 
Rubia tinctorum L. Rubiaceae Roots 
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2.3. The challenge of absolute configuration 
Stereoisomerism 
Stereoisomerism arises because molecules having the same constitution may still differ, as 
isomers, in the spatial arrangements of their atoms. Stereoisomers which are related as object and 
nonsuperimposable mirror image are called enantiomers of antipodes, whereas those which are 
not so related are called diastereomers. The relationship between enantiomers simply resembles 
the relationship between right and left-handed helices. The screw sense (right or left) which 
characterizes a given dissymmetric conformation or helix is the chirality, a term which may be 
applied to any dissymmetric object or molecule and which refers to the handedness of given 
enantiomeric form.  
 
 
The concepts of chirality have been known since the 1870s, the time of fundamental statements 
by J. H. van’t Hoff and J. A. Lebel, and even earlier when first experimental evidences were 
obtained by J. B. Biot and L. Pasteur. Pasteur manually separated crystals of sodium ammonium 
tartrate into two groups of crystals. Also, he recognized that solutions of one type of crystals – 
(+)-tartaric acid –rotated linearly polarized light to the right, whereas the other cristal form, the (-
)-enantiomer, rotated it to the left. He was the first person who proposed that the source of 
natural optical activity is the molecular asymmetry. In 1904, Lord Kelvin introduced term of 
chirality on his lecture on Molecular Dynamics and the Wave Theory of Light:
68
 “ …. I call any 
geometrical figure, or group of points, chiral, and say it has chirality, if its image in plane 
mirror, ideally realized, cannot be brought to coincide with itself.” 
In stereochemistry  absolute configuration is the spatial arrangement of the atoms of a chiral 
molecular entity (or group) and its stereochemical description. In 1966, three chemists, R. S. 
Cahn (England), C. K. Ingold (England), and V. Prelog (Switzerland), devised a system of 
nomenclature of chiral molecules called CIP system or CIP conventions. In the CIP system of 
nomenclature, each chiral center in a molecule is assigned a prefix (R or S), depending to 
whether its configuration is right- or left-handed by giving a priority to each substituent on the 
stereogenic atom Cabcd.  
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According to this system, one enantiomer of 2-butanol should be designated (R)-2-butanol and 
the other enantiomer should be designated (S)-2-butanol. [(R) and (S) are from the Latin words 
rectus and sinister, translated by right and left, respectively.]  
The origin of optical activity- plane polarized light 
Optical activity has its origins in microscopic phenomena, such as molecular structure and 
chromophores. It can be observed through macroscopic phenomena, such as chiroptical 
spectroscopic measurements. Light is an electromagnetic phenomenon. A beam of light consists 
of two mutually perpendicular oscillating fields: an oscillating electric field and an oscillating 
magnetic field (Figure 7). The oscillation of the electrical field occurs in all possible planes 
perpendicular to the direction of propagation (The same would be true of the magnetic field).  
 
 
Figure 7. The oscillating electric and magnetic fields of a beam of ordinary light in one plane. The waves depicted here occur in 
all possible planes in ordinary light.69 
When ordinary light is passed through a polarizer, the polarizer interacts with the electric field so 
that the electric field of the light that emerges from the polarizer (and the magnetic field 
perpendicular to it) is oscillating only in one plane. Such light is called plane-polarized light. 
When plane polarized light passes through an optically active sample, the light is rotated because 
of electronic interaction with the chiral molecules present, and the plane of light polarization 
emerging from the sample tube is rotated from the original plane of polarization (Figure 8). A 
second polarizer (analyzer) placed at the sample tube exit is rotated by the observer either 
clockwise or counterclockwise until the light intensity is greatest.
69
  
 
30
  
 
Figure 8. The principal working parts of a polarimeter and the measurement of optical rotation of chiral compounds using 
polarized light.69 
If the analyzer is rotated in a clockwise direction, the rotation α (measured in degrees) is said to 
be positive (+). If the rotation is counterclockwise, the rotation is said to be negative (-). A 
substance that rotates plane-polarized light in the clockwise direction is also said to be 
dextrorotatory, and one that rotates plane-polarized light in a counterclockwise direction is said 
to be levorotatory (Latin: dexter, right, and laevus, left). Two enantiomers generate equal 
rotations magnitudes but opposite sign, and therefore can be easily distinguished. Polarimetry 
has traditionally been used for the analysis of the enantiomeric purity of chiral compounds with 
known specific rotations based on an equation (1).  
    
    
   
  
  (1) 
Where     
  is the specific rotation, and [α] is the measured optical rotation in degrees; l is the 
length of the cuvette in dm; and c is the sample concentration in g/mL, for sample at a temrature 
T (given in degrees Celsius) and wavelength λ (in nm). The optical rotation value of a chiral 
compound depends on the wavelength of the linearly polarized light and the solvent, 
temperature, and sample concentration. The presence of small amounts of (chiral) impurities can 
significantly affect the accuracy of polarimetric measurements, in particular when compounds 
with small rotation angles are analyzed. Horeau and others have pointed out that, in the case of 
associating chiral analytes such as carboxylic acids, determination of the optical rotation for 
stereochemical analysis can be misleading. 
70, 71
 The optical rotation of a chiral compound does 
not always increase linearly with the enantiomeric purity, and is therefore not necessarily 
representative of the actual enantiomeric composition. It is important to notice that there is no 
simple relationship between the sign of the optical rotation of a chiral compound and its absolute 
configuration. Accordingly, polarimetry is generally not used for determination of absolute 
configurations unless a reference is available. Today's application of high level of quantum 
chemical calculation allows the prediction of a magnitude and sign of specific or molecular 
rotation with reasonable accuracy. 
8, 15, 72
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Determination of absolute configuration  
Available techniques for assigning absolute configurations (ACs) may be divided into two large 
categories, that are non chiroptical, so called, “chemical” methods (X-ray, NMR, synthesis) and 
spectroscopic, in particular chiroptical methods (OR, ORD, ECD, VCD). The latter ones permit 
to distinguish between stereoisomers in even sub-μg amounts without requiring great 
experimental efforts. 
Non chiroptical methods 
X-ray single crystal 
The most widely known instrumental method for the determination of absolute configuration is 
X-ray crystallography. In 1951, Bijvoet used anomalous dispersion (Resonant Scattering) to 
solve the absolute structure of chiral compounds which contained elements with high imaginary 
resonant-scattering components.
73, 74
 Bijvoet and his coworkers achieved the first experimental 
determination of the absolute configuration of sodium rubidium tartrate. In this compound 
rubidium atoms were the ones close to the absorption edge. The use of a CuKα radiation source 
has made absolute configuration assignments possible without introduction of a heavy atom in 
the molecule.
75
 An essential precondition of using X-ray crystallography, however, still is the 
availability of crystals of suitable quality, 
76
 which sometimes appears to be a non-trivial task. 
NMR techniques 
NMR spectroscopy which is most frequently used technique for structural elucidation of 
compounds may also be applicable for the assignment of absolute configuration in two general 
approaches:
77-79
 
a) Substrate analysis without derivatization (i.e., by the addition of a chiral solvating agent).  
b) Analysis of the derivatives prepared from the substrate and the two enantiomers from a 
chiral derivatization agent. 
In the first approach there is no covalent linkage between the substrate and the chiral “reagent”, 
The two enantiomers must be available for comparison, and no clear-cut correlations between 
the absolute configuration and the NMR spectra can be established. The second and more 
common approach, involves derivatization of a pure enantiomer with the two enantiomers of a 
chiral agents, such as Mosher acid [α-methoxy- α -(trifluoromethyl)phenyl acetic acid],78 O-
methylatrolactic acid,
80
 ADPD (5-amino-2,2-dimethyl-4-phenyl-1,3- dioxan),
81
 or phosphorus-
containing reagents.
82
 In this approach an enantiomeric mixture can be converted to a pair of 
diastereomers, which can easily be distinguished by classical methods (Fig. 7). After 
derivatization the diastereomer, in which specific substituents are shielded by the aromatic 
group of the chiral shift reagent, will exhibit upfield chemical shifts for those substituents 
relative to the same substituents in the second diastereoisomer (Figure 9). This change in 
chemical shift values, due to the shielding effect of the aromatic group, is commonly 
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represented as a Δδ value, calculated for MTPA (methoxytrifluoromethylphenylacetic acid) 
esters as Δδ = δS – δR or Δδ = δR – δS, while for MPA (methoxyphenylacetic ester) and other 
esters as Δδ = δR – δS. To establish the absolute configuration, values of Δδ should be localized 
on the structure, and based on their arrangement the configuration can be concluded. 
 
Figure 9. Typical 1H NMR spectrum “Chiral derivatizing agents” showing variation on chemical shift of L-1 and L-2 resonances. 
Analysis of the chemical shifts of diastereomers (Δ= S-R) allowed the assignment of the absolute configuration of chiral 
alcohols, amines, and carboxylic acids.78 
Partial to total synthesis 
Total enantioselective synthesis has been used for the determination of absolute configurations of 
chiral compounds.
83-86
 This method is a very effective and reliable, but sometimes also expensive 
and time-consuming. In this approach final configuration will confirm in stereochemical manner 
by using semi or total synthesis of chiral compounds from corresponding starting material. 
Chemical degradation 
Determination of ACs of chiral compound can be done by chemical degradation to optically 
active products suited for further comparison with authentic samples of known absolute 
configurations.
87, 88
 
Chiroptical approaches  
Spectroscopic measurements of chiroptical properties; such as optical rotation, optical rotatory 
dispersion (ORD), and circular dichroism (CD), represent excellent tools for the elucidation of 
the absolute configurations of chiral compounds. The main advantages of these methods are that 
they allow the rapid and unambiguous differentiation between stereoisomers without major 
experimental efforts and consume only small amounts of substance. 
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Optical rotatory dispersion (ORD) 
Optical rotatory dispersion is the variation in the optical rotation of a substance with a change in 
the wavelength of light. Optical rotatory dispersion can be used to find the absolute configuration 
of chiral compounds. Biot found out that if the angle of rotation α (or [α] or [ɸ]) can be measured 
as a function of the wavelength. Greater absolute values are obtained at shorter wavelengths 
(Figure 10). This behavior is described as “plain curve” (normal ORD), and in spectral regions 
that are remote from the absorption bands, it can be expressed by a Drude equation 
     ∑     
    
 
    (2) 
(Ai and λi are constants).
89
  
 
Figure 10. Typical ORD spectra: normal, plain curves (black) and anomalous ORD spectra, defined as positive (red) and 
negative (blue) COTTON effects (CE).89 
Two types of ORD spectra are exist: the normal, plain curves (background rotation), which are 
characterized by a monotonic increase of [α]T while the wavelength is decreased; and the 
anomalous spectra of dispersion, which are defined by reversal of direction and inflection in the 
curves around a maximum of an absorption band (Figure 10).
89
 The presences of chromophores 
in vicinity of chiral element exhibit the anomalous behavior that has a maximum in the UV/vis 
region. The anomalous ORD is also described as a COTTON effect (CE) curve. In particular, a 
CE is called positive if the rotation magnitude first increases with a decreasing λi; conversely, the 
curve corresponds to a negative CE if the rotation value first decreases while going towards 
shorter wavelengths. It is remarkable that, for example an originally positive specific rotation 
[α]T a two principal types of anomalous ORD spectra are possible (Figure 10).  
Elucidation of the absolute configuration by using ORD spectroscopy is mainly based on the 
comparison of the ORD spectra of the examined molecule with the ORD curves of closely 
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related compounds of known configurations.
90
 Furthermore, analogous to optical rotation, the 
ORD spectra can be predicted by quantum chemical calculations.
72
 
Electronic circular dichroism (ECD) 
UV-vis spectroscopy offers a way to understand the nature of ground and electronic states and 
the excitation process. Usually organic molecules adsorb light in the UV-vis region of an 
electromagnetic spectrum. The absorption of light in UV-vis spectroscopy associated with 
measuring both energy and probability of exciting a molecule from its ground electronic state to 
an electronically excited state. Circular dichroism (CD) as a unique type of UV-vis spectroscopy, 
which is sensitive only to chiral molecules, and can provide much information and a better 
understanding of the electronic structure. CD and UV-vis spectroscopy have their origins in the 
same photophysical process: raising an electronic ground state to an electronically excited state 
by movement of an electron. Consequently, their spectra closely resemble each other (Figure 11). 
However, CD involves measuring a difference in absorption; CD curves can take on either a 
positive or a negative bell shape. In contrast, UV-vis spectra are always positive. In UV-vis 
spectroscopy ordinary light is used.  
 
Figure 11. The general pattern of CD and UV spectra10 
In CD spectroscopy light is anisotropic and circularly polarized, which is achieved by filtering 
ordinary light through a polarizer to give linearly polarized light. The linearly polarized light is 
then separated into its left and right circularly polarized components by passing it through a 
stress plate modulator. When difference in absorption of left and right circularly polarized light 
is non-zero (ΔA =AL-AR ≠ 0), circular dichroism can be measured for electronic transitions 
(Figure 12).  
35
  
 
Figure 12. a) Left-circularly polarized light propagating in z-direction, b) Linear polarized light can be viewed as a superposition 
of opposite circular polarized light of equal amplitude and phase. (b): different absorption of the left- and right hand polarized 
component leads to ellipticity (CD). http://www.ruppweb.org/cd/cdtutorial.htm 
In fact CD is the difference between the absorption coefficients for the left and right circularly 
polarized light. The original linearly polarized light is composed of left- and right –circularly 
polarized beams of equal intensity. However when these two oppositely polarized beams pass 
through a solution of chiral compounds their absorptions coefficients change and become 
unequal. The angle of θ of the ellipsoidally polarized transmitted light is defined as ellipticity 
angle (Figure 13). 
 
Figure 13. α rotation angle; θ, ellipticity angle; El and Er, electric field vectors of left- and right-circularly polarized lights, 
respectively. 
      
                       
                      
 (3) 
The output of CD instruments is usually measured as ellipticity θ (in mdeg), Molar ellipticity [θ] 
is correlated to molar CD "Δԑ" as follows: related to CD through θ (mdeg) = 3300 Δε. 
Δԑ = εl - εr  (4) 
Where εl and εr are absorptions of left and right circularly polarized light, respectively.  
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In practice the following equation is used for obtaining molar CD Δε. 
 
  
               (5) 
where ΔA is CD absorbance, c’ is the molar concentration (mol solute/dm3 solution), and l’ the 
cell length (cm). 
The equation (5) shows that CD can be measured only in correspondence to absorption bands. A 
a dichroic peak is also called a CE on account of Frank Albert Cotton (April 9, 1930 – February 
20, 2007), the discoverer of the phenomenon. It is worth observing that CD is a signed quantity, 
because εl, may be smaller or larger than εr. It is easy to show that for each absorption band, the 
CD of two enantiomers are always exactly opposite. 
Similarly as the ORD curve can be obtained, the measurement of the Δε value as a function of 
the wavelength λ leads to a CD spectrum. In general, the measured CD effect is directly 
associated with the ORD anomaly, since they both reflect the interaction of the polarized light 
with the same chiroptical chromophore. The maximum of the CD curve coincides with the 
wavelength of anomalous ORD crossover, and the sign of CE in ORD spectrum corresponds to 
that of CD (Figure 14). 
 
Figure 14. CD and ORD spectra describing (a) the positive and (b) negative CEs of a single electronic transition.89 
 
Although both phenomena afford complementary information, CD spectroscopy has now 
completely replaced the ORD technique, because it provides better discrimination between 
overlapping bands, whereas the ORD curves often possess a fine structure due to molecular 
vibrations, which complicates the interpretation of the spectra. 
Requirements for ECD phenomena  
There are two requirements for a molecule or group of atoms in a molecule to exhibit a circular 
dichroism (CD) spectrum.  
1) The first is the presence of a chromophore i.e., a group that can absorb radiation by virtue of 
the electronic configuration of its resting or ground state at room temperature. The energy 
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absorbed results in a transition to a higher-energy or excited state, which has a different 
distribution of electrons around the nucleus. It can therefore interact with its environment in a 
way that differs from the ground state. A chromophore is a molecular moiety, responsible for one 
or more electronic transitions, allied to absorption bands in the UV or in the visible range. In the 
context of organic chemistry, it is usually a functional group or a combination of several groups 
with a more or less extended π electron system. A few common examples are depicted in Figure 
15. 
 
Figure 15. A few simple common organic chromophores with their main transitions; electric transition dipoles in red, magnetic 
in purple (last three structures).10 
2) Close associated chromophores with, an optically asymmetric environment. For these reasons 
a crucial step which must precede any attempt in analyzing a CD spectrum requires a correct 
recognition of pertinent chromophoric unit(s). A careful estimation of similarity between two 
chromophores is an important issue, not only when we compare experimental data of different 
compounds, but also when we apply computational methods. 
Solid state circular dichroism 
Historically all chiroptical properties, [α]T, ORD, and ECD, have always been discussed as 
observables in solution. Although it usually requires more complex techniques, these effects can 
also be measured in both gas and solid states. Solid-state CD can provide information on solute–
solvent interactions when compared with the solution spectra in various solvents. Solvent effect 
on the rotatory power is often the result on the formation of some kind of coordination between 
the solvent and the optically active molecules concerned in solution. This may affect the optical 
activity of the molecule by way of conformation alteration in the case of flexible compounds, or 
through vicinal effects. Furthermore, those conformations that are unstable in solution can be 
frozen in the crystalline state and then investigated.  
Samples can be single crystals, microcrystals, or films. One big advantage for studying the CD of 
crystals is that the location of relevant atoms and molecules can be revealed through X-ray 
structure analysis. The ECD spectrum predicted for these well-defined, X-ray derived structures 
by using, e.g. quantum chemical calculations, can be compared with the experimental solid-state 
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ECD curve, thereby allowing an assignment of the absolute configuration. This is a rather new 
and not much investigated field of application of solid-state ECD spectroscopy. 
Vibrational circular dichroism (VCD) 
The vibrational circular dichroism (VCD) technique is infrared counterpart of ECD, and works in 
the same way as ECD. In the last few years many papers have described VCD for the 
determination of the AC in combination with high-level ab initio quantum chemical calculations. 
These methods likewise permit to determine the absolute configuration.
91-96
 The first solution-
phase measurements date back to the mid-1970s using a dispersive IR spectrometer.
97, 98
 Today, 
measuring VCD over large spectral regions with a specially equipped Fourier Transformed 
Infrared (FT-IR) spectrometer is becoming more common practice. The main advantage of the 
vibrational chiroptical techniques with respect to ECD is their ability to distinguish equally well 
between the enantiomers irrespective of the presence of a chromophore, whereas in ECD, the 
presence of a chromophore is a fundamental precondition. In comparison with ECD curves, 
vibrational optical activity spectra contain much more transitions, through which the absolute 
stereochemistry can be determined. Also from the theoretical point of view, VCD spectra are 
easier to accurately calculate than ECD curves, since only ground electronic state properties have 
to be considered.
16, 99-101
 CD in vibrational transitions, however, is a weak phenomenon, with 
magnitudes of typically around 10
-5
 absorbance units. Today, all VCD instruments are equipped 
with an FT-IR spectrometer. Because of the small magnitude of VCD it requires sophisticated 
modulation techniques for its observation.
102
 Despite obvious advantages of VCD, the standard 
ECD, due to its wider availability, high sensitivity, and ease of handling, still remains the leading 
method. 
Methods for interpretation of ECD spectra 
The measured ECD spectra can be analyzed by using either empirical or semi-emprical relations, 
or it can be simulated by aid of quantum chemical calculation of ECD spectra and comparing 
with experimental data. 
Empirical comparison of experimental ECD spectra 
Determination of absolute configuration of a new natural or synthetic molecule can be easily 
deduced from a simple empirical comparison of the respective measured CD spectrum with the 
CD data of a previously obtained compound, for which the absolute stereostructure has been 
already defined. Furthermore, the comparison with the CD spectra of closely related substances 
of known configurations may also give hints at the configuration of the investigated molecule. It 
has to be mentioned that an unambiguous attribution of the absolute stereostructure is possible 
only if a reference compound possesses an identical chromophoric framework. The small 
modification and changes on the chromophor or conformation alterations may cause substantial 
changes in the CD spectrum and we are not allowed directly compare data. 
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 Empirical rules 
Up to now a number of Sector Rules have been postulated, to elucidate the absolute 
stereochemistry of various chiral molecules possessing an inherently achiral chromophore, such 
as benzene (Quadrant Rule), carbonyl (Octant rule), or alkene (Diene Rule). The basic idea of 
these rules is that the sign of a CE associated with a specific transition is considered to be very 
sensitive to contributions from all substituents (“perturbers”) in a chromophore surrounding. 
These contributions are assessed by dividing the 3D space around the chromophore into sectors 
characterized by empirically attributed signs.  
For compounds having a single chromophore (carbonyl, aryl, diene, enone, etc.), qualitative 
approaches such as sector and helicity rules have been developed. They link the sign of the ECD 
CEs allied to the main electronic transitions of the chromophore to the AC. These approaches, 
although widely employed, often present some ambiguity and can lead to incorrect assignments. 
ECD spectra are sensitive to conformation and chromophores, since small modifications in the 
Structure of the chromophore or even minor conformational alterations may cause substantial 
changes in the ECD spectrum. For this reason, although qualitative methods are often the “first” 
choice for their simplicity and rapidity, they sometimes need to be supported by more rigorous 
computational analysis.
7
 
The carbonyl chromophore – Octant rule 
The oldest and most popular sector rule is the so-called “octant rule,” allowing us to assign the 
AC of saturated ketones by the sign of the CE allied to the n → π∗ transition of the carbonyl 
around 300 nm. 
1, 7, 103
 Although it was originally proposed on empirical grounds,
104
 it was later 
supported by theoretical studies on the origin of the ketone n → π∗ CE. 105 The carbonyl group is 
characterized by a weak magnetic dipole transition (n → π*) around 300 nm. The n and π-
orbitals define three orthogonal nodal planes, as shown in Figure 16, two of which are also 
symmetry planes. Overall, they divide the space into eight sectors called octants, which are 
associated with the signs of contribution to the CD (300 nm) depicted in the Figure 16. 
 
Figure 16. Saturated ketone octant rule; Left: the nodal planes of the chromophore define 8 octants; the signs of the contributions 
to the CD of the band around 300 nm are shown. Right: how the projection in the rear octant is built for (R)-3-
methylcyclohexanone (Δεmax = +0.57 at 284 nm).
10 
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Figure 1 shows application of the octant rule is (R)-3-methylcyclohexanone. In Octant rule, all 
space surrounding the carbonyl group is divided up to eight octants, and the octant occupied by a 
particular perturber determines the sign of its contribution to rotatory strength of the n → π∗ 
transition. In order to apply the octant rule to determine the AC of a ketone, the conformation of 
the latter must be known. A major problem arises when the molecule shows an equilibrium of 
several conformations, since the octant rule only allows predicting the sign of the n → π∗ band 
for each conformer but not its intensity. For this reason the octant rule has usually been applied 
to cyclic, conformationally defined ketones. Another problem of the octant rule concerns the 
priority assessment of substituents that fall in different octants (opposite signed). 
Dienes and trans-enones 
Dienes and enones form a class of chromophores that can be helical due to non-planarity of the 
π-bond system. The conformations of these molecules may be conveniently described by 
considering their helicities. 1,3-Dienes can exist in two planar conformations defined as S-trans 
and S-cis and an infinite number of nonplanar, skewed forms, traditionally called cisoid or 
transoid, depending on the conformation of the nearer planar form. 
 
Figure 17. a) Possible planar and nonplanar conformations of 1,3-dienes and enones and b) definition of M- and P-helicities in 
the cases of cisoid and transoid 1,3-dienes.7 
The electronic transitions of 1,3-dienes and enones are reflections of their structures (Figure 17). 
Conjugated 1,3-dienes show absorption in the 220-280 nm range (π →π* transitions) depending 
on the  possible substitution and ring size. The degree of electron delocalization determines 
intensity and energy of the low-energy π –π* electronic transition in the diene chromophore. 
When the diene is skewed, an inherently chiral chromophor is present. The corresponding 
absolute configuration is correlated with the sign of CE by means of the diene helicity rule. 
Calculation shows that p helicity is correlated with positive CE, and M helicity give rise to 
negative CE. Exceptions to the rule are found especially when the double bonds are not 
homoannular.  
41
  
The semiempirical exciton chirality  
Exciton Chirality was used for first time in 1969 by Harada and Nakanishi for determination AC 
of adjacent hydroxyl groups. The sign of strong CE from π→π* transition of the glycol 
dibenzoate derivatives used for the determination of the configuration from the.
106, 107
 When two 
chromophores are in close spatial proximity to one another, and so disposed that a chiral array 
results, interaction (dynamic coupling) between the individual chromophores gives rise to 
distinctive CE couplets, often called exciton coupling in the ECD spectrum, from which the 
configuration of the chiral array may be easily deduced. However, current method has been 
frequently applied in an empirical manner, in fact it is based on a non-empirical coupled 
oscillator 
108, 109
 and on group polarizability
110
 theories. Molecules possess two or more well-
separated, strongly absorbing chromophores, the movement of an electron creates the oscillating 
transition dipoles localized on each chromophore which can spatially interact by dipole - dipole 
coupling in a symmetric and antisymmetric manner. This gives rise to a split of the energy level 
of the excited state (Δλ, Davydov splitting), resulting in a broadening of the respective UV 
absorption band. The CD band corresponding to this transition becomes bisignate (Figure 18a). 
The intensity of such a CD split is inversely proportional to the square of the inter-chromophoric 
distance.
111
 
 
Figure 18. (a) Exciting splitting of two chromophores with negative chirality, (b) representing of geometrical parameters 
necessary is for predicting CD, (c) expected  UV absorption and (d) CD spectra.10 
According to the Harada and Nakanishi’s Exciton Chirality Rule,112 when the relevant transition 
moments are oriented to form a positive (+) torsion angle (positive chirality), the long 
wavelength component of the associated exciton couplet can be expected to exhibit a positive 
CE. When they are oriented to form a negative (-) torsion angle (negative chirality), the long 
wavelength CE is negative (Figure 18b).  
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2.4. AC through quantum chemical calculation  
The past decade has witnessed revolutionary advancements in the area of quantum mechanical 
calculations of ECD as well as other molecular chiroptical properties such as VCD, ORD and 
OR. The use of TDDFT method, followed by a comparison with the experimental data, 
represents a powerful tool for the unambiguous determination of the AC of chiral molecules.
76, 
112, 113
 
In particular, chiroptical data such as ECD, VCD spectra and OR values are extremely sensitive 
to the overall molecular geometry in terms of both conformation and configuration. Any solution 
CD spectrum amounts to the sum of contributions from all populated conformations; therefore 
the set of input structures to be considered in the calculation must be representative of the whole 
conformational ensemble. Whenever a molecular property is predicted by theory, and used for 
comparison with the experiment, it is crucial to employ a correct input structure. “Correct” 
means it must represent possible and true structure (or structures) responsible for the observed 
property. 
In 1993, Bringmann and co-workers developed a Boltzmann approach for the assignment of ACs 
of NPs, in particular by employing semiempirical QM and TDDFT calculations of ECD spectra 
for first time (Figure 19). 
114
 Comparison of calculated and experimentally measured ECD 
spectra provides an excellent and efficient analytical tool for the assignment of the AC of chiral 
compounds.
1, 13, 39, 76
 
From a practical point of view the concept of “ECD calculations” implies three general steps: 
1- Conformational search and energy minimization of a chiral molecule 
2- Calculation of the rotatory and oscillator strengths 
3- Treatment of the obtained values, leading to the simulation of the ECD and UV curves, 
which are then compared with the experimental data. 
A conformational analysis is normally started with a rapid computational procedure, based on 
Monte Carlo or molecular dynamics approaches at a low level of theory, such as molecular 
mechanics (MM).
115
 These conformational search routines provide a set of structures that are 
further optimized at a higher level of theory, usually density functional theory (DFT) or other ab 
initio methods. After a reliable set of input structures has been generated with an initial arbitrary 
AC, ECD calculations must be run on all minima within a certain energy threshold (2–3 
kcal/mol) that is, with significant population (>3 – 5%) at the working temperature (normally, 
298 or 300 K). 
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Figure 19: The principal approaches for the assignment of absolute configuration of chiral compounds by quantum chemical 
ECD calculations in combination with experimental ECD measurements; the conformation-dependent chiroptical behavior is 
interpreted by conformational analysis.39 Adapted from Reference 39.  
Thereafter, a weighted average of all computed ECD spectra is estimated according to the 
Boltzmann weights at the working temperature. Reliable populations can be obtained by single 
point calculations at a higher calculation level which used for geometry optimizations. 
Furthermore, internal energies should be corrected with zero-point vibrational and entropy terms 
to afford true free energies. Finally, the weighted average ECD is compared with the 
experimental ECD spectrum: If the agreement is good with either the calculated ECD (for the 
initially assumed AC) or its mirror image (i.e., for the opposite AC), the configuration may be 
assigned.  
Conformational analysis  
ECD investigations can normally only distinguish between stereoisomers with a sufficient 
chiroptical differentiation, i.e. usually between enantiomers, whose CD curves are fully opposite. 
A reliable prediction of ECD requires a thorough conformational analysis. The signs of predicted 
ECD bands can vary among different conformers (with the same absolute 
configuration).Therefore it is important that all predominant conformations are identified. In the 
case of more than one stereogenic element, the relative configuration has to be known in advance 
by other methods (e.g., by X-ray diffraction or NMR). 
In the earlier days, conformational analysis used to be conducted manually by constructing the 
structures of different possible conformers, and optimizing their geometries. This laborious task 
can now be automated, using commercial conformational analysis programs, which include 
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SPARTAN,
116
 SYBYL,
117
 CONFLEX,
118
 HYPERCHEM,
119
 and MACROMODEL.
120
 These 
programs generate conformers by rotating atoms around different bonds or by wagging chosen 
atoms, and they use molecular mechanics force constants to optimize their structures. These 
rotations can be selected systematically (using rules predefined within the software) or randomly 
(Monte Carlo method). In addition, molecular mechanics force constants are associated with 
classically defined bonds (single, double, etc.), and rotations can occur only around single bonds. 
Therefore the starting structural definitions that are entered as input into the molecular 
mechanics-based conformational analysis programs are to be identified with classical bonds.
7
  
Geometry optimization (minimization) 
The geometry of a molecule determines many of its physical and chemical properties. In this 
regard it is very important to know the precise geometry of a molecule when running the 
computation. In computational chemistry we are specifically concerned with optimizing bond 
angles (degrees), bond distances (angstroms), and dihedral angles (degrees). The arrangement of 
atoms in the molecules and more specifically the electrons around the atom determine the energy 
level of that molecule. In fact, the energy of a molecular system varies even with small changes 
in its structure. This is why geometry is so important when performing calculations. The 
objective of geometry optimization is to find the configuration of minimum energy of the 
molecule, because this is where the molecule is most stable and most likely to be found in nature. 
One way to observe the effect of different geometries on energy level is to calculate a potential 
energy surface (PES). The PES is just a mathematical relationship correlating the particular 
molecular structure and its single point energy, and describes how the energy of the molecule in 
a particular state varies as a function of the structure of the molecule.
121
 A PES (Figure 20) can 
be visualized as a hilly landscape, with valleys, peaks, and mountain passes. Geometry 
optimization usually attempts to locate minima on the PES, thereby predicting equilibrium 
structures of molecular systems. Optimization can also locate transition structures. Geometry 
optimization begins at the molecular structure specified as input, and steps along potential energy 
surfaces. It computes the energy. The procedure calculates the wave function and the energy at a 
starting geometry and then proceeds to search a new geometry of a lower energy. This is 
repeated until the lowest energy geometry is found. In the final, minimum energy geometry the 
force on each atom is zero.  
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Figure 20. Model potential energy surface showing minima, transition structures, second-order saddle points, reaction paths, and 
a valley ridge inflection point.121 
The energies calculated with molecular mechanics methods are not accurate, but as long as a 
large energy window are used to identify the possible conformations, the conformers generated 
by molecular mechanics can serve as a reasonable set of starting conformers for further 
optimization at a higher level of theory, for example . by means of the density functional theory 
(DFT), mainly with use of the B3LYP or the BLYP functional, often together with the resolution 
of identity (RI) approximation and with use of a split-valence double-zeta basis set such as 6–
31G** to locate all minimum conformers that are significantly populated at ambient temperature. 
Basis set 
A basis set is a mathematical description of the orbitals of a system, which is used for the 
approximate theoretical calculation or modeling. It is a set of basic functional building blocks 
that can be stacked or added to have the features that we need. It was John C. Slater who first 
turned to orbital computation using basis sets, known as Slater Type Orbitals (STOs).
122
  
The electron cloud of an atom in the molecule is usually perturbed in comparison with the 
isolated atom. The common way to solve this problem is to introduce polarization functions into 
the basis set. The polarization function have a higher angular quantum number and so correspond 
to p orbitals for hydrogen and d orbitals for the first- and second-row elements. Polarization 
functions denoted in Pople’s sets by an asterisk. For example 6-31G* refers to 6-31G basis set 
with polarization functions on the heavy atoms (non-hydrogen). The 6-31G** indicates 
polarization functions on heavy atoms and hydrogen or helium. 
For example, the 6-31G code means, that the inner shells are represented by “1” contraction 
constructed from 6 primitives and the valence shell is represented by double zeta with an “inner” 
contraction constructed from 3 and an “outer” constructed from 1 primitive.122 
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To properly describe the species such as anions and molecules containing lone pairs, additional 
diffuse functions are used. These basis sets are denoted ‘+’; thus 6-31+G contain an additional 
single set of diffuse s-and p-type Gaussian functions. 6-31++G indicates diffuse functions 
included for hydrogen as well as for heavy atoms. 
As soon as a basis set is specified, the software will then compute the energy and the gradient at 
that point, and decide if it has reached a stopping point (convergence). It then varies the 
geometry based on the size of the gradient. The self-consistent field (SCF) calculations are done, 
by calculation of new integrals and the system will reach to a new energy and gradient. These 
steps are repeated until the software reaches convergence and finds a stationary point. Finally, 
these energetically favorable minimum structures are then subjected to the actual calculations of 
excited states.
123
 
Computing chiroptical properties 
Assuming that one or several optimized structures for the system of interest are available, the 
next task is then to compute the chiroptical response property (See Figure 19 for a flow chart of 
computational tasks leading up to the point of chiroptical computations). The main goal in CD 
spectroscopy is determination of the rotatory strength and the intensity of an absorption band 
(oscillator strength) ranging from wavelengths λ1 to λ2 given (in cgs units) by 
 
For a transition between states Ψ0 (ground state) and |Ψi (excited state), it is theoretically defined 
as 
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Where, μ and m  are the electric and magnetic dipole operators, respectively. An inspection of the 
equation (7) shows that the electric and magnetic transition dipole moments and  as well as 
the angle between both moments has to be determined. The sign of theoretical ECD response (R) 
depends on the relative orientation of two transition moment vectors. Therefore, an accurate 
prediction of rotatory strengths represents a significantly more demanding task than the 
calculation of oscillator strengths. 
 
 
TDDFT together with coupled cluster (CC) theory are the most popular functions used to 
simulate a reliable ECD. Nevertheless, the TDDFT, has been considered to provide the best 
balance between accuracy and computational cost, hence being the most frequently used method 
of choice. However, in the case of highly conjugated π system, TDHF is preferred over TDDFT 
since the later method overestimated the extent of conjugation. Precise TDDFT-based ECD 
predictions can be obtained using B3LYP functional and moderate to large basis sets depending 
on the system such as 6-31G(d), 6-311+G(2d,2p), aug-cc-pVTZ, etc. To obtain a more optimal 
correlation with the experimental trace, some case studies show variation in the choice of hybrid 
functional (BPW91, BHLYP). Up to now, a high computational level which has been used for 
ECD calculation is a hybrid method called TDDFT/MRCI (where MR stands for multi-reference 
and CI for configuration-interaction). In this method the electron correlation is considered, and 
provides even more reliable ECD predication, but is expensive and highly time consuming and at 
the moment cannot applied for big systems.
7, 13, 14, 72, 89, 124
  
Simulation of the band-shape curves 
In practice, predictions of at least 10 excited states are necessary to simulate an ECD spectrum 
over a typically measured range (200-800 nm). Both Lorentzian and Gaussian bandshapes have 
been utilized for simulating the theoretical ECD trace. Normally simulation of the band-shape of 
curves Δε (λ) and ε(λ) from the bar spectra is performed by utilizing a Gaussian distribution. 
Thus, for each kth electronic excitation centered at the wavelength λk the Gaussian shape 
function is constructed according to expression (Eq. 8), followed by the addition of these 
Gausses over the whole wavelength range λ to provide the final CD curve Δε(λ), or the UV 
spectrum ε(λ) when pursuing equation (Eq. 9). 
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In these equations, σ is the exponential half-width, i.e., half the width of the CD or UV band at 
1/e height, which is used as an adjustable parameter for reproducing the experimental CD or UV 
features.  
Dependence of the shape of predicted CD spectrum on the σ value is represented in Figure 21. 
The detailed CD spectrum is obtained in smaller σ values, whereas larger σ values make the 
smoother and broader spectrum (Figure 21). In this thesis to simulate CD spectra the half width 
ranged from 0.15 eV to 0.2 eV. 
 
Figure 21. Influence of σ on the shape of a simulated “Gauss”  
Obtaining of the overall spectra  
The next step is the summing up of the single spectra of the individual conformers to provide the 
overall CD or UV spectrum. For the conformers obtained from the conformational analysis, 
adding up is carried out in accordance with the Boltzmann statistics. Thus, the contribution of the 
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particular single spectrum to the overall one is estimated by calculating the weighting factor fi 
for each ith conformer in the dependence on its relative energy ΔEi with respect to the global 
minimum structure (Eq. 10).
13, 89
 
 
Here, kB is the Boltzmann constant T is the absolute temperature, and Nconf is the number of all 
conformers considered.  
           ∑       
     
 
 and            ∑       
     
 
 
The overall CD or UV spectrum is then obtained as the weighted average of the single spectra 
(Figure 22). 
 
Figure 22. Representation for Boltzmann weighting, single calculated CD spectra of all possible conformers (right), overlaid 
experimental and calculated Boltzmann weighted CD spectrum (left).  
 
Matching of experimental spectra 
To figure out systematic error of used methods, the calculated UV spectrum is compared with the 
experimental UV curve in order to estimate the accuracy of the calculations. Generally, 
semiempirical methods provide overestimated result and the calculated spectrum has to be red-
shifted to reproduce the measured curve, whereas the TDDFT calculations often provide 
underestimate transition energies, so that a correcting blue shift is required to match the 
experimental UV spectrum (Figure 23). Finally, the assignment of the absolute configuration of 
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chiral compound will done after UV correction by comparison of corrected theoretical CD 
spectrum with the measured curve.
89
 
 
Figure 23: Principle of a UV correction  
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3.1. Abietane diterpenoids from Salvia sahendica - antiprotozoal activity and 
determination of their absolute configurations 
 
Samad Nejad Ebrahimi, Stefanie Zimmermann, Janine Zaugg, Martin Smiesko, Reto Brun, 
Matthias Hamburger 
Planta Med. 2013 Jan; 79(2):150-6. doi: 10.1055/s-0032-1328063 
 
HPLC-based activity profiling n-hexane extract from roots of Salvia sahendica led to the 
identification of seven known and one new abietane-type diterpenoid which inhibited the growth 
of P. falciparum K1 strain. Structure elucidation was achieved by analysis of spectroscopic data 
including 1D and 2D NMR. The absolute configuration of sahandol (7) and sahandone (8) were 
assigned by comparison of experimental ECD spectra with calculated ECD data, using time-
dependent density functional theory and methanol as the solvent. In vitro biological activity 
against P. falciparum and Trypanosoma brucei rhodesiense STIB 900 strain and cytotoxicity in 
rat myoblast (L6) cells were determined. The IC50 values of the compounds ranged from 0.8 µM 
to over 8.8 µM against P. falciparum, and from 1.8 µM to over 32.3 µM against T. brucei 
rhodesiense. The cytotoxic IC50 values ranged from 0.5-15.5 µM. Selectivity indices for P. 
falciparum were 0.1 to 18.2, and 0.1 to 1.2 for T. brucei rhodesiense. 
 
Extraction of plant material, isolation, recording and interpretation of analytical data for 
structure elucidation (HPLC-PDA-ESI-MS and 1D and 2D-NMR optical rotation, ECD), quantum 
chemical calculations ECD spectra and optical rotation (some advice from Martin Smiesko and 
Janine Zaugg), writing of the manuscript draft, and preparation of figures were my contributions 
to this publication. Antiprotozoal tests were done by Stefanie Zimmermann.  
 
Samad Ebrahimi 
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Introduction
!
Salvia is the largest genus of the Lamiaceae family,
with over 900 species found throughout the
world. It is represented in the Iranian flora by 58
species, of which 17 are endemic [1]. Some of
these species have been used as medicinal, aro-
matic, and ornamental plants [2,3]. For Iranian
Salvia species, such as S. leriifolia, S. hydrangea, S.
macrosiphon, and S. viridis, antibacterial, antifun-
gal, antiplasmodial, and antibacterial properties
have been reported [4–6]. Salvia species are par-
ticularly rich in diterpenoids, and they are re-
sponsible for various biological activities of these
plants. Salvia sahendica Boiss. & Buhse is used in
Iranian folk medicine as antibacterial and anti-
fungal, and for treatment of dyspepsia [7]. Its es-
sential oil composition as well as antibacterial
and antioxidant activities have been studied [8].
Previous phytochemical studies of the aerial parts
of S. sahendica led to identification of sesterter-
penes, nor-sesterterpenes, and nor-diterpenes
[9,10], whereas rearranged abietane diterpenoids
have been reported from the roots [11].
In recent years we successfully applied HPLC-
based activity profiling for the rapid localization,
dereplication, and characterization of bioactive
natural products in extracts. This approach was
successfully applied for the identification of new
anti-protozoal substances, positive GABA(A) re-
Abstract
!
In a screening of Iranian plants for antiprotozoal
activity, an n-hexane extract of the roots of Salvia
sahendica potently inhibited the growth of Plas-
modium falciparum K1 strain. Subsequent HPLC-
based activity profiling led to the identification
of seven known and one new abietane-type diter-
penoid. Structure elucidation was achieved by
analysis of spectroscopic data including 1D and
2DNMR. The absolute configuration of sahandol
(7) and sahandone (8) were assigned by compari-
son of experimental ECD spectra with calculated
ECD data, using time-dependent density func-
tional theory andmethanol as the solvent. In vitro
biological activity against P. falciparum and Trypa-
nosoma brucei rhodesiense STIB 900 strain and cy-
totoxicity in rat myoblast (L6) cells were deter-
mined. The IC50 values of the compounds ranged
from 0.8 μM to over 8.8 μM against P. falciparum,
and from 1.8 μM to over 32.3 μM against T. brucei
rhodesiense. The cytotoxic IC50 values ranged from
0.5–15.5 μM. Selectivity indices for P. falciparum
were 0.1 to 18.2, and 0.1 to 1.2 for T. brucei rhode-
siense.
Abbreviations
!
TDDFT: time-dependent density functional
theory
ECD: electronic circular dichroism
CE: Cotton effect
SCRF: self-consistent reaction field
CPCM: conductor-like polarizable continuum
model
MPLC: medium-pressure liquid chromatog-
raphy
NP: normal phase
OR: optical rotation
Rvel: rotatory strength R in dipole velocity
Rlen: dipole length
MMFF Merck molecular force field
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ceptor modulators, and anti-HIV compounds [12–19]. Continuing
in our screening of medicinal plants for the discovery of new
antiparasitic natural products with scaffolds new for the target,
we recently screened over 150 plant extracts mainly from the La-
biatae and Asteraceae families from the Iranian flora. These
plants were selected based on ethnobotanical studies and taxo-
nomical considerations. One of the most active extracts against
P. falciparum K1 was a n-hexane extract of the roots of S. sahend-
ica that inhibited parasites by 70% when tested at a concentra-
tion of 0.85 μg/mL. HPLC-based activity profiling was used to
identify the active constituents in the extract. Here we report on
the isolation and identification of anti-protozoal compounds
from roots of S. sahendica and also on determination of the abso-
lute configuration of compounds 7 and 8 by simulation of ECD
spectra using TDDFT calculation.
Material and Methods
!
General experimental procedures
Optical rotations weremeasured using a JASCO P-2000 automatic
digital polarimeter. ECD spectra were recorded in MeOH (16 μg/
mL) on an AVIV CD spectrometer model 62ADS and analyzed
with the AVIV 60DS V4.1 software. NMR spectra were recorded
at a target temperature of 18°C on a Bruker Avance III 500MHz
spectrometer operating at 500.13MHz for 1H and 125.77MHz
for 13C. A 1-mm TXI microprobe with a z-gradient was used for
1H-detected experiments. 13C‑NMR spectra were recorded with
a 5-mm BBO probe head with z-gradient. Spectra were analyzed
using Bruker TopSpin 2.1 software. HRESI‑MS spectra in positive
and negative ion modes were recorded on a Bruker microTOF
ESI‑MS systemwith a scan range ofm/z 200–1500. MS calibration
was performed using a reference solution of sodium formate 0.1%
in isopropanol-water (1 :1) containing 5mM sodium hydroxide.
The typical mass accuracy was ± 3 ppm. HyStar 3.0 software
(Bruker Daltonics) was used for data acquisition and processing.
HPLC separations were performed on an Agilent 1100 series
HPLC system consisting of a quaternary low-pressure mixing
pumpwith degasser module, column oven, PDA detector, and au-
tosampler. For MPLC, a Buchi Sepacore system consisting of a
control unit C-620, a fraction collector C-660, and two pump
modules C-605 was used. Waters SunFire C18 (3.5 μm, 3.0 ×
150mm) and SunFire® Prep C18 (5 μm, 30 × 150mm) columns
were used for analytical HPLC and preparative RP-HPLC, respec-
tively. HPLC solvents contained 0.1% HCO2H for separations. NP
column chromatography was carried out on silica gel (Merck,
40–63 μm; 460 × 50mm). Pre-coated silica gel 60 F254 plates
(Merck) were used for TLC. Detection was at 254 and 366 nm or
by spraying with anisaldehyde sulfuric acid reagent and subse-
quently heating (120°C for 5min). CDCl3 (100 Atom% D) for
NMRwas purchased from Armar Chemicals. Solvents used for ex-
traction, open column chromatography, and MPLC were of tech-
nical grade and were purified by distillation.
Plant material
The roots of Salvia sahendica Boiss. & Buhse were collected in
September 2009 from Sardrood-Tabriz (East Azarbaijan Province,
Iran). The plant material was identified by Dr. Ali Sonboli, and a
voucher specimen (MPH-848) has been deposited at the Herbar-
ium of the Department of Biology, Medicinal Plants and Drugs
Research Inistitute, Shahid Beheshti University, Tehran, Iran.
Microfractionation for activity profiling
Aliquots of 350 μg of n-hexane extract from the extract library
(35 μL of 10mg/mL solution in DMSO) were separated on a Sun-
Fire C18 column (5 μm, 10 × 150mm; Waters) with 0.1% formic
acid in H2O (solvent A) and MeCN (solvent B) using the following
gradient: 80% B to 100% B in 30 minutes, hold for 10min. The
flow rate was 0.4mL/min. Thirty-two one-minute fractions were
collected in 96-well deep well plates. The plates were dried in a
GeneVac EZ-2 Plus evaporator and submitted to bioassay.
Extraction and isolation
The dried root samples were ground with a Retsch ZM1 mill. The
powdered roots (1.3 kg) were extracted at room temperature
with n-hexane (3 × 5 L). The extract was concentrated under re-
duced pressure at a temperature around 40°C to give 22.5 g of a
dark red residue. A portion (13.0 g) of the n-hexane extract was
separated by MPLC on silica gel (Merck, 40–63 μm; 460 ×
50mm). The column was eluted with a gradient of n-hexane/
CH2Cl2 (100/0 to 0/100%) over 150min, followed by CH2Cl2/
MeOH (100/0 to 0/100%) over 160min. The flow rate was
20mL/min. One-minute fractions were collected and pooled into
14 fractions (Fr 1–14) according to similar composition as as-
sessed by TLC (Merck silica gel 60F254, mobile phase n-hexane/
EtOAc 8:2): Fr 1 (340mL, 0.12 g), Fr 2 (380mL, 0.22 g), Fr 3
(500mL, 1.5 g), Fr 4 (400mL, 0.75 g), Fr 5 (300mL, 0.35 g), Fr 6
(460mL, 1.8 g), Fr 7 (800mL, 3.5 g), Fr 8 (280mL, 0.25 g), Fr 9
(460mL, 0.25 g), Fr 10 (320mL, 0.35 g), Fr 11 (400mL, 0.45 g), Fr
12 (500mL, 1.0 g), Fr 13 (400mL, 0.3 g), and Fr 14 (600mL,
0.45 g). Compounds 1 and 2 (2.8 g) were obtained as a mixture
in a red precipitate from Fr 7. An aliquot (100mg) of this mixture
was separated by column chromatography with AgNO3-impreg-
nated silica gel (40–63 μm; 200 × 20mm). Elution with n-hex-
ane-EtOAc (80:20) afforded pure 1 (35mg, > 98% [1H‑NMR])
and 2 (40mg > 98% [1H‑NMR]). A step gradient separation of a
portion of Fr 6 (700mg) using a mixture of n-hexane-EtOAc [8 :2
(200mL)→ 7:3 (100mL) → 6:4 (200mL) → 5:5 (150mL) → 4:6
(120mL)→ 1:9 (200mL) → 0:10 (200mL) on silica gel (40–
63 μm; 400 × 20mm)] afforded seven subfractions (Fr 6–1 to Fr
6–7). A portion of subfraction Fr 6–4 (200mg) was further puri-
fied by preparative RP-HPLC (MeCN‑H2O, 75:25→ 90:10 in
35min; flow rate 20mL/min, detection at 280 nm) to afford 3
(6.0mg, tR = 24.5, > 97.5% [1H‑NMR]), 4 (3mg, tR = 30.7, > 98%
[1H‑NMR]), and 5 (47mg, tR = 32.5, > 99% [1H‑NMR]). A portion
(50mg) of Fr 6–5 was purified by preparative RP-HPLC
(MeCN‑H2O, 85:15→ 0:100 in 30min; flow rate 20mL/min, de-
tection at 280 nm) to afford 8 (17mg, tR = 20.5, > 96% [1H‑NMR]).
A portion of Fr 4 (200mg) was purified by preparative RP-HPLC
(MeCN‑H2O, 80:20→ 0:100 in 40min; flow rate 20mL/min, de-
tection at 280 nm) to afford 7 (125mg, tR = 35.5, > 98.5%
[1H‑NMR]). Compound 6 (90mg, > 99% [1H‑NMR]) precipitated
as yellowish needles during evaporation of Fr 9.
Antiplasmodial and antitrypanosomal assay
Testing for antiplasmodial and antitrypanosomal activity and de-
termination of cytotoxicity was done as previously reported [18,
19]. Cytotoxicity was determined using rat skeletal myoblast L6
cells. Assays were performed in three independent experiments
as duplicates. IC50 values were calculated from sigmoidal growth
inhibition curves. Melarsoprol (Arsobal®, purity > 95%; Sanofi-
Aventis) and artesunate® (purity > 95%; Mepha) were used as ref-
erence drugs (details on the bioassays are provided as Supporting
Information).
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Conformational analysis, geometrical optimization,
and ECD calculation
Conformational analyses of compounds 7 and 8 were performed
with Schrödinger MacroModel 9.1 software (Schrödinger, LLC)
using the MMFFs (Merck Molecular Force Fields) force field in
H2O. Conformers occurring within a 2 kcal/mol energy window
from the particular global minimum were chosen for the gas-
phase geometrical optimization and energy calculation using
the density functional theory (DFT) with the B3LYP functional
and the 6–31G** basis-set as implemented with the Gaussian 09
program package [20]. Vibrational analysis was performed at the
same level to confirm stability of the minima. Time-dependent
density function theory calculation at the TD‑DFT/B3LYP/6–
31G** level in the gas phase and in MeOH using the SCRF with
the CPCM was employed to calculate excitation energy (denoted
by wavelength in nm) and Rvel and Rlen forms. ECD curves were
calculated based on rotatory strengths using half bandwidth of
0.2 eV with conformers of 7 and 8 using SpecDis version 1.53
[21]. The OR calculations were carried out with TDDFT/GIAO
methodology using PBE0/6–31G++ (2d,2p) in the CHCl3 (SCRF/
CPCM) [22,23]. The ECD spectra and optical rotation values were
constructed based on the Boltzmann-weighting according to
their population contribution.
Isolates
Sahandol (7): yellowish oil, [α]D24 = − 56.5 (c 0.8, CHCl3); UV
(MeOH): λmax (log ε) 244 (3.72), 312 (3.12), 342 (3.25); CD
(MeOH, c = 0.3mM, 0.1 cm): [θ]221 = − 26802, [θ]247 = + 36265,
[θ]309 = − 6556, [θ]337 = + 1267; 1H‑NMR (CDCl3, 500MHz) and
13C‑NMR (CDCl3,125MHz), see l" Table 1; HREIMS m/z 297.1855
[M + H]+, calcd. for C20H24O2, 296.1776.
Sahandone (8): yellow gummy material, [α]D24 = − 198.1 (c 0.06,
MeOH); UV (MeOH): λmax (log ε) 243 (3.83), 342 (3.48); CD
(MeOH, c = 0.05mM, 1.0 cm): [θ]210 = − 109493, [θ]243 = + 27913,
[θ]259 = − 2863, [θ]340 = + 26180, [θ]386 = − 28252; 1H‑NMR
(CDCl3, 500MHz) and 13C‑NMR (CDCl3,125MHz), see Supporting
Information.
Supporting information
1H‑NMR- 13C‑NMR spectra of compounds 7 and 8, calculated ECD
spectra, optical rotation values of conformers of compounds 7
and 8, and details for the bioassay can be found as Supporting In-
formation available online.
Results and Discussion
!
In a library-based medium-throughput screening of 150 extracts
prepared from Iranian plants against the chloroquine-resistant P.
falciparum K1 strain, an n-hexane extract of S. sahendica roots
produced 70% inhibition at a test concentration of 0.85 μg/mL.
The antiplasmodial activity was localized with the aid of HPLC-
based activity profiling using a previously validated protocol
[19]. The analytical HPLC chromatogram (210–700 nm) and the
corresponding activity profiling of the time-based microfraction-
ation (32 microfractions of 60 s each) are shown in l" Fig. 1A and
B, respectively. The highest activities were found in fractions 23,
19, and 13 (79, 69, and 43% inhibition, respectively). Targeted
preparative isolation of active compounds was subsequently
achieved by a combination of normal phase MPLC and prepara-
tive RP-HPLC. In total, seven known abietane diterpenoids, sa-
handinone (1), 12-deoxy-salvipisone (2), 12-deoxy-6,7-dehy-
droroyleanone (3), Δ9-ferruginol (4), ferruginol (5), 7α-acetoxyr-
oyleanone (6), sahandone (8), and one new diterpene, sahandol
(7), were identified by HR-ESIMS, 1D and 2DNMR spectroscopy,
and by comparison with published data (l" Fig. 2) [11,24–26].
Compound 7 was obtained as yellow oil. The molecular formula
of C20H24O2 was deduced from HRESI-TOFMS (m/z 297.1855 [M
+ H]+, calcd. 296.1776) and accounted for 9 degrees of unsatura-
tion. The UV spectrum in MeOH showed absorption maxima at
244, 312, and 342 nm and was indicative of a highly conjugated
naphthalene system [27]. The 1H‑NMR spectrum (l" Table 1,
Fig. 1S) showed resonances of five methyl groups at δH 2.37 (s),
1.86 (d, 1.5 Hz), 1.81 (d, 1.5 Hz), 1.37 (d, 6.6 Hz), and 1.35 (d,
6.6 Hz), three aromatic and one olefinic proton resonating at δH
7.53 (d, 8.4 Hz), 7.24 (s), 7.12 (d, 8.4 Hz), and 5.53 (brd, 8.5 Hz),
two deshielded diastereotopic methylene protons [δH 3.12 (dd,
16.4, 3.1 Hz), 2.97 (dd, 16.4, 10.8 Hz)], one methine proton [δH
3.44, (sep, J = 6.6 Hz)], and a signal of a deshielded proton at δH
4.93, (ddd, 10.8, 8.5, 1.5 Hz). The 13C‑NMR spectrum exhibited
20 signals. Of these, 10 signals for sp2-carbons could be assigned
to a naphthalene system, while the other 2 sp2-carbon reso-
nances were attributed to olefinic carbons. In addition, the spec-
trum showed 8 saturated sp3-carbons which were attributed to
one oxygen bearing C-atom, a methylene group, one methine,
and five methyl groups. The protonated carbons and their at-
tached protons were correlated with the aid of an HSQC spec-
trum. The presence of an isopropyl group as a substituent of an
aromatic ring was highly reminiscent of an abietane skeleton.
Further analysis of 1H-1H COSY and HMBC spectra of compound
7 established a 4,5-seco-rearranged abietane diterpenoid skele-
ton (l" Fig. 3). HMBC correlations between H-15 and C-13, C-12,
and C-14 confirmed the attachment of the isopropyl moiety at
C-13. Correlations between CH3-20 and C-5 and C-10, and be-
tween H-6 and C-5 established the attachment of CH3-20 at C-7.
The key HMBC correlations of H-2 (δ 4.93) with C-11 (136.2) and
C-1 (32.5) indicated that the aromatic moiety was linked to C-2
by an ether bridge. HMBC cross signals between H-2 and C-3,
and H-3 and C-1 corroborated the position of a vinyl group at C-
Table 1 1H and 13C‑NMR spectral data of sahandol (7) (CDCl3, J in Hz).
Position δH δC
1α 2.97 dd (16.4, 10.8) 32.5
1β 3.12 dd (16.4, 3.1)
2 4.93 ddd (10.8, 8.5, 3.1) 73.2
3 5.53 brd (8.5) 124.4
4 – 136.4
5 – 129.2
6 7.12 d (8.4) 125.1
7 7.53 d (8.4) 126.5
8 – 124.5
9 – 120.2
10 – 125.3
11 – 138.0
12 – 138.6
13 – 136.2
14 7.24 s 115.9
15 3.44 sep (6.6) 27.9
16 1.37 d (6.6) 22.7
17 1.35 d (6.6) 22.8
18 1.81 d (1.5) 18.5
19 1.86 d (1.5) 25.8
20 2.37 s 18.4
OH 5.80 s –
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2. Detailed analysis of vicinal coupling constants in the 1H‑NMR
spectrum and NOESYmeasurements was employed to character-
ize the heterocyclic ring. Vicinal couplings of H-2/H1α (J = 10.8)
and H-2/H1β (J = 3.1) corresponded to the dihedral angles of 180
and 60°, respectively. Hence, H-2 was in an axial orientation, and
the oxene ring showed a half chair conformation.
Since compound 7 contained only one stereogenic center, two
stereoisomers (2R and 2S) were possible. A conformation analysis
of the 2R-stereoisomer using the MMFFs method found six con-
formers within a 2 kcal/mol energy window from the particular
global minimum. These conformers were subjected to geometri-
cal optimization and energy calculation by the DFT/B3LYP/6–
31G** basis set in the gas phase. Vibrational frequency analysis
was carried out to confirm minima. No imaginary frequencies
were found. Conformation analysis using relative free energy re-
Fig. 1 HPLC‑UV chromatogram (254 nm) of the n-
hexane extract (A) and antiplasmodial activity of
microfractions (B).
Fig. 2 Structures of diterpenes 1–8.
Fig. 3 A Key HMBC correlations; B key NOESY correlations in the DFT-
optimized structure of the most stable conformer of 7.
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vealed the presence of six stable conformers (l" Fig. 4A). The su-
perimposed structures showed two core conformers (96.1 and
3.9%, respectively) and minor differences arising from the rota-
tion of the isopropyl and vinyl moieties. ECD spectra of optimized
conformes were calculated by TDDFT-B3LYP/6–31G** and MeOH
as solvent (SCRF/CPCM). The averaged spectrum resulting from
Boltzmann weighting of ECD spectra for individual conformers
showed a positive CE at 245 nm and two negative CE at 220 and
320 nm. Comparison of experimental and calculated ECD spectra
showed an excellent fit with the data calculated for the 2R-ster-
eoisomer (l" Fig. 4B). In particular, the negative CE at 220 nm and
the positive CE at 245 nmmatched with the pattern of the exper-
imental spectrum. Comparison between the experimental
(− 56.50) and calculated (− 35.99) optical rotation gave the same
sign and a similar magnitude for the 2R-stereoisomer (Table 1S).
Compound 7 is a new natural product and was named (2R)-sa-
handol.
Sahandone (8) had been previously isolated from roots of S. sa-
hendica [11]. Its relative stereochemistry was at that time pro-
posed on the basis of 2DNMR studies including ROESY data. Due
to cross signals between H-2, themethoxy group, and Hα-1 in the
ROESY spectrum, the relative configuration was proposed as
(2S*,11S*). We compared optical rotation, 1H and 13C‑NMR data
of our compound with the original substance and found them to
be identical. We also measured a NOESY spectrum of 8 and found
similar correlations as initially reported. In the context of this
study, we re-examined the compound to establish its absolute
configuration. l" Fig. 5B shows the experimental ECD spectrum
of 8 in MeOH. The stereocenter at C-11 is close to the naphthale-
none chromophore, whereas the second stereocenter C-2 is re-
mote from this portion of the molecule and close to the vinyl
chromophore. Hence, the spectrum is dominated by π→π* transi-
tions of the aromatic and vinyl chromophores. We calculated the
ECD spectrum of the (2S,11S)-stereoisomer for a comparison
Fig. 4 A Superimposed lowest energy conformers (within 2 kcal/mol
range from the global minimum) of (R)-sahandol (7). Conformers obtained
from the conformational search were recalculated using DFT at the B3LYP/
6–31G** level in the gas phase. Compound 7 showed two core conform-
ers which differed in the orientation of H-2 (axial, 96.1%; equatorial, 3.9%).
B Comparison of experimental and calculated ECD spectra of 7. The cal-
culations were performed with TDDFT at the B3LYP/6–31G** level with
MeOH as the solvent.
Fig. 5 A Superimposed lowest energy conformers
(within 2 kcal/mol range from the global minimum)
of (2R,11S)-sahandone (8). Conformers obtained
from the conformational search were recalculated
using DFT at the B3LYP/6–31 G** level in the gas
phase. Compound 8 shows one core conformer,
two differing orientations of the methoxy group
(8a–c and 8 d–f, respectively). B Comparison of
experimental and calculated ECD spectra for two
stereoisomers [(2S,11S) and (2R,11S)] of 8. The cal-
culations were performed with TDDFT at the B3LYP/
6–31G** level and MeOH as solvent.
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with the experimental ECD data. A conformational search re-
vealed 13 conformers within a 2 kcal/mol energy window from
the particular global minimum (Fig. 9S A). Geometrical optimiza-
tion and energy calculation followed by calculation of ECD spec-
tra were performed as described above (l" Fig. 5B). The calcu-
lated data showed a negative and a positive CE at 340 and
300 nm, respectively, which fitted with the experimental data.
However, the fit of the calculated ECD spectrum in the region
200–250 nm was not satisfactory. Hence, we calculated the ECD
spectrum for the (2R,11S) stereoisomer. Six conformers differing
in orientation of the isopropyl and methoxy moieties were found
within a 2 kcal/mol energy window from the particular global
minimum (l" Fig. 5A). The averaged ECD spectrum for the
(2R,11S)-stereoisomer and experimental data were in good
agreement. In particular, the negative CEs at 350 and 220 nm
along with positive CEs at 250 and 300 nm matched with the
ECD pattern of 8 (l" Fig. 5B). Differences between calculated and
experimental spectra were apparently due to minor differences
between calculated and solution conformers [17]. However, the
differences to the calculated spectrum of the (2S,11S)-stereo-
isomer were not such as to unambiguously exclude it. We there-
fore calculated optical rotation values for both stereoisomers and
compared themwith the experimental data. The averaged [α]D of
the (2R,11S) and (2S,11S)-stereoisomers were − 164.1 and
− 97.2°, respectively (Table 1S and 2S), while the experimental
value was − 198.1° (the optical rotation previously reported for 8
was − 202° [11]). Taking into account the good agreement be-
tween calculated and experimental ECD spectra and optical rota-
tion values and considering the biosynthetic relationship be-
tween 7 and 8, we concluded that sahandone (8) had the
(2R,11S)-configuration. The NOESY cross-peaks between H-2,
the methoxy group, and Hα-1, which led to the previous stereo-
chemical assignment, are compatible with both stereoisomers,
given the size of the methoxy group and its rather free rotation.
The natural occurrence of compound 8 was confirmed by
HPLC‑MS analysis (RP-18 with H2O/MeCN) of a crude n-hexane
extract.
Compounds 1-8 were tested for their in vitro antiplasmodial,
antitrypanosomal, and cytotoxic activities (l" Table 2). Ferruginol
(5), Δ9-ferruginol (4), and 7-acetoxy royleanone (6) were the
most active antiplasmodial compounds, followed by sahandol
(7), sahandinone (2), 12-deoxy-salvipisone (1), and sahandone
(8). The IC50 values against P. falciparum ranged from 0.9 to
17.8 μM, and cytotoxicity from 0.2 to 15.5 μM, respectively. Thus,
the selectivity indices were between 0.1 and 18.2. Compounds 1,
2, and 3 were the most active against trypanosomes (IC50 values
of 2.5, 1.8, and 2.9 μM, respectively) but were also the most cyto-
toxic diterpenoids of this series (IC50 values of 0.4, 0.5, and
0.2 μM, respectively) and, hence, exhibited nonselective toxicity.
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Spectral data of sahandone (8) 
 
1H NMR (500 MHz, CDCl3) į 7.08 (1H, d, J = 7.6 Hz, H-6), 6.95 (1H, d, J = 7.3 Hz, H-7), 6.87 
(1H, s, H-12), 5.48 (1H, dq, J = 8.5, 1.1 H-3), 5.01 (ddd, J = 13.1, 8.9, 4.4 Hz, H-2), 3.24 (s, O-
CH3), 2.95 (sep, J = 7.0 Hz, H-15), 2.68 (dd, J = 17.0, 4.3 Hz, Hȕ-1), 2.53 (dd, J = 17.1, 11.1 Hz, 
HĮ-1), 2.19 (s, H-20), 1.80 (d, J = 1.1 Hz, CH3-18 ), 1.78 (d, J = 1.1 Hz, CH3-19), 1.15 (d, J = 7.0 
Hz, CH3-16), 1.14 (d, J = 7.0 Hz, CH3-17). 13C NMR (125 MHz, CDCl3) į 30.9 (CH2-1), 65.4 
(CH-2), 125.0 (CH-3), 136.2 (C-4), 136.7 (C-5), 130.5 (CH-6), 126.4 (CH-7), 128.4 (C-8), 132.3 
(C-9), 133.5 (C-10), 93.6 (C-11), 135.7 (CH-12), 140.2 (C-13), 195.5 (C-14), 27.2 (CH-15), 22.1 
(CH3-16), 21.4 (CH3-17), 25.9 (CH3-18), 18.4 (CH3-19), 18.9 (CH3-20), 50.3 (O-CH3).
Micro-fractionation and processing for bioassay 
Fractions of 60 sec each starting from minute 0.00 were collected on a FC 204 fraction collector 
(Gilson) into deep well plates (ScreenMate 96 well; Matrix Technology) during the run and dried 
in a GeneVac EZ-2 Plus evaporator (Genevac Ltd.) at 40°C using the pre-installed “HPLC-
fractions” vacuum settings. Typical evaporation time was 24 h. 
The dried microfractions were dissolved in 5 ȝL of DMSO and then diluted with 95 ȝL of PBS 
buffer (137 mM NaCl, 10 mM phosphate, 2.7 mM KCl, pH 7.4). This gave the stock solution 
which could be used for any of the three assays. 
 
Antiplasmodial assay against Plasmodium falciparum strain K1 
A modification of the [3H]-hypoxanthine incorporation assay was used for determining intra-
erythrocytic inhibition of parasite growth [1, 2]. Infected erythrocytes (100 ȝL per well with 
© Georg Thieme Verlag KG · DOI 10.1055/s-0032-1328063 · Planta Med · Ebrahimi SN et al.
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2.5% hematocrit and 0.3% parasitemia) were added to each drug plate in duplicates. The second 
test concentration was a six fold dilution of this. After 48 h incubation, 0.5 ȝCi of 
[3H]hypoxanthine in 50 ȝL medium was added, and plates were incubated for an additional 24 h. 
Parasites were harvested onto glass-fiber filters, and radioactivity was counted using a Betaplate 
liquid scintillation counter (Wallacand). The results were recorded as counts per minute (cpm) 
per well at each drug concentration and expressed as percentage of the untreated controls. IC50s 
were estimated by linear interpolation [4]. 
 
Antitrypanosomal assay against Trypanosoma brucei rhodesiense 
Minimum essential medium (50 ȝL), supplemented according to Baltz et al. [5] with 2 
mercaptoethanol and 15% heat-inactivated horse serum, was added to each well of a 96-well 
microtiter plate [6]. 2000 T. brucei rhodesiense STIB 900 bloodstream forms in 45 ȝL of 
medium were added to each well, and the plate incubated at 37°C under a 5% CO2 atmosphere 
for 72 h. 10 ȝL of resazurin solution (12.5 mg resazurin dissolved in 100 mL distilled water) was 
then added to each well, and incubation continued for a further 2–4 h. The plate was then read in 
a Spectramax Gemini XS microplate fluorometer (Molecular Devices Cooperation) using an 
excitation wavelength of 536 nm and emission wavelength of 588 nm. Fluorescence 
development was measured and expressed as percentage of the control. Data were transferred 
into the graphic programme Softmax Pro (Molecular Devices) which calculated IC50 values.  
 
Cytotoxicity assay 
The cytotoxicity assay was performed using the Alamar Blue assay [6] described above with rat 
skeletal myoblasts (L6-cells) seeded in 100 ȝL RPMI 1640 in 96-well micro titer plates (4000 
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cells/well). After 24 h the medium was removed and replaced by 100 ȝL of fresh RPMI 1640 
with or without a serial threefold drug dilution. Podophyllotoxin (purity > 95%; Sigma-Aldrich) 
was used as the reference drug. After 70 h of incubation under a humidified 5% CO2 atmosphere, 
10 ȝL of the Alamar blue was added to all wells. The plates were incubated for an additional 2 h. 
A Spectramax Gemini XS micro plate fluorescence reader (Molecular Devices) was used to read 
the plates using an excitation wavelength of 536 nm and an emission wavelength of 588 nm. The 
IC50s were calculated from the sigmoidal growth inhibition curves using Softmax Pro software 
(Molecular Devices).
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 Fig. 7S Comparison of the computed ECD spectra for the six lowest energy conformers of (2R)-
7. The calculations were performed with TDDFT at the B3LYP/6-31G(d,p) level using the 
CPCM solvent continuum model with methanol as the solvent. 
 
 
 
Table 1S Calculated OR values for the six lowest energy conformers of (2R)-7 and the  
conformational average compared to experimental [Į]D. 
 
Conformer Population (%) [Į]D
7a 48.5 -62.26 
7b 44.4 -15.02 
7c 1.0 +188.88 
7d 2.2 +202.92 
7e 0.7 -150.10 
7f 3.1 -131.33 
Conformational average -35.99 
Experimental -56.50 
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Fig. 8S Comparison of the computed ECD spectra for the six lowest energy conformers of 
(2R,11S)-8. The calculations were performed with TDDFT at the B3LYP/6-31G(d,p) level using 
the CPCM solvent continuum model with methanol as the solvent. 
 
 
Table 2S Calculated OR values for the six lowest energy conformers of (2R, 11S)-8, and the  
conformational average compared to experimental [Į]D. 
 
Conformer Population (%) [Į]D 
8a 24.3 -118.5 
8b 21.7 -96.8 
8c 11.3 -104.1 
8d 16.5 -221.5 
8e 17.9 -255.8 
8f 8.0 -239.9 
Conformational average -164.1 
Experimental -198.1 
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 A
 
B
 
 
Fig. 9S A) Superimposed lowest energy conformers (within 2 kcal/mol range from the global 
minimum) of (2S,11S)-sahandone (8). Conformers obtained from the conformational search were 
re-calculated using DFT at the B3LYP/6-31Gככ level in the gas phase. B) Comparison of the 
computed ECD spectra for the six energy lowest conformers with a (2S,11S) configuration. The 
calculations were performed with TDDFT at the B3LYP/6-31G(d,p) level using the CPCM 
solvent continuum model with methanol as the solvent. 
© Georg Thieme Verlag KG · DOI 10.1055/s-0032-1328063 · Planta Med · Ebrahimi SN et al.
80
  
Table 3S Calculated OR values for the six lowest energy conformers of (2S,11S)-8, and the  
conformational average compared to experimental [Į]D. 
 
Conformer Population (%) [Į]D 
8a 28.3 -80.28 
8b 23.1 -71.2 
8c 13.0 -93.0 
8d 1.4 -219.00 
8e 1.2 -221.2 
8f 5.3 -78.6 
8g 2.6 -110. 8 
8h 2.9 -156.2 
8i 4.8 -62.5 
8j 4.8 -254.2 
8k 4.0 -218.0 
8l 5.3 -78.5 
8m 2.4 -75.0 
Conformational average  -97.2 
Experimental -198.1 
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3.2. Bisabololoxide derivatives from Artemisia persica, and determination of 
their absolute configurations by ECD 
 
Fahimeh Moradi-Afrapoli, Samad Nejad Ebrahimi, Martin Smiesko, Melanie Raith, Stefanie 
Zimmermann, Farsad Nadjafi, Reto Brun , Matthias Hamburger 
Phytochemistry (2012), http://dx.doi.org/10.1016/j.phytochem.2012.08.017 
 
 
 
HPLC based activity profiling enabled the identification five new bisabololoxide derivatives 
from an EtOAc extract of Artemisia persica. Structures were elucidated by mass spectrometry 
and microprobe NMR. The absolute configuration of the compounds 1-5 was determined by 
ECD supported by in silico base simulation of ECD spectra. Bisaboloids 1-4 exhibited in vitro 
antimalarial activity against Plasmodium falciparum, with IC50 values ranging from 2.8 to 20.1 
µM, and selectivity indices (SI) in L-6 cells of 3.7–11.9. 
 
Extraction of plant material for isolation, isolation of compounds (major part was done by 
Fahimeh Moradi), HPLC microfractionation, recording and interpretation of analytical data for 
structure elucidation (mass spectrometry, microprobe NMR, optical rotation, ECD), data 
analysis, experimental measurement and quantum-chemical calculation of ECD spectra, taking 
part in writing of the manuscript, and preparation of figures were my contribution to this 
publication. Antimalarial tests were done by Stefanie Zimmermann.  
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cidation was achieved by 1D and 2D NMR experiments. Relative configurations of cyclohexenone/
cyclohexene and tetrahydropyran moieties of 1–5 were established on the basis of 3JH–H coupling con-
stants and NOE difference spectra. Stereochemical correlation of the two rings, and assignment of abso-
lute configuration of 1–5 were achieved by comparison of experimental ECD spectra with simulated ECD
data for possible stereoisomers, by using time dependent density function theory (TDDFT). Bisaboloids 1–
4 exhibited in vitro antimalarial activity against Plasmodium falciparum, with IC50 values ranging from 2.8
to 20.1 lM, and selectivity indices (SI) in L-6 cells of 3.7–11.9.
 2012 Elsevier Ltd. All rights reserved.1. Introduction
The genus Artemisia belongs to the Asteraceae family and com-
prises more than 400 species. Several Artemisia species have been
used in various traditional and folk medicines as a treatment for
fever and malaria (Ortet et al., 2008; Tu, 2011). From the tradi-
tional Chinese herb Artemisia annua, artemisinin was isolated
and served as lead for today’s most effective antimalarial drugs
(Meshnick et al., 1996). In Iran, Artemisia species with the local
name of ‘‘Dermaneh’’ are distributed all over the country (Mozaff-
arian, 2007). They have been traditionally used for treatment of
intermittent fever and chills which are the main symptoms of
malaria (Biruni, 2004; Hoseyni, 1997; Mirjalili et al., 2007; Razi,
2006; Rustaiyan and Masoudi, 2011). Artemisia persica Boiss. is
an indigenous plant that grows mainly in the Zagros mountains,
south-western, southern and central parts of Iran (Ghahreman,
1978–2005).
HPLC-based activity profiling is a miniaturized and rapid ap-
proach for the localization, dereplication, and characterization of
bioactive natural products in extracts (Potterat and Hamburger,ll rights reserved.
+41 612671474.
. Hamburger).
852006), which we have successfully applied to discovery of new
anti-protozoal compounds (Adams et al., 2010, 2011, 2009; Slu-
sarczyk et al., 2011; Zimmermann et al., 2012). We here report
on the identification of new antiplasmodial sesquiterpenes by this
HPLC-based approach, and on the assignment of relative and abso-
lute stereochemistries by a combination of NMR spectroscopy and
electronic circular dichroism (ECD) measurements and calcula-
tions. In particular, on a series of bisabolol oxide esters we demon-
strate the assignment of absolute configuration by ECD calculation
for compounds in which relative stereochemistry of two discrete
parts of the molecule but not of its entirety could be established
by NMR.2. Results and discussion
In screening for new antiparasitic natural products from plants
of the Iranian flora (Farimani et al., 2011, 2012), an EtOAc extract of
A. persica tested active against the chloroquine-resistant Plasmo-
dium falciparum K1 strain (77% inhibition at a test concentration
of 0.8 lg/ml). The antiplasmodial activity was localized with the
aid of HPLC-time-based activity profiling using a previously vali-
dated protocol (Adams et al., 2009). Briefly, 350 lg of extract was
separated by analytical gradient HPLC, UV and MS data recorded
on-line, while time-based microfractions for bioassay were
144 F. Moradi-Afrapoli et al. / Phytochemistry 85 (2013) 143–152collected via a T-splitter. The HPLC-MS trace and corresponding
activity profile are shown in Fig. 1a and b, respectively. Fraction
26 (Rt 25–26 min) contained a major peak of activity. The LC-MSn
and off-line microprobe NMR data of the fraction revealed that
the active peak was composed of several compounds. Preparative
isolation of new sesquiterpene diesters 1–5 (Fig. 2) in the active
time-window was achieved by a combination of normal-phase
medium pressure liquid chromatography (MPLC) and semi-pre-
parative RP-HPLC. Structures were established by ESI-TOF-MS, 1D
and 2D NMR experiments. The relative configurations in the two
rings were established by analysis of vicinal coupling constantsFig. 1. HPLC-MS trace (ESI positive, TIC m/z 200–1500) of the EtOAc extrac
86and NOE experiments, while the absolute configuration was deter-
mined by comparison of experimental ECD data with calculated
spectra of possible stereoisomers.
Compound 1 was obtained as colorless oil. Its molecular for-
mula of C22H32O7 (HRESIMS m/z 431.2039 [M+Na]+; calcd.
431.2046) accounted for 7 of unsaturation. The 1H NMR spectrum
(500 MHz, C6D6, Table 1) showed resonances attributable to six
methyl groups, an olefinic methine (d 6.96), two deshielded diaste-
reotopic methylene protons at d 4.35 (d, Jgem = 10.3 Hz) and 3.94 (d,
Jgem = 10.3 Hz), and protons of two oxygen-bearing methines (d
4.99, 2.94). The signal at d 6.96 (qq, J = 7.0, 1.1 Hz) and two vinylict (a), and antiplasmodial activity of the one-minute microfractions (b).
Fig. 2. Structures of sesquiterpene diesters 1–5.
Table 1
1H NMR data (500 MHz) of sesquiterpene diesters 1–5.
No. 1a 2a 2b 3a 4a 5a
1 – – – 4.59 (br d, 9.8) 6.04 (br d, 10.0) 5.90 (dd, 10.5, 2.0)
2 2.94 (s) 5.77 (br s) 5.88 (br s) 5.64 (br s) 5.74 (dd, 10.0, 2.4) 5.74 (ddd, 10.5, 2.5, 1.6)
3 – – – – – –
4a 1.26 (ddd, 4.0, 13.0,
13.0)c
1.84d 2.17c 1.67 (ddd, 17.0, 12.4,
3.5)c
1.81 (ddd, 13.0, 4.0, 4.0)c 1.56 (dddd, 13.2, 4.5, 3.4,
1.6)c
4b 1.69 (ddd, 4.0, 4.0, 13.0)c 2.26 (ddd, 18.2, 4.4, 4.4)c 1.86 (dd, 17.0, 5.0, 2.2)c 1.39 (ddd, 13.0, 13.0,
4.0)c
1.77 (dddd, 13.2, 13.2,
4.5, 2.5)c
5a 1.76d 2.31d 2.44 (dddd, 13.2, 4.4, 4.4,
4.4)c
1.34 (dddd, 13.0, 3.5, 2.2,
2.2)c
1.47 (dddd, 13.0, 13.0,
11.0, 4.0)c
1.17 (dddd, 13.2, 13.2,
10.7, 3.4)c
5b 1.91 (dddd, 4.0, 13.0,
13.0, 13.0)c
1.64d 1.85 (dddd, 13.2, 11.5,
11.5, 4.4)c
1.06 (dddd, 13.0, 13.0,
12.4, 5.0)c
1.55 (dddd, 8.0, 3.0, 4.0,
4.0)c
1.65 (dddd, 13.2, 4.5, 4.5,
8.0)c
6 2.06 (dd, 6.0, 13.0)c 2.31d 2.51(dd, 4.4, 11.5)c 1.69 (ddd, 13.0, 9.0, 2.2)c 2.05 (ddd, 11.0, 8.0, 2.4)c 2.20 (dddd, 10.7, 8.0, 2.0,
1.6)c
7 – – – – – –
8a 1.90 (ddd, 4.0, 4.0, 13.5)c 1.93 (ddd, 13.6,
13.2, 4.2)c
2.10 (13.2, 13.2, 2.2)c 0.80 (ddd, 3.5, 3.5, 13.3)c 0.92d 0.89d
8b 2.00d 2.36 (ddd, 13.6, 3.5,
3.5)c
2.34 (ddd, 13.2, 4.4, 4.4)c 1.87d 1.71d 1.68d
9a 1.74d 1.74d 1.90d 1.72d 1.71d 1.71d
9b 1.84d 2.15d
10 4.99 (dd, 3.2, 3.2) 5.02 (dd, 3.0, 3.0) 5.14 (dd, 2.3, 3.7) 4.92 (dd, 3.0, 3.0) 4.99 (dd, 2.5, 2.5) 5.01 (dd, 3.0, 3.0)
11 – – – – – –
12a 3.94 (d, 10.3) 3.94 (d, 10.4) 4.07 (d, 10.5) 3.94 (d, 10.7) 4.00 (d, 10.4) 3.92 (d, 10.4)
12b 4.35 (d, 10.3) 4.34 (d, 10.4) 4.41 (d, 10.5) 4.28 (d, 10.7) 4.29 (d, 10.4) 4.38 (d, 10.4)
13 1.11 (s) 1.16 (s) 1.39 (s) 1.10 (s) 1.17 (s) 1.19 (s)
14 1.14 (s) 1.23 (s) 1.37 (s) 1.08 (s) 1.04 (s) 1.00 (s)
15 0.95 (s) 1.39 (s) 1.75 (br s) 1.61 (br s) 1.25 (br s) 1.23 (s)
10 – – – – – –
20 – – – – – –
30 6.96 (qq, 7.0, 1.1) 6.90 (qq, 7.2, 1.2) 7.04 (qq, 7.0, 1.2) 7.08 (qq, 1.2, 7.1) 7.00 (qq, 7.1, 1.1) 6.99 (qq, 7.2, 1.2)
40 1.39 (qd, 7.0, 1.1) 1.38 (dq, 7.2, 1.2) 1.64 (qd, 7.0, 1.2) 1.43 (qd, 1.2, 7.1) 1.44 (qd, 7.1, 1.1) 1.42 (qd, 7.2, 1.2)
50 1.82 (qd, 1.1, 1.1) 1.78 (br s) 1.90 (qq, 1.2, 1.2) 1.84 (br s) 1.83 (br s) 1.82 (qd, 1.2, 1.2)
100 – – – – – –
200 1.69 (s) 1.70 (s) 2.02 (s) 1.69 (s) 1.71 (s) 1.70 (s)
OH – – – 4.31 (s) – 5.00 (s)
a In C6D6.
b In pyridine-d5.
c Signals were resolved by 1D selective TOCSY experiments.
d Multiplet signals.
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formed a discrete spin system indicative of a tigloyl moiety. The
13C NMR spectrum (Table 2) showed 22 carbon signals which were
resolved through a DEPT experiment into six methyl, five methy-
lene, four methine, and seven quaternary carbons. Additional reso-
nances of a ketone carbonyl (d 206.2) and two ester carbonyls (d
167.0, 170.1) were observed, whereas six carbon signals at d 75.9
(C), 74.7 (C), 68.9 (CH), 68.7 (CH2), 63.7 (CH), and 61.8 (C) were as-
signed to oxygen bearing sp3 carbons. The protonated carbons and87their attached protons were correlated by an HSQC spectrum.
Based on the correlations observed in 1H–1H COSY and HMBC spec-
tra (Fig. 3) compound 1 was found to be a bisabololoxide deriva-
tive. HMBC correlations from Me-13 to C-11, C-12, and from Me-
14 to C-6, C-7, and C-8 confirmed the location of Me-13 at C-11
and Me-14 at C-7, respectively. Correlations between Me-15 and
C-2, C-3, C-4 indicated that the methyl group was located at C-3.
Correlations between H-6 and C-7, C-8, and C-14 confirmed the
linkage of rings A and B via the C6–C7 bond. An HMBC cross peak
Table 2
13C NMR data of compounds 1–5 (125 MHz, C6D6).
No. 1 2 3 4 5
1 206.2 (C) 198.7 (C) 68.2 (CH) 130.8 (CH) 128.5 (CH)
2 63.7 (CH) 128.7 (CH) 126.9 (CH) 135.1 (CH) 136.8 (CH)
3 61.8 (C) 159.8 (C) 134.2 (C) 66.6 (C) 68.3 (C)
4 28.8 (CH2) 31.7 (CH2) 30.8 (CH2) 37.7 (CH2) 38.9 (CH2)
5 18.0 (CH2) 23.9 (CH2) 23.4 (CH2) 20.1 (CH2) 22.6 (CH2)
6 59.4 (CH) 58.9 (CH) 52.8 (CH) 48.9 (CH) 48.7 (CH)
7 75.9 (C) 75.5 (C) 79.7 (C) 75.4 (C) 75.6 (C)
8 30.2 (CH2) 30.4 (CH2) 23.5 (CH2) 24.6 (CH2) 24.7 (CH2)
9 20.9 (CH2) 20.9 (CH2) 20.3 (CH2) 20.4 (CH2) 20.4 (CH2)
10 68.9 (CH) 69.3 (CH) 68.8 (CH) 68.6 (CH) 68.5 (CH)
11 74.7 (C) 74.9 (C) 75.2 (C) 74.1 (C) 74.4 (C)
12 68.7 (CH2) 68.9 (CH2) 68.5 (CH2) 68.4 (CH2) 68.3 (CH2)
13 24.1 (CH3) 24.2 (CH3) 23.3 (CH3) 23.5 (CH3) 23.6 (CH3)
14 22.6 (CH3) 21.7 (CH3) 25.4 (CH3) 24.5 (CH3) 24.0 (CH3)
15 21.8 (CH3) 23.6 (CH3) 23.0 (CH3) 30.2 (CH3) 28.3 (CH3)
10 167.0 (C) 167.0 (C) 166.5 (C) 166.7 (C) 166.6 (C)
20 129.5 (C) 129.7 (C) 128.9 (C) 129.2 (C) 129.6 (C)
30 137.5 (CH) 137.3 (CH) 138.0 (CH) 137.5 (CH) 137.4 (CH)
40 14.4 (CH3) 14.3 (CH3) 14.1 (CH3) 14.1 (CH3) 14.0 (CH3)
50 12.6 (CH3) 12.6 (CH3) 12.1 (CH3) 12.2 (CH3) 12.1 (CH3)
100 170.1 (C) 170.2 (C) 169.5 (C) 169.8 (C) 169.7 (C)
200 20.7 (CH3) 20.7 (CH3) 20.2 (CH3) 20.4 (CH3) 20.4 (CH3)
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170.1 (C-100) corroborated the presence of an acetoxy moiety which
was attached at C-12 (HMBC correlation of C-100 (d 170.1) with H-
12a and H-12b (d 3.94 and 4.35, respectively)). The tigloyl moiety
was attached to C-10, as indicated by a cross peak between H-10 (d
4.99) and the carbonyl group at d 167.0. Hence, compound 1 was
found to be a sesquiterpene diester. In the 1H NMR spectrum, over-
lapping signals in the range of d 1.5–2.0 were deconvoluted withFig. 3. 1D-TOCSY and key HMBC correlations observed for 1 (a), and key NOE correlatio
(left), and 2S,3S,6S,7S,10S,11S (right) (b).
88the aid of 1D selective TOCSY experiments. Excitation of H-6 led
to detection of H-4a, H-4b, H-5a, and H-5b in ring A, while excita-
tion of H-10 revealed that H-9, H-8a, and H-8b formed a spin sys-
tem in ring B (Supporting information).
The relative configurations of the cyclohexanone and tetrahy-
dropyran portions of 1 were derived from vicinal coupling con-
stants and by NOE difference measurements (Fig. 3). H-4a/H-5b
and H-5b/H-6 (3JH–H = 13.0 Hz) had both trans-diaxial orientations,
with dihedral angles of ca. 180. In a NOE difference experiment,
presaturation of the H-6 resonance led to enhancement of H-2
and H-4a. Therefore, ring A adopted an envelope conformation
with H-4a, H-5b, and H-6 in axial positions, corresponding to
two possible absolute configurations of ring A (2R,3R,6R or
2S,3S,6S). The vicinal coupling constants between H-9a/H-10 and
H-9b/H-10 (both 3JH–H = 3.2 Hz) corresponded to dihedral angles
of ca. 60. Hence, H-10 had to be in an equatorial position. Presat-
uration of H-10 in an NOE difference experiment resulted in
enhancement of Me-13 and Me-14, while irradiation of Me-13
led to enhancement of H-9. Thus, Me-13 and Me-14 were both lo-
cated in the axial position and in a cofacial orientation with H-10.
Consequently, ring B had a chair conformation with two possible
configurations (7S,10S,11S or 7R,10R,11R). Since rings A and B were
linked through a rotatable C6–C7 bond, relative stereochemical
correlation of the cyclohexanone and the tetrahydropyran portions
of the molecule was not possible through NOE data. Hence, four
stereoisomers were conceivable at that point, namely
2R,3R,6R,7S,10S,11S, 2S,3S,6S,7S,10S,11S, 2R,3R,6R,7R,10R,11R or
2S,3S,6S,7R,10R,11R. The absolute configuration of 1 was finally
established by measurement of the ECD spectra and comparison
with calculated ECD data calculated using time dependent density
function theory (TDDFT) method. For that purpose, we selected
two stereoisomers, 2R,3R,6R,7S,10S,11S and 2S,3S,6S,7S,10S,11S,ns of DFT-optimized conformer of two possible stereoisomers, 2R,3R,6R,7S,10S,11S
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mirror images of the ECD spectra. Conformational analysis of the
two stereoisomers revealed five and six conformers, respectively,
within a 1 kcal/mol energy window from the particular global min-
imum. These conformers were subjected to geometrical optimiza-
tion and energy calculation using density function theory (DFT)
with the Becke’s nonlocal three parameter exchange and correla-
tion functional, and the Lee–Yang–Parr correlation functional level
(B3LYP) using the 6-31G⁄⁄ basis set in the gas-phase. Vibrational
frequency calculations were carried out to confirm these minima.
No imaginary frequencies were found. Conformational analysis
using relative free energies indicated the presence of five and six
stable conformers, respectively (Fig. 4, Fig. S17).
ECD spectra of the conformers were calculated by the TDDFT
(time-dependent density functional theory) method at B3LYP/6-
31G⁄⁄ with MeOH as the solvent, using the SCRF (Self-consistent
reaction field) method with the CPCM (Conductor-like polarizable
continuum) model. For the 2R,3R,6R,7S,10S,11S stereoisomer, the
ECD spectrum resulting from Boltzmann weighting of ECD spectra
for individual conformers (Fig. 5a) showed two positive cotton ef-
fects (CE) around 220 and 320 nm. There was excellent agreement
of the overall patterns of the calculated and experimental ECD
spectra. The positive CE at around 320 nm was likely due to an
n? p⁄ transition of the ketone group. The calculated ECD spec-
trum of the 2S,3S,6S,7S,10S,11S stereoisomer (Fig. 5a) was dis-
tinctly different from the experimental data, with two negative
and one positive CEs at 210, 320, and 225 nm, respectively. Hence,
the 2R,3R,6R,7S,10S,11S configuration of 1 was confirmed, and all
other three possible stereoisomers could be ruled out.
Compound 2 was obtained as colorless oil. The molecular for-
mula of C22H32O6 was deduced from HRESIMS (m/z 415.2090
[M+Na]+, calcd. 415.2097). Based on 1D- and 2D-NMR data (Tables
1 and 2) and comparison with 1, compound 2 was also found to
be a bisabololoxide derivative. Notable differences were only found
in the signals attributable to ring A. In the 13C NMR spectrum, the
olefinic carbons C-2 and C-3 were observed at d 128.7 and 159.8,
respectively, indicative of a replacement of the C-2, C-3 epoxy moi-
ety by a double bond. The carbonyl carbon (C-1)was shifted to high-
er field (d 198.7) due to conjugation with the C-2, C-3 double bond.
In the 1HNMR spectrum, the vinylic protonH-2 appeared downfield
at d 5.77. The H-6 signal overlappedwith that of H-5a (d 2.31). Mea-
surement in pyridine-d5 resolved the overlap (Table 1). Vicinal cou-
pling constants derived from 1H NMR and selective TOCSY spectra,
and NOE difference measurements in pyridine-d5 were used to de-
fine the relative configurations of rings A and B, respectively
(Fig. 6a). Vicinal coupling constants of H-5b/H-6 (J = 11.5 Hz) and
H-5a/H-6 (J = 4.4 Hz) corresponded to dihedral angles of ca. 150
and 40, respectively. Hence, H-6 was in an axial orientation. Ring
A contained only one stereocenter (6R or 6S). The vicinal coupling
constants of H-9a/H-10 (J = 2.3 Hz) and H-9b/H-10 (J = 3.7 Hz)
corresponded to dihedral angles of 60–70 and indicated thatFig. 4. Low energy conformers of the 2R,3R,6R,7S,10S,11S (left; five conformers within a
(right; six conformers) of 1. The calculations were performed in the gas phase with DFT
89H-10 was equatorial. Key NOEs observed for ring B (Fig. 6b) were
similar to those of 1. Hence, four stereoisomers (6R,7R,10R,11R,
6R,7S,10S,11S, 6S,7R,10R,11R or 6S,7S,10S,11S) were possible for 2.
A conformational search for the 6R,7S,10S,11S stereoisomer yielded
five conformers within 1 kcal/mol from the global minimum.
The conformers were subjected to geometrical optimization
(DFT/B3LYP/6-31G⁄⁄) in gas phase followed by analysis of vibra-
tional modes. The superimposed conformers showed differences
arising from rotation around the C-6/C-7 bond, and from orienta-
tion of ester moieties (Fig. 7, Fig. S19). The ECD spectra of conform-
ers were calculated (TDDFT/B3LYP/6-31G⁄⁄) with MeOH as the
solvent (SCRF/CPCM). The average spectrum resulting from Boltz-
mann weighting of ECD spectra for individual conformers showed
a positive CE at 230 nm along with a negative CE at 215 nm. On the
other hand, the simulated ECD spectrum of the 6S,7S,10S,11S ste-
reoisomer showed a negative CE at 230 nm and two positive CEs
at 243 and 215 nm. The experimental ECD spectrum of 2 showed
a positive CE at 236 nm along with a negative CE at 213 nm. The
positive CE at around 240 nm was likely due to a p? p⁄ transition
of a,b-unsaturated carbonyl group. Comparison of the experimen-
tal ECD spectrum revealed an excellent fit with the data calculated
for the 6R,7S,10S,11S stereoisomer (Fig. 5b), and we thus concluded
that the absolute configuration of compound 2 was 6R,7S,10S,11S.
Compound 3 was obtained as colorless oil. The molecular for-
mula of C22H34O6 was deduced from HRESIMS (m/z 417.2285
[M+Na]+, calcd. 417.2253). 1D and 2D NMR data of compound 3
(Table 1) were in part similar to those of 1 and 2, indicating a ses-
quiterpene diester structure with an identical ring B. Notable dif-
ferences were found with resonances attributable to ring A. In
the 13C NMR spectrum, the signals of C-1 and C-3 appeared at d
68.2 and 134.2, respectively, and C-6 was located at d 52.8 due to
an allylic alcohol instead of the carbonyl group at C-1. In the 1H
NMR spectrum an additional signal was observed at d 4.59 (H-1,
br d, 9.8 Hz). Overlapping signals in the range of 1–2 ppm were re-
solved by 1D selective TOCSY experiments into discrete spin sys-
tems and supported the proposed structure of 3. H-2 appeared as
a broad singlet, indicative of a dihedral angle (aH1,C1,C2,H2) of 70–
80 and, hence, of a pseudo-axial orientation of H-1. The vicinal
coupling of H-1/H-6 (J = 9.8 Hz) and H-5b/H-6 (J = 13.0 Hz) corre-
sponded to dihedral angles of approx. 140 and 150–160, respec-
tively. Hence, H-6 was in an axial orientation. Close inspection of
the splitting pattern of all protons on ring A indicated a pseudo-
chair conformation. Given the conformational flexibility of ring A,
there was some uncertainty regarding its relative configuration.
Therefore, we performed a conformational analysis of 3 with three
of the four possible configurations (1S,6S, 1S,6R, 1R,6S, 1R,6R) for
ring A, whereby the absolute configuration of ring B was identical
with that in 1 and 2 (7S,10S,11S).
The ECD spectrum of 3 in MeOH showed a negative CE around
205 nm and two positive CEs at 221 and 232 (shoulder) nm. The
negative CE at 205 nm was likely due to a p? p⁄ transition of1 kcal/mol range from the global minimum) and 2S,3S,6S,7S,10S,11S stereoisomers
at the B3LYP/6-31G⁄⁄ level.
Fig. 5. Comparison of experimental spectra with those calculated for relevant stereoisomers of 1–5. The calculations were performed with TDDFT at the B3LYP/6-31G⁄⁄ level
with MeOH as the solvent.
Fig. 6. (a)1D-TOCSY and key HMBC correlations; (b) key NOE correlations of the DFT-optimized structure of the most stable conformer of 2 (6R,7S,10S,11S stereoisomer).
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sulted from the p? p⁄ transition of the ester moiety in ring B.
The ECD spectra for three stereoisomers (1S,6S,7S,10S,11S,
1S,6R,7S,10S,11S, and 1R,6R,7S,10S,11S) were calculated with
TDDFT at the B3LYP/6-31G⁄⁄ level and MeOH as solvent. The sim-
ulated ECD spectrum of the 1S,6S,7S,10S,11S stereoisomer showed
a negative CE at 205 nm and two positive CEs at 220 and 230
(shoulder) and, thus, was in excellent agreement with the experi-
mental data. The ECD spectrum of the 1R,6R stereoisomer was dis-
tinctly different, with a negative CE at 220 nm and a positive CE
around 250 nm. The 1S,6R stereoisomer exhibited a negative CE
around 205 and a positive CE at 220. In addition, conformational
analysis of the 1S,6R,7S,10S,11S configuration revaled that H-190would be in an equatorial orientation in the stable conformers.
This, in turn, would result in dihedral angles and coupling con-
stants (aH1,C1,C2,H2) of 40, 3JH1–H2 8 Hz) differing from those ob-
served in NMR data of compound 3. On the basis of these
observations we concluded that the absolute configuration of 3
was 1S,6S,7S,10S,11S.
Compounds 4 and 5 had the same molecular formula C22H32O6
(based on HRESIMS data) and very similar NMR spectroscopic data
(Tables 1 and 2). Ring B in 4 and 5 was identical with compounds
1–3. In compound 4, a double bond was located between C-1 (d
130.8) and C-2 (d 135.1) of ring A, and C-3 (d 66.6) was substituted
by a hydroxyl and a methyl moiety (d 1.25). Vicinal coupling
constants of H-1/H-6 (<2.0 Hz) and H-5a/H-6 (11.0 Hz) were
Fig. 7. Superimposed lowest energy conformers (within 1 kcal/mol range from the global minimum) of 2–5. Conformers obtained from the conformational search were re-
calculated using DFT at the B3LYP/6-31G⁄⁄ level in the gas phase. Compound 2 (6R,7S,10S,11S) showed two core conformers which differed in the orientation of ring A, 3
(1S,6S,7S,10S,11S) showed six conformers, and epimers 4 (3R,6S,7S,10S,11S) and 5 (3S,6S,7S,10S,11S) showed five and five conformers, respectively.
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a pseudo-axial orientation of H-6. H-4b/H-5a showed a vicinal
coupling constant of 13 Hz and thus were in a trans-diaxial rela-
tionship. In a 1D NOE difference experiment, presaturation of H-
6 resulted in enhancement of H-4b and H-5b, while irradiation of
Me-15 enhanced H-4a and H-4b (Fig. 8). Hence, Me-15 was in a
pseudo-equatorial orientation, and ring A adopted a pseudo-chair
conformation with two probable configurations (3R,6S or 3S,6R).
In compound 5, the splitting pattern of the protons on ring A indi-
cated a pseudo-chair conformation with H-4b and H-5a in axial,
and H-6 in pseudo-axial orientation as in 4 (Table 1). Small differ-
ences in 1H NMR shifts were observed for ring A, in particular for
H-4a (d 1.81 in 4, d 1.56 in 5), H-4b (d 1.39 in 4, d 1.77 in 5) and
H-5a (d 1.47 in 4, d 1.17 in 5). 13C NMR chemical shifts of C-1, 2,
3, 4, 5, and Me-15 in 4 and 5were comparable (Table 2). A diagnos-
tic difference was detected by NOE difference experiments. In 5,Fig. 8. Key NOE correlations of DFT-optimized of the
91presaturation of Me-15 led to an enhancement of H-4a but not
H-4b (Fig. 8). Thus, Me-15 had to be in a pseudo-axial position.
Ring A of 5 adopted a pseudo-chair conformation, with two possi-
ble configurations (3R,6R or 3S,6S). Hence, 4 and 5 were epimers.
The experimental ECD spectra of 4 showed positive CEs at 202
and 243 nm, and a negative CE at 210 nm, while 5 showed negative
CEs at 202 and 210 nm, and a positive CE at 243 nm. Calculated
ECD spectra for the 3R,6S,6R,7S,10S,11S and 3S,6S,7S,10S,11S ster-
eoisomers showed excellent fit with the experimental data of 4
and 5, respectively (Fig. 5), whereas the calculated ECD spectrum
of the 3R,6R,7S,10S,11S and 3S,6R,7S,10S,11S stereoisomers were
distinctly different (data not shown). Consequently, 4 and 5 were
confirmed to be 3R and 3S epimers, respectively.
Antiplasmodial activity of 1–5 and cytotoxicity in murine L6
cells were assessed, and selectivity indices (SI) were calculated as
an indicator of differential toxicity towards the parasite (Table 3).most stable conformers of 4 (left) and 5 (right).
Table 3
Antiplasmodial and cytotoxic activities (IC50 valuesa) of Compounds 1–5.
Compound P. falciparum L-6 cells SI
1 2.8 ± 0.4 10.4 ± 1.0 3.7
2 14.9 ± 1.7 90.9 ± 8.5 6.1
3 20.1 ± 0.7 88.4 ± 7.4 4.4
4 19.1 ± 2.2 >227.3 11.9
5 NAb – –
Artesunate 0.002
Podophyllotoxin 0.021
a Values are expressed in lM. Each value corresponds to the mean ± standard
error of the mean from at least three independent bioassays.
b Not active at >20 lM, SI = Selectivity index (IC50 in L6 cells (cytotoxicity) divi-
ded by IC50 against P. falciparum).
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moderate selectivity (IC50 2.8 lM; SI 3.7). Compounds 2, 3, and 4
showed moderate inhibition, with IC50 values ranging from 14.9
to 20.1 lM, and SI values between 6 and 12. Compound 5 was
not active at the concentrations tested.3. Conclusions
Bisabololoxides are a rather rare type of sesquiterpenoids. Their
occurrence appears limited to some sections of the family Astera-
ceae. Bisaboloxide A is one of the main constituents in the essential
oil of German chamomile (Matricaria recutita) (Ogata et al., 2010;
Salamon et al., 2010). In the genus Artemisia, derivatives of bisab-
ololoxide A have only been reported from Artemisia abrotanum
and Artemisia lucentica (Artemisia hispanica). (Cubukcu et al.,
1990), (Marco et al., 1997; Mericli et al., 1988; Sanz et al., 1989).
However, these compounds were monoesters bearing an acetyl
group at C-10. Compounds 1–5 bear an additional ester moiety
at C-12 and, hence, an additional stereocenter in ring A. Relative
stereochemistry and absolute configuration of simple bisaboloids
have been established in part, and this was achieved either by syn-
thesis from known compounds and comparison of optical rotation
values, or with the aid of NMR shifts reagents (Delay and Ohloff,
1979; Flaskamp et al., 1981a,b).
We here performed the first ECD analysis of bisaboloids. We
confirmed that the absolute configurations at C-7 and C-10 in 1–
5 were identical with those of bisabolol oxide (Franke and Schil-
cher, 2005). Most important though, we demonstrated that the
absolute configuration could be established with the aid of ECD
calculation in cases where relative stereochemical correlation of
two portions of a molecule was not known. In the case of com-
pounds 1–5, calculated lowest energy conformers of the possible
stereoisomers were sufficiently different to result in distinctly dif-
ferent ECD spectra after Boltzmann weighting. Comparison of ECD
curves obtained for individual conformers of a compound showed
that even subtle conformational differences may lead to substan-
tial changes of the chiroptical properties (see Supporting informa-
tion). Consequently, the quality of predicted ECD data critically
depends on a careful conformational analysis. There are extremely
few cases where calculation of ECD spectra established the abso-
lute configuration of molecules with unknown relative stereo-
chemical correlation of flexibly linked molecular portions. To our
knowledge, this approach was successfully used for the simple ses-
quiterpenoid cycloabisequine A (Yang et al., 2009), whereas in
microdiplodiasone some degree of uncertainty remained about
the absolute configuration of one of the stereocenters (Siddiqui
et al., 2011). It was not successful in cases such as the aflaquinol-
ones where the ECD-relevant stereocenters in the two molecular
portions were too remote from each other to produce distinguish-
able ECD spectra of stereoisomers (Neff et al., 2012). Given that
numerous natural products possess flexibly linked moieties with92stereocenters, the ECD approach described here for this series of
bisaboloxides may be more widely applicable in natural products
chemistry.4. Experimental section
4.1. General experimental procedures
Optical rotations were measured using a JASCO P-2000 auto-
matic digital polarimeter. NMR spectra were recorded at target
temperature 18 C on a Bruker Avance III 500 MHz spectrometer
operating at 500.13 MHz for 1H, and 125.77 MHz for 13C. A 1 mm
TXI-microprobe with a z-gradient was used for 1H-detected exper-
iments; 13C NMR spectra were recorded with a 5 mm BBO-probe
head with z-gradient. Spectra were analyzed using Bruker TopSpin
2.1 software. HRESIMS spectra in positive and negative ion modes
were recorded on a Bruker microTOF ESI-MS system with a scan
range of m/z 200–1500. ECD spectra were recorded in MeOH
(400 lg/ml) on an AVIV CD spectrometer model 62ADS and ana-
lyzed with the AVIV 60DS V4.1 software. HPLC separations were
performed on an Agilent 1100 series HPLC system consisting of a
quaternary low-pressure mixing pump with degasser module, col-
umn oven, PDA detector, and an autosampler. For medium-pres-
sure liquid chromatography (MPLC) a Buchi Sepacore system
consisting of a control unit C-620, a fraction collector C-660, and
two pump modules C-605 was used. The MPLC unit was controlled
with the Sepacore Control software (version 1.0.3000.1). Waters
SunFire C18 (3.5 lm, 3.0  150 mm) and SunFire Prep C18
(5 lm, 10  150 mm) columns were used for analytical HPLC and
semipreparative RP-HPLC, respectively. HPLC solvents contained
0.1% HCO2H for analytical separations. NP-Column chromatogra-
phy was carried out on silica gel (70–230 and 230–400 mesh;
Merck). Pre-coated silica gel 60 F254 plates (Merck) were used for
TLC. Detection was at 254 and 366 nm (CAMAG), or by spraying
with anisaldehyde sulfuric acid reagent and subsequent heating
(120 C for 5 min). C6D6 (100 Atom% D) and pyridine-d5 (100
Atom%) for NMR was purchased from Armar Chemicals. Solvents
used for extraction, open column chromatography, and MPLC were
of technical grade and purified by distillation.
4.2. Plant material
The aerial parts of Artemisia persica Boiss. (110 g) were collected
from Botanical Garden of Ferdowsi University of Mashhad, Iran.
The plant material was identified by Mr. M. R. Joharchi, Research
Center for Plant Sciences Ferdowsi University of Mashhad, Mash-
had, Iran. A voucher specimen (44518) has been deposited at the
Herbarium of the Research Center for Plant Sciences Ferdowsi Uni-
versity of Mashhad.
4.3. Microfractionation for activity profiling
Aliquots of 350 lg of EtOAc extract (35 ll of 10 mg/ml soln. in
DMSO) were separated on a SunFire C18 column (5 lm,
10  150 mm; Waters) with 0.1% formic acid in water (solvent A)
and acetonitrile (solvent B) using the following gradient: 10% B
to 100% B in 30 minutes, hold for 10 min. The flow rate was
0.4 ml/min. Thirty-two one-minute fractions were collected in
96-well deep well plates. The plates were dried in a GeneVac EZ-
2 Plus evaporator and submitted to bioassay.
4.4. Extraction and isolation procedures
The grounded plant material (100 g) was successively perco-
lated with n-hexane, EtOAc and MeOH. The EtOAc extract (2.3 g)
F. Moradi-Afrapoli et al. / Phytochemistry 85 (2013) 143–152 151was separated by NP-MPLC on silica gel (24  5 cm i.d., 230–400
mesh) using a linear gradient n-hexane-EtOAc 100:0? 0:100 in
6 h, followed by EtOAc–MeOH 100:0? 0:100) in 5 h. Flow rate
was 5 ml/min. Eleven fractions (F1–F11) were combined on the ba-
sis of TLC patterns. Fractions were also monitored by HPLC-PDA-
ESIMS analysis and compared with the activity and LC-MS profiles
in order to localize the bioactive compounds. They were found in F5
and F7. F5 (32.0 mg) was subjected to semi-preparative RP-HPLC
using gradient of H2O–MeCN (80:20 to 0:100%) as mobile phase.
Flow rate was 4 ml/min, and detection at 254 and 210 nm). Com-
pounds 1 (tR = 25, 2.0 mg) and 2 (tR = 26, 1.5 mg) were obtained.
The single peak (tR = 45) in the active time window of F7
(65.0 mg) was obtained by semi-preparative RP-HPLC (H2O–MeOH,
70:30 to 0:100%, flow rate 4 ml/min, detection at 254 and 210 nm)
as subfraction F7–1 (15 mg). F7–1 was separated on a silica gel col-
umn (20  1 cm, 0.040  0.063 lm) with n-hexane-EtOAc (7:3)
into compounds 3 (7.4 mg), 4 (1.8 mg) and 5 (1.0 mg).4.5. Conformational analysis, geometrical optimization, and ECD
calculation
Conformational analysis of compounds 1–5 was performed
with Schrödinger MacroModel 9.1 software (Schrödinger, LLC,
New York) using the OPLS 2005 (Optimized Potential for Liquid
Simulations) force field in H2O. Conformers occurring within
1 kcal/mol energy window from the particular global minimum,
were chosen for the gas-phase geometrical optimization and en-
ergy calculation using the density function theory (DFT) with the
B3LYP functional and the 6-31G⁄⁄ basis-set as implemented in
the gas-phase with the Gaussian 03 program package (Frisch
et al., 2004). Vibrational analysis was formed at the same level to
confirm stability of minima. Time dependent density function the-
ory TD-DFT/B3LYP/6-31G⁄⁄ in the gas phase and in MeOH using the
‘‘self-consistent reaction field’’ method (SCRF) with the conductor-
like polarizable calculation model (CPCM) was employed to calcu-
late excitation energy (denoted by wavelength in nm) and rotatory
strength R in dipole velocity (Rvel) and dipole length (Rlen) forms.
ECD curves were calculated based on rotatory strengths using half
bandwidth of 0.2 eV with conformers of 1–5. The spectra were con-
structed based on the Boltzmann-weighting according to their
population contribution.4.6. Spectral data
4.6.1. Compound (1)
Colorless oil, ½a24D  + 62.5 (c 0.8, MeOH); CD (MeOH, c = 1.0 mM,
0.1 cm): [h]214 = +12555, [h]310 = +9810; UV (kmax 213 nm); 1H
NMR (C6D6, 500 MHz) and 13C NMR (C6D6,125 MHz) see Tables 2
and 3, respectively; HRESIMS m/z 431.2039 [M+Na]+, calcd. for
C22H32O7, 431.2046.4.6.2. Compound (2)
Colorless oil, ½a24D  + 34.3 (c 3.9, MeOH); CD (MeOH, c = 1.0 mM,
0.1 cm): [h]213 = 19415, [h]236 = +30820; UV (kmax 213 nm); 1H
NMR (C6D6, 500 MHz) and 13C NMR (C6D6,125 MHz) see Tables 2
and 3, respectively; HRESIMS m/z 415.2090 [M+Na]+, calcd. for
C22H32O6, 415.2097.4.6.3. Compound (3)
Colorless oil, ½a24D  + 25.3 (c 10.0, MeOH); CD (MeOH, c = 1.0 mM,
0.1 cm): [h]205 = 2483, [h]221 = +5685, [h]232 = +2222; UV (kmax
213 nm); 1H NMR (C6D6, 500 MHz) and 13C NMR (C6D6,125 MHz)
see Tables 2 and 3, respectively; HRESIMS m/z 417.2285 [M+Na]+,
calcd. for C22H34O6, 417.2253.934.6.4. Compound (4)
Colorless oil, ½a24D   9.0 (c 5.6, MeOH); CD (MeOH, c = 1.0 mM,
0.1 cm): [h]202 = +4764, [h]210 = 8743, [h]243 = + 911; UV (kmax
213 nm); 1H NMR (C6D6, 500 MHz) and 13C NMR (C6D6,125 MHz)
see Tables 2 and 3, respectively; HRESIMS m/z 417.2281 [M+Na]+,
calcd. for C22H34O6, 417.2253.
4.6.5. Compound (5)
Colorless oil, ½a24D   29.7 (c 3.7, MeOH); CD (MeOH, c = 1.0 mM,
0.1 cm): [h]202 = 13575, [h]210 = 5101, [h]243 = + 1517; UV (kmax
213 nm); 1H NMR (C6D6, 500 MHz) and 13C NMR (C6D6,125 MHz)
see Tables 2 and 3, respectively; HRESIMS m/z 417.2277 [M+Na]+,
calcd. for C22H34O6, 417.2253.
4.7. Biological assays
4.7.1. Antiplasmodial assay
Antiplasmodial activity of extracts and pure compounds were
determined against P. falciparum strain K1 (resistant to chloro-
quine and pyrimethamine), using a modified [3H]-hypoxanthine
incorporation assay as previously described. Artesunate served as
a positive control. Assays were run in three independent experi-
ments in duplicates. IC50 values were calculated from sigmoidal
growth inhibition curves (Adams et al., 2009).
4.7.2. Cytotoxicity assay
Cytotoxicity was determined using rat skeletal myoblast L6
cells. Pure substances were tested as previously described, and
podophyllotoxin was used as a positive control. Tests were run in
three independent experiments in duplicates. IC50 values were cal-
culated from sigmoidal growth inhibition curves (Adams et al.,
2009).
Acknowledgements
F. M. A. is grateful for a research fellowship from Ministry of
Health and Medical Education of Iran. S. N. E. thanks the Ministry
of Science, Research, and Technology of Iran (MSRT) for a Ph.D. fel-
lowship (No. 24/87100055). Support from the Swiss National Sci-
ence Foundation through Grant 205320_126888/1 (to M.H.) is
gratefully acknowledged. We thank Ms. T. Schulthess for technical
assistance with measurement of UV and CD spectra.Appendix A. Supplementary data
Supplementary data associated with this article can be found, in
the online version, at http://dx.doi.org/10.1016/j.phytochem.2012.
08.017.
References
Adams, M., Christen, M., Plitzko, I., Zimmermann, S., Brun, R., Kaiser, M., Hamburger,
M., 2010. Antiplasmodial lanostanes from the Ganoderma lucidum mushroom. J.
Nat. Prod. 73, 897–900.
Adams, M., Gschwind, S., Zimmermann, S., Kaiser, M., Hamburger, M., 2011.
Renaissance remedies: antiplasmodial protostane triterpenoids from Alisma
plantago-aquatica L. (Alismataceae). J. Ethnopharmacol. 135, 43–47.
Adams, M., Zimmermann, S., Kaiser, M., Brun, R., Hamburger, M., 2009. Protocol for
HPLC-based activity profiling for natural products with activities against
tropical parasites. Nat. Prod. Commun. 4, 1377–1381.
Biruni, M., 2004. Kitab al-saydana. Iranian Academy of Persian Language and
Literature, Tehran.
Cubukcu, B., Bray, D.H., Warhurst, D.C., Mericli, A.H., Ozhatay, N., Sariyar, G., 1990.
In vitro antimalarial activity of crude extracts and compounds from Artemisia
abrotanum L. Phytother. Res. 4, 203–204.
Delay, F., Ohloff, G., 1979. Syntheses and absolute-configuration of (E)-alpha-
bisabolenes and (Z)-alpha-bisabolenes. Helv. Chim. Acta 62, 369–377.
Farimani, M.M., Bahadori, M.B., Taheri, S., Ebrahimi, S.N., Zimmermann, S., Brun, R.,
Amin, G., Hamburger, M., 2011. Triterpenoids with rare carbon skeletons from
152 F. Moradi-Afrapoli et al. / Phytochemistry 85 (2013) 143–152Salvia hydrangea: antiprotozoal activity and absolute configurations. J. Nat.
Prod. 74, 2200–2205.
Farimani, M.M., Taheri, S., Ebrahimi, S.N., Bahadori, M.B., Khavasi, H.R.,
Zimmermann, S., Brun, R., Hamburger, M., 2012. Hydrangenone, a new
isoprenoid with an unprecedented skeleton from Salvia hydrangea. Org. Lett.
14, 166–169.
Flaskamp, E., Nonnenmacher, G., Isaac, O., 1981a. On the diastereoisomerism of
natural and synthetic alpha-bisabolols. Z. Naturforsch. B 36, 114–118.
Flaskamp, E., Nonnenmacher, G., Zimmermann, G., Isaac, O., 1981b. On the
stereochemistry of the bisaboloids from Matricaria chamomilla L. Z.
Naturforsch. B 36, 1023–1030.
Franke, R., Schilcher, H., 2005. Chamomile: Industrial Profiles. Taylor & Francis, Boca
Raton.
Frisch, M.J., Trucks, H.B., Schlegel, H.B., Scuseria, G.E., Robb, M.A., Cheeseman, J.R.,
Montgomery Jr., J.A., Vreven, T., Kudin, K.N., Burant, J.C., Millam, J.M., Iyengar,
S.S., Tomasi, J., Barone, V., Mennucci, B., Cossi, M., Scalmani, G., Rega, N.,
Petersson, G.A., Nakatsuji, H., Hada, M., Ehara, M., Toyota, K., Fukuda, R.,
Hasegawa, J., Ishida, M., Nakajima, T., Honda, Y., Kitao, O., Nakai, H., Klene, M., Li,
X., Knox, J.E., Hratchian, H.P., Cross, J.B., Bakken, V., Adamo, C., Jaramillo, J.,
Gomperts, R., Stratmann, R.E., Yazyev, O., Austin, A.J., Cammi, R., Pomelli, C.,
Ochterski, J.W., Ayala, P.Y., Morokuma, K., Voth, G.A., Salvador, P., Dannenberg,
J.J., Zakrzewski, V.G., Dapprich, S., Daniels, A.D., Strain, M.C., Farkas, O., Malick,
D.K., Rabuck, A. D., Raghavachari, K., Foresman, J.B., Ortiz, J.V., Cui, Q., Baboul,
A.G., Clifford, S., Cioslowski, J., Stefanov, B.B., Liu, G., Liashenko, A., Piskorz, P.,
Komaromi, I., Martin, R.L., Fox, D.J., Keith, T., Al-Laham, M.A., Peng, C.Y.,
Nanayakkara, A., Challacombe, M., Gill, P.M.W., Johnson, B., Chen, W., Wong,
M.W., Gonzalez, C., Pople, J.A., 2004. Gaussian 03, Revision E.01. Gaussian, Inc.,
Wallingford CT.
Ghahreman, A., 1978–2005. Flora of Iran. Research Institute of Forests and
Rangelands, Tehran.
Hoseyni, M.M., 1997. Tohfe-ye-hakim moemen. Ketabforoushi-e-Mahmoodi,
Tehran.
Marco, J.A., SanzCervera, J.F., GarciaLliso, V., Batlle, N., 1997. Sesquiterpene lactones
from Artemisia lucentica. Phytochemistry 45, 755–763.
Mericli, A.H., Cubukcu, B., Jakupovic, J., Ozhatay, N., 1988. Alpha-bisabololoxide
derivatives from Artemisia abrotanum. Planta Med., 463–464.
Meshnick, S.R., Taylor, T.E., Kamchonwongpaisan, S., 1996. Artemisinin and the
antimalarial endoperoxides: from herbal remedy to targeted chemotherapy.
Microbiol. Rev. 60, 301–315.94Mirjalili, M.H., Tabatabaei, S.M.F., Hadian, J., Ebrahimi, S.N., Sonboli, A., 2007.
Phenological variation of the essential oil of Artemisia scoparia Waldst. et Kit
from Iran. J. Essent. Oil Res. 19, 326–329.
Mozaffarian, V., 2007. A Dictionary of Iranian Plant Names. Farhang Moaser, Tehran.
Neff, S.A., Lee, S.U., Asami, Y., Ahn, J.S., Oh, H., Baltrusaitis, J., Gloer, J.B., Wicklow,
D.T., 2012. Aflaquinolones A–G: secondary metabolites from marine and
fungicolous isolates of Aspergillus spp.. J. Nat. Prod. 75, 464–472.
Ogata, I., Kawanai, T., Hashimoto, E., Nishimura, Y., Oyama, Y., Seo, H., 2010.
Bisabololoxide A, one of the main constituents in German chamomile extract,
induces apoptosis in rat thymocytes. Arch. Toxicol. 84, 45–52.
Ortet, R., Prado, S., Mouray, E., Thomas, O.P., 2008. Sesquiterpene lactones from the
endemic cape verdean Artemisia gorgonum. Phytochemistry 69, 2961–2965.
Potterat, O., Hamburger, M., 2006. Natural products in drug discovery – concepts
and approaches for tracking bioactivity. Curr. Org. Chem. 10, 899–920.
Razi, M.Z., 2006. Al-Havi. Academy of Medical Sciences of Iran, Tehran.
Rustaiyan, A., Masoudi, S., 2011. Chemical constituents and biological activities of
Iranian Artemisia species. Phytochem. Lett. 4, 440–447.
Salamon, I., Ghanavati, M., Abrahimpour, F., 2010. Potential of medicinal plant
production in Iran and variability of chamomile (Matricaria recutita L.) essential
oil quality. J. Essent. Oil Bearing Plants 13, 638–643.
Sanz, J.F., Barbera, O., Marco, J.A., 1989. Sesquiterpene lactones from Artemisia
hispanica. Phytochemistry 28, 2163–2167.
Siddiqui, I.N., Zahoor, A., Hussain, H., Ahmed, I., Ahmad, V.U., Padula, D., Draeger, S.,
Schulz, B., Meier, K., Steinert, M., Kurtan, T., Florke, U., Pescitelli, G., Krohn, K.,
2011. Diversonol and blennolide derivatives from the endophytic fungus
Microdiplodia sp.: absolute configuration of diversonol. J. Nat. Prod. 74, 365–
373.
Slusarczyk, S., Zimmermann, S., Kaiser, M., Matkowski, A., Hamburger, M., Adams,
M., 2011. Antiplasmodial and antitrypanosomal activity of tanshinone-type
diterpenoids from Salvia miltiorrhiza. Planta Med. 77, 1594–1596.
Tu, Y.Y., 2011. The discovery of artemisinin (qinghaosu) and gifts from Chinese
medicine. Nat. Med. 17, 1217–1220.
Yang, X.W., Ding, Y., Li, X.C., Ferreira, D., Shen, Y.H., Li, S.M., Wang, N., Zhang, W.D.,
2009. Cycloabiesesquine A, a unique sesquiterpenoid from Abies delavayi. Chem.
Commun. (Camb), 3771–3773.
Zimmermann, S., Kaiser, M., Brun, R., Hamburger, M., Adams, M., 2012.
Cynaropicrin: the first plant natural product with in vivo activity against
Trypanosoma brucei. Planta Med. 78, 553–556.
Supporting information  
Bisabololoxide derivatives from Artemisia persica, and determination of their absolute 
configurations by ECD  
 
Fahimeh Moradi-Afrapoli a,1 Samad Nejad Ebrahimi b,c,1 Martin Smiesko d, Melanie Raith b, 
Stefanie Zimmermann b,e, Farsad Nadjafi f, Reto Brun e, Matthias Hamburger b,*  
 
a Department of Pharmacognosy, Faculty of Pharmacy, MazandaranUniversity of Medical 
Sciences, Sari, Iran. 
b Division of Pharmaceutical Biology, University of Basel, Klingelbergstrasse 50, 4056 Basel, 
Switzerland. 
c Department of Phytochemisty, Medicinal Plants and Drugs Research Institute, Shahid Beheshti 
University, G. C., Evin, Tehran, Iran.  
d Division of Molecular Modeling, University of Basel, Klingelbergstrasse 50, 4056 Basel, 
Switzerland. 
e Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health 
Institute, Basel, Switzerland. 
f Department of Agriculture, Medicinal Plants and Drugs Research Institute, Shahid Beheshti 
University, G. C., Evin, Tehran, Iran. 
1 These authors contributed equally to this work 
*Corresponding author. Tel.: +41 612671425; fax: +41 612671474.  
E-mail address: matthias.hamburger@unibas.ch (M. Hamburger)  
95
Figure S1: 1H-NMR spectrum of compound 1(500MHz, Benzene-d6) 
Figure S2: DEPT-Q spectrum of compound 1(125 MHz, Benzene-d6)  
Figure S3: 1H-1H COSY spectrum of compound 1 
Figure S4: HSQC-DEPT spectrum of compound 1 
Figure S5: HMBC spectrum of compound 1 
Figure S6: 1D-Selective TOCSY spectra of compound 1  
Figure S7: Expanded 1D-Selective TOCSY spectra of compound 1 
Figure S8: 1H-NMR spectrum of compound 2 (500MHz, Benzene-d6)  
Figure S9: DEPT-Q spectrum of compound 2 (125 MHz, Benzene-d6)  
Figure S10: 1H-NMR spectrum of compound 2 (500MHz, Pyridine-d5)  
Figure S11: 1H-NMR spectrum of compound 3 (500MHz, Benzene-d6)  
Figure S12: DEPT-Q spectrum of compound 3 (125 MHz, Benzene-d6)  
Figure S13: 1H-NMR spectrum of compound 4 (500MHz, Benzene-d6)  
Figure S14: DEPT-Q spectrum of compound 4 (125 MHz, Benzene-d6)  
Figure S15: 1H-NMR spectrum of compound 5 (500MHz, Benzene-d6)  
Figure S16: DEPT-Q spectrum of compound 5 (125 MHz, Benzene-d6 
Figure S17. Minimized conformers of 1 in the gas phase using DFT at the B3LYP/6-31G∗ level: 
compound 1, showing five conformers in 1 kcal/mol range from the global minimum 
Figure S18: Calculated ECD spectra of the minimized conformers of 1 
Figure S19. Minimized conformers of 2 in the gas phase using DFT at the B3LYP/6-31G∗ level: 
compound 2, showing fiveconformers in 1 kcal/mol range from the global minimum 
Figure S20: Calculated ECD spectra of the minimized conformers of 2  
Figure S21. Minimized conformers of 3 in the gas phase using DFT at the B3LYP/6-31G∗ level: 
compound 3, showing six conformers in 1 kcal/mol range from the global minimum  
Figure S22: Calculated ECD spectra of the minimized conformers of 3  
Figure S23. Minimized conformers of 4 in the gas phase using DFT at the B3LYP/6-31G∗ level: 
compound 3, showing six conformers in 1 kcal/mol range from the global minimum 
Figure S24. Minimized conformers of 5 in the gas phase using DFT at the B3LYP/6-31G∗ level: 
compound 5, showing six conformers in 1 kcal/mol range from the global minimum 
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 Figure S1: 1H-NMR spectrum of compound 1(500MHz, Benzene-d6) 
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 Figure S2: DEPT-Q spectrum of compound 1(125 MHz, Benzene-d6) 
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  Figure S3: 1H-1H COSY spectrum of compound 1  
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 Figure S4: HSQC-DEPT spectrum of compound 1 
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 Figure S5: HMBC spectrum of compound 1 
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Figure S6: 1D-Selective TOCSY spectra of compound 1; a) The whole 1H-NMR spectrum, b) Excitation of H-10 resulted in detection of H-
9, H-8α, and H-8β (a spin system in ring B), c) Excitation of H-6 led to detection of H-4α, H-4β, H-5α, and H-5β (a spin system in ring A). 
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 Figure S7: Expanded 1D-Selective TOCSY spectra of compound 1 (0.9-2.15 ppm); a) 1H-NMR spectrum, b) Selective xcitation of H-10, c) 
Selective xcitation of H-6  
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 Figure S8: 1H-NMR spectrum of compound 2 (500MHz, Benzene-d6) 
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Figure S9: DEPT-Q spectrum of compound 2 (125 MHz, Benzene-d6) 
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 Figure S10: 1H-NMR spectrum of compound 2 (500MHz, Pyridine-d5)  
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Figure S11: 1H-NMR spectrum of compound 3 (500MHz, Benzene-d6) 
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  Figure S12: DEPT-Q spectrum of compound 3 (125 MHz, Benzene-d6)  
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Figure S13: 1H-NMR spectrum of compound 4 (500MHz, Benzene-d6)  
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 Figure S14: DEPT-Q spectrum of compound 4 (125 MHz, Benzene-d6)  
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Figure S15: 1H-NMR spectrum of compound 5 (500MHz, Benzene-d6)   
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Figure S16: DEPT-Q spectrum of compound 5 (125 MHz, Benzene-d6) 
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 Figure S17. Minimized conformers of 1 in the gas phase using DFT at the B3LYP/6-31G∗ level: 
compound 1, showing five conformers in 2 kcal/mol range from the global minimum. 
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 Figure S18. Calculated ECD spectra of the minimized conformers of 1 in MeOH 
(DFT/B3LYP/6-31G**); 2R,3R,6R,7S,10S,11S (top) 2S,3S,6S,7S,10S,11S (down) 
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 Figure S19. Minimized conformers of 2 in the gas phase using DFT at the B3LYP/6-31G∗ level: 
compound 2, showing five conformers in 2 kcal/mol range from the global minimum. 
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 Figure S20. Calculated ECD spectra of the minimized conformers of 2 in MeOH 
(DFT/B3LYP/6-31G**); 6R,7S,10S,11S (top) 6S,7S,10S,11S (down) 
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Figure S21. Minimized conformers of 3 in the gas phase using DFT at the B3LYP/6-31G∗ level: 
compound 3, showing six conformers in 2 kcal/mol range from the global minimum. 
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 Figure S22. Calculated ECD spectra of the minimized conformers of 3 in MeOH (DFT/B3LYP/6-31G**) 
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 Figure S23. Minimized conformers of 4 in the gas phase using DFT at the B3LYP/6-31G∗ level: 
compound 4, showing five conformers in 2 kcal/mol range from the global minimum. 
 
 
Figure S24. Minimized conformers of 5 in the gas phase using DFT at the B3LYP/6-31G∗ level: 
compound 5, showing five conformers in 2 kcal/mol range from the global minimum 
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 Figure S25. Calculated ECD spectra of the minimized conformers of 4 and 5 in MeOH 
(DFT/B3LYP/6-31G**) 
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3.3. Disesquiterpene and sesquiterpene coumarins from Ferula pseudalliacea, 
and determination of their absolute configurations 
 
Dara Dastan, Peyman Salehi, Ahmad Reza Gohari , Stefanie Zimmermann, Marcel Kaiser, 
Matthias Hamburger, Hamid Reza Khavasi, Samad Nejad Ebrahimi  
Phytochemistry 78 (2012) 170–178, doi:10.1016/j.phytochem.2012.02.016 
 
 
 
The first disesquiterpene coumarin, a new sesquiterpene coumarin, and four known 
sesquiterpene coumarins were isolated from the roots of Ferula pseudalliacea. The absolute 
configurations of four of the compounds were established by comparison of experimental and 
simulated ECD spectra using TDDFT. 
 
 
Extraction of plant material for isolation, isolation of compounds, recording, and interpretation 
of analytical data for structure elucidation (mass spectrometry, microprobe NMR, optical 
rotation) were done by Dara Dastan. Experimental and quantum-chemical calculations of ECD 
spectra, contributing in writing of the manuscript, and preparation of some figures (Figure 2, 3, 
6, 7, and 9) were my part to this publication. Antimalarial testing was done by Stefanie 
Zimmermann.  
 
Samad Ebrahimi 
  
121
Phytochemistry 78 (2012) 170–178Contents lists available at SciVerse ScienceDirect
Phytochemistry
journal homepage: www.elsevier .com/locate /phytochemDisesquiterpene and sesquiterpene coumarins from Ferula pseudalliacea,
and determination of their absolute configurations
Dara Dastan a, Peyman Salehi a,⇑, Ahmad Reza Gohari b,⇑, Stefanie Zimmermann c,d, Marcel Kaiser d,e,
Matthias Hamburger c, Hamid Reza Khavasi f, Samad Nejad Ebrahimi a,c
aDepartment of Phytochemistry, Medicinal Plants and Drugs Research Institute, Shahid Beheshti University, G. C., Evin, Tehran, Iran
bMedicinal Plants Research Center, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
cDivision of Pharmaceutical Biology, University of Basel, Klingelbergstrasse 50, 4056 Basel, Switzerland
dDepartment of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, 4002 Basel, Switzerland
eUniversity of Basel, 4003 Basel, Switzerland
fDepartment of Chemistry, Shahid Beheshti University, G. C., Evin, Tehran, Iran
a r t i c l e i n f o a b s t r a c tArticle history:
Received 14 December 2011
Received in revised form 30 January 2012
Available online 20 March 2012
Keywords:
Ferula pseudalliacea
Apiaceae
Sesquiterpene coumarin
ECD
X-ray analysis
TDDFT
Plasmodium falciparum0031-9422/$ - see front matter  2012 Elsevier Ltd. A
doi:10.1016/j.phytochem.2012.02.016
⇑ Corresponding authors. Tel.: +98 2122431621; fa
E-mail addresses: p-salehi@sbu.ac.ir (P. Saleh
(A. Reza Gohari).The first disesquiterpene coumarin, sanandajin, five sesquiterpene coumarins, kamolonol acetate, fekry-
nol acetate, ethyl galbanate, methyl galbanate, farnesiferol B, and a sesquiterpene, aristolone, were iso-
lated from a n-hexane extract of Ferula pseudalliacea roots. The structures were elucidated by 1D and
2D NMR, HR-ESIMS data, and kamolonol acetate was confirmed by single-crystal X-ray analysis. The
absolute configuration of compounds was established by comparison of experimental and simulated
ECD spectra using time dependence density function theory (TDDFT). In vitro antiplasmodial activity
against Plasmodium falciparum K1 strain was determined. sanandajin, kamolonol acetate and methyl
galbanate showed moderate antiplasmodial activity, with IC50 values of 2.6, 16.1 and 7.1 lM,
respectively.
 2012 Elsevier Ltd. All rights reserved.1. Introduction
The genus Ferula (Apiaceae) comprises about 180 species which
grow mainly in central Asia, the Middle East, and central Europe
(Pimenov and Leonov, 2004). Several species, such as Ferula
asafetida, Ferula gumosa and Ferula latisecta have been used in folk
medicine to treat stomachache, hysteria, infant colitis, and asthma
(Eigner and Scholz, 1999; Zargari, 1997). The genus Ferula is known
to be a rich source of biologically active compounds, such as
sesquiterpenes (Abd El-Razek et al., 2001; Ahmed, 1999; Iranshahi
et al., 2008; Kanani et al., 2011; Tamemoto et al., 2001) and couma-
rins (Abd El-Razek et al., 2001; Iranshahi et al., 2004, 2007, 2009;
Zhou et al., 2000). Ferula pseudalliacea Rech.f. is an indigenous spe-
cies of the Kurdistan (Sanandaj) mountains in western Iran. As part
of a phytochemical study of endemic plants of Iran, and an ongoing
screening for new antiprotozoal natural products (Adams et al.,
2009a,b; S´lusarczyk et al., 2011), we investigated a n-hexane ex-
tract from roots of F. pseudalliacea. We here report on the identifi-ll rights reserved.
x: +98 2122431783.
i), goharii_a@sina.tums.ac.ir
12cation of new disesquiterpene and sesquiterpene coumarins, along
with known sesquiterpene coumarins, and on their in vitro anti-
plasmodial activity. Structures including their absolute configura-
tion were established by a combination of methods, such as 1D
and 2D NMR, high-resolution mass spectrometry, single-crystal
X-ray analysis, and ECD spectroscopy.2. Results and discussion
The n-hexane extract of F. pseudalliacea roots was separated by
normal and reversed phase chromatography to give two new (1
and 2) and four known sesquiterpene coumarins (3–6), and a ses-
quiterpene (Scheme. 1), aristolone (7). Compound 1 was obtained
as a colorless gum. Its molecular formula C39H52O5 was deduced
from HR-ESIMS (m/z 623.3722 [M+Na]+, calc. 623.3712). The planar
structure of 1was established by analysis of the NMR spectral data.
The 13C NMR spectrum displayed 39 carbon signals (Table 1). A
downfield resonance (dc 174.2) in the 13C spectrum suggested
the presence of an ester. Other carbon signals were six methyl
groups (dc 10.4, 16.0, 20.1, 20.2, 22.4 and 23.8), eight aliphatic
methylene carbons, an olefinic methylene and two primary oxy-
genated carbons (dc 68.3 and 71.6). The nine remaining downfield2
Scheme 1. Compounds 1–4.
D. Dastan et al. / Phytochemistry 78 (2012) 170–178 171resonances were reminiscent of a 7-hydroxycoumarin, while the
other thirty signals indicated an isoprenoid residue. The presence
of an umbelliferyl moiety was confirmed by resonances at dH
6.22 (d, J = 9.5 Hz), 6.74 (d, J = 2.2 Hz), 6.8 (dd, J = 8.6, 2.3 Hz),
7.33 (d, J = 8.6 Hz) and 7.62 (d, J = 9.5 Hz) in the 1H NMR spectrum.
Analysis of the COSY, HSQC and HMBC spectra suggested the
presence of two discrete sesquiterpene residues (Fig. 1 and Table 1).
The 1H NMR spectrum exhibited resonances of four singlets corre-
sponding to four tertiarymethyl groups, and twodoublets (3H each)
of secondary methyl groups. An HMBC correlation from Me-130 (dH
0.9) to C-90 (dc 40.7) and C-80 (dc 34.8), and a COSY correlation be-
tween H-80 (dH 1.86) and Me-130 (dH 0.9) confirmed a Me-130 at C-
80. HMBC correlation of the Me-1400 (dH 0.81) with the resonance
at dc 31.4 (C-1300), and COSY crosspeak between H-1300 (dH 2.38)
andMe-1400 confirmed the attachment of Me-1400 at C-1300 (Table 1).
The location of double bonds C-40–C-50, and C-700–C-1200 was derived
from HMBC connectivities. Me-140 (dH 1.45) and Me-150 (dH 1.61)
showed correlations with C-40 (dc 125.9) and C-50 (dc 129.6), and
H-1200a (dH 4.58) andH-1200b (dH 4.69) showed cross-peakswith res-
onances of C-600 (dc 36.0) and C-700 (dc 152.6), respectively. HMBC
correlations of H-300 (dH 5.5) with C-200 (dc 30.4), C-1000 (dc 44.4)
and C-1100 (dc 23.8) confirmed a double bond at C-300–C-400. Other
important HMBC and COSY correlations are given in Fig. 1. The
linkage of the three moieties was established by diagnostic HMBC
connectivities. The methylene protons at C-110 (dH 3.87 and 3.69)
showed long-range correlation with C-7 (dc 161.9) and, thus, con-
firmed the attachment of the first sesquiterpene residue to the cou-
marinmoiety. HMBC correlations of the H-10, H-20 andH-1500 signals
(dH 1.86, 2.14, and 3.98, respectively) with the resonance at dc 174.2
(C-30) revealed the location of the ester carbonyl group (C-30), as
well as the attachment of the second sesquiterpene unit. The rela-
tive configuration of the two sesquiterpene units was established
by a NOESY spectrum (Fig. 1). NOESY crosspeaks of H-100/H-110,
Me-130/H-110 and Me-120/H-80 confirmed that Me-120 and H-80
were located on the same face of the six-membered ring also
H-100 and Me-130. NOESY crosspeaks between H-100 and H-1000,123and the J900 ,1000 = 11.2 Hz (trans orientation of H-900 and H-1000) de-
fined the relative configuration of the stereogenic centers at C-100,
C-900 and C-1000 as depicted (Fig. 1).
The absolute configuration of 1was investigated by comparison
of experimental ECD spectra with calculated spectra using time
dependent density functional theory (TDDFT). For this purpose,
the 3D structure of 1 was submitted to a systematic conforma-
tional search in H2O by Optimized Potential for Liquid Simulations
(OPLS-2005) force field, within an energy window of 2 kcal/mol
from particular global minima. A total of 28 conformational species
were found. All conformers were subjected to geometrical optimi-
zation (DFT/B3LYP/6-31G⁄) in the gas phase combined with calcu-
lation of vibrational modes to confirm these minima. No imaginary
frequencies were found. Conformational analysis using relative
free energies indicated the presence of seven conformers, 1a
(72.94%), 1b (8.54%), 1c (6.79%), 1d (3.91%), 1e (2.94%), 1f
(2.55%), and 1g (2.33%) in the gas phase (Fig 2). For these conform-
ers, ECD spectra were calculated (TDDFT /B3LYP/6-31G⁄) in MeCN
using the SCRF (self-consistent reaction field) method with the
CPCM (conductor-like polarizable continuum) model. Calculated
ECD spectra were assigned a Boltzmann weight according to the
energy of the minimized conformers at 298.15 K and overlaid prior
to comparison with the experimental ECD spectrum (Fig. 3). The
calculated ECD spectrum of 1 closely matched with the experimen-
tal data, in particular positive Cotton effects (CE) in the 300–
350 nm and 200–220 nm regions, a shoulder between 270–
290 nm, and a negative CE in the region of 220–260 nm. Differ-
ences between calculated and experimental spectra were appar-
ently due to minor difference between calculated and solution
conformers of this flexible molecule (Zaugg et al., 2011). The posi-
tive CE between 270 and 350 nm in the experimental spectrum
was likely due to a p? p⁄ transition in the extended p-system of
coumarin moiety, while the weak n? p⁄ transitions were buried
by strong p? p⁄ transition. On the basis of these data the absolute
configuration of the inner sesquiterpene moiety was unambigu-
ously established. For the second sesquiterpene residue, only the
Table 1
1H and 13C NMR spectroscopic data for compounds 1–4 (CDCl3, 500 MHz for dH, 125 MHz for dc).a
Position 1 2 3 4
dC dH (J in Hz) dC dH (J in Hz) dC dH (J in Hz) dC dH (J in Hz)
2 161.2 161.0 161.2 161.2
3 112.7 6.22, d (9.5) 112.9 6.25, d (9.5) 112.7 6.22, d (9.5) 112.7 6.22, d (9.5)
4 143.4 7.62, d (9.5) 143.2 7.63, d (9.5) 143.4 7.62, d (9.5) 143.4 7.62, d (9.5)
5 128.5 7.33, d (8.6) 128.8 7.37, d (8.6) 128.5 7.33, d (8.5) 128.5 7.33, d (8.5)
6 113.1 6.80, dd (8.6, 2.3) 113.3 6.83, dd (8.6, 2.4) 113.0 6.80, dd (8.5, 2.0) 113.0 6.80, dd (8.5, 2.0)
7 162.8 161.9 162.8 162.8
8 101.1 6.74, d (2.2) 101.3 6.79, d (2.3) 101.1 6.74, d (2.0) 101.1 6.74, d (2.0)
9 155.9 155.8 155.9 155.9
10 112.2 112.7 112.2 112.2
10 22.2 1.86b 23.0 1.90 23.2 1.86f 22.2 1.86g
20 32.3 2.14 41.1 2.36, a 26.7 1.40 32.3 2.14
2.40, b
30 174.2 210.9 64.8 4.05 174.2
40 125.9 57.5 2.52, d (6.6) 125.1 125.9
50 129.6 45.4 130.0 129.6
60 24.4 2.50, d (13.8) 75.1 5.10, dd (11.1, 4.7) 24.4 2.50, d (12.5) 24.4 2.50, d (12.5)
70 31.9 1.20, dd (13.1, 4.3) 32.1 1.70, a 31.9 1.20 31.9 1.20
1.85, b
80 34.8 1.86b 36.2 1.99 34.8 1.86f 34.8 1.86g
90 40.7 39.3 40.7 40.7
100 42.6 2.92 43.7 2.25, dd (11.5, 4.2) 42.9 2.92 42.6 2.92
110 71.6 3.87, d (8.3) 75.2 3.78, d (9.1) 71.6 3.87, d (8.0) 71.6 3.87, d (8.0)
3.69, d (8.3) 3.74, d (9.1) 3.69, d (8.0) 3.69, d (8.0)
120 22.4 1.10, s 19.7 1.12, s 22.4 1.15, s 22.4 1.11, s
130 16.0 0.90, d (7.0) 9.1 0.90, d (6.6) 16.0 0.90, d (7.0) 16.0 0.90, d (7.0)
140 20.1 1.45, s 10.2 0.94, s 20.1 1.44, s 20.17 1.43, s
150 20.2 1.61, s 15.1 1.13, d 20.2 1.60, s 20.19 1.60, s
160 171.0 60.2 4.1, q (7.0)
170 21.0 2.03, s 14.2 1.25, t (7.0)
100 42.3 1.48c 170.3
200 30.4 2.02 21.7 2.02, s
300 121.8 5.50, s
400 135.3
500 27.0 1.67d, a
1.23, b
600 36.0 2.06, a
2.40e, b
700 152.6
800 25.6 1.50c, a
1.96, b
900 44.1 1.70d
1000 44.4 1.77
1100 23.8 1.69d
1200 103.6 4.69
4.58
1300 31.4 2.38e
1400 10.4 0.81, d (7.0)
1500 68.3 3.98, dd (7.6, 6)
a d values were established from HMBC, COSY, HSQC and DEPT experiments.
b–g Overlapping signals.
Fig. 1. Key COSY, HMBC and NOESY correlations of 1.
172 D. Dastan et al. / Phytochemistry 78 (2012) 170–178relative configuration could be determined, due to the conforma-
tional flexibility of the linker and absence of diagnostic NOESY12crosspeaks between the two moieties. Thus, the configuration of
1 was established as 80S,90S,100S,100S,900R,1000S. Independent4
Fig. 2. Minimized conformers of 1 in the gas phase using DFT at the B3LYP/6-31G⁄ level: compound 1, showing seven conformers in 2 kcal/mol range from the global
minimum.
Fig. 3. Experimental (blue) and calculated (red) ECD spectra of 1. Calculated spectra
were obtained by using TDDFT at B3LYP/6-31G⁄ level in MeCN. (For interpretation
of the references to colour in this figure legend, the reader is referred to the web
version of this article.)
D. Dastan et al. / Phytochemistry 78 (2012) 170–178 173evidence is needed to unambiguously determine the absolute con-
figuration of the cadinene moiety in 1.
Compound 2 was isolated as colorless crystals. A molecular
formula C26H32O6 was deduced from HR-ESIMS (m/z 463.2061125[M+Na]+, calc 463.2097). Diagnostic signals in the 1H and 13C
NMR spectra suggested a sesquiterpene coumarin. The 13C NMR
spectrum of 2 displayed 26 carbon signals (Table 1). Nine were
indicative of an umbelliferyl moiety, while the remaining 17 sig-
nals suggested a sesquiterpene residue and an acetyl group. Reso-
nances at dH 6.25 (d, J = 9.5 Hz), 6.79 (d, J = 2.3 Hz), 6.8 (dd, J = 8.6,
2.4 Hz), 7.37 (d, J = 8.6 Hz) and 7.63 (d, J = 9.5 Hz) in the 1H NMR
spectrum corroborated the coumarin portion.
The 13C NMR signals were assigned to five methyl groups (dc
9.1, 10.2, 15.1, 19.7 and 21.7), three aliphatic methylenes (dc
23.0, 32.1 and 41.1), a primary oxygenated carbon (dc 75.2), a sec-
ondary oxygenated carbon (dc 75.1), and eight quaternary carbons
including two carbonyl groups (dc 210.9 and 170.3) in the
non-coumarin portion of 2. The location of the carbonyl groups
at C-30 and C-100 were determined by HMBC correlation: Me-130
(dH 0.9), H-40 (dH 2.52), H-20 eq (dH 2.4) and H-20 ax (dH 2.36)
showed crosspeaks with C-30 (dC 210.9), while Me-200 (dH 2.02)
and H-60 (dH 5.1) were correlated to C-100 (dC 170.3). Positions of
methyl and carbonyl groups, and the attachment of the acetyl
and sesquiterpene moieties were established by HMBC spectra
(Fig. 4). The relative configuration of stereocenters at C-40, C-50,
C-60, C-80, C-90 and C-100 was determined by NOESY data (Fig. 4).
Crosspeaks of H-110/H-100, and H-80/Me-120 established an b-orien-
tation for both H-100 and Me-150, and a a-orientation for Me-120.
Crosspeaks of H-100 with H-40 and H-60 established a-orientation
of Me-130, Me-140 and the acetyl group. The proposed structure
174 D. Dastan et al. / Phytochemistry 78 (2012) 170–178of 2 was corroborated by X-ray crystallographic analysis of the
compound (Fig. 5).
The absolute configuration of 2 was established by comparison
of experimental and calculated ECD spectra. A conformational
search based on the X-ray relative configuration revealed eight
conformers within a 2 kcal/mol energy window from the particular
global minimum. These conformers were subjected to geometrical
optimization and energy calculation using density function theory
(DFT) with the B3LYP function and 6-31G⁄ in the gas-phase com-
bined with calculation of vibrational modes to confirm these min-
ima. No imaginary frequencies were found. Conformational
analysis using relative free energies indicated the presence of 6 sta-
ble conformers, 2a (39.02%), 2b (30.02%), 2c (11.77%), 3d (9.63%),
2e (7.11%), and 2f (2.45%) in the gas phase (Fig. 6). Calculation of
the ECD spectra for these conformers were performed as described
above. The weighted ECD spectrum in MeCN is shown in Fig 7.
Experimental and calculated ECD spectra were in good agreement.
Two negative CEs at 323 and 235 nm, two positive CEs at 290 and
210 nm, and a shoulder between 250 and 280 nm were also found
in the calculated ECD spectrum. The differences between calcu-
lated and experimental spectra in the region 220–230 nm presum-
ably resulted from an overestimation of the UV absorbance in the
calculations, or from minor difference in solution conformation.
Thus, the absolute configuration of 2 was established as
40S,50R,60S,80S,90S,100R.
Fekrynol acetate (3) and ethyl galbanate (4) had been previ-
ously reported from Ferula krylovii (Veselovskaya et al., 1981)Fig. 5. Thermal elli
Fig. 4. Key HMBC and NO
12and Ferula gummosa (Bednyak, 1962), respectively, but no spectral
data were recorded at that time. We report here full NMR spectral
assignments and determination of absolute configuration for these
two compounds (Fig 8 and Table 1) which were obtained as a 1:1
mixture. The specific rotation for the mixture of compounds 3 and
4 was ½a20D  17.0 (c = 1, CHCl3).
The molecular models of 3 and 4 were built with the relative
configuration represented in Scheme. 1, and the 3D structures sub-
jected to conformational search using OPLS-2005 molecular
mechanics force field. The conformational analysis afforded 21
conformers for 3 and 23 conformers for 4. The DFT energy calcula-
tion at B3LYP/6-31G⁄ level of theory yielding 15 relevant conform-
ers for 3 and 12 conformers for 4 within an energy range of 2 kcal/
mol from the global minimum. In both cases the conformers dif-
fered with respect to orientation of coumarin and ester moieties
(Fig. 9A). ECD spectra were calculated for these conformers in
MeCN (TDDFT/B3LYP/6-31G⁄/SCRF/CPCM). Each calculated ECD
spectrum was assigned a Boltzmann weight according to the en-
ergy of the minimized conformers at 298.15 K and overlaid prior
to comparison with the experimental ECD spectrum (Fig. 9B). The
simulated ECD spectra showed very good agreement with the
experimental spectrum. Two negative CEs were observed at 258
and 221 nm, along with two positive CEs at 322 and 246 nm. The
difference between calculated and experimental spectra likely re-
sulted from an overestimation of the UV absorbance in the calcula-
tions, or from minor conformational differences in solution.
Calculated ECD spectra for 3 and 4 were similar. Hence, the esterpsoid plot of 2.
ESY correlations of 2.
6
Fig. 6. Minimized conformers of 2 in the gas phase using DFT at the B3LYP/6-31G⁄ level: compound 2, showing six conformers in 2 kcal/mol range from the global minimum.
Fig. 7. Experimental (blue) and calculated (red) ECD spectra of 2. Calculated spectra
were obtained in MeCN using TDDFT at B3LYP/6-31G⁄ level. (For interpretation of
the references to colour in this figure legend, the reader is referred to the web
version of this article.)
D. Dastan et al. / Phytochemistry 78 (2012) 170–178 175moiety had no effect on the ECD because of its distance from the
stereogenic centers. Thus, we conclude that the absolute configura-
tion of both compounds was 80S,90S,100S.
Compounds 1–6 were tested for in vitro antiplasmodial activity
(Plasmodium falciparum K1 strain) and for cytotoxicity in rat skele-
tal fibroblasts (L6-cell line) (Table 2). Disesquiterpene coumarin 1
showed moderate activity against Plasmodium falciparum
(IC50 = 2.6 lM) with moderate selectivity index of 5.9 (selectivity127index = IC50 of the L6 cells (cytotoxicity) divided by IC50 of the
parasite), while compounds 2 and 5 were non-selectively cyto-
toxic. The IC50 values of compounds 3, 4 and 6 were greater than
10 lM in the antiplasmodial assay. It seems that in the biosynthe-
sis of the compounds, the key structure is compound 2 because
cleavage of the C-30/C-40 bond provides entry into the same frame-
work as compounds 1, 3 and 4.3. Conclusions
The first disesquiterpene coumarin, a new sesquiterpene cou-
marin, four known sesquiterpene coumarins, and a sesquiterpene
were isolated from the roots of F. pseudalliacea. The configurations
of compound 1–4 were determined as 80S,90S,100S,100S,900R,1000S
(sanandajin), 40S,50R,60S, 80S,90S,100R (kamolonol acetate),
80S,90S,100S, (fekrynol acetate) and 80S,90S,100S, (ethyl galbanate),
respectively. The occurrence of sesquiterpene coumarins in higher
plants is essentially limited to the families Apiaceae and Astera-
ceae, where they have been reported from the genus Ferula (Mur-
ray et al., 1982; Nazari and Iranshahi, 2011), and Artemisia, Achillea
and Anthemis, respectively (Hofer et al., 1983; Hofer and Greger,
1984). There have been reports on isolation of these compounds
from other families, e.g., Euphorbiaceae (Fraga, 2005). Whether
disesquiterpene coumarins are a unique feature of F. pseudalliacea
remains to be clarified by a targeted search for such compounds.
The sesquiterpene coumarins in Apiaceae and Asteraceae differ
by the substitution pattern of the coumarin moiety. Umbelliferone
derived sesquiterpene ethers are characteristic of Apiaceae,
whereas isofraxidin (7-hydroxy-6,8-dimethoxycoumarin) and
occasionally scopoletin (7-hydroxy-6-methoxycoumarin) are the
typical coumarin residues in the Asteraceae. The absolute configu-
ration of the sesquiterpene moiety has been established for
Fig. 8. Key COSY and HMBC correlations of 3 and 4.
Fig. 9. (A) Minimized conformers of 3 and 4 in gas phase using DFT at the B3LYP/6-31G⁄ level. (B) Experimental (blue) and calculated (black and green) ECD spectra of 3 and 4.
Calculated spectra were obtained via averaging of simulated spectra of compounds (ratio 1:1) by using TDDFT at B3LYP/6-31G⁄ level in MeCN. (For interpretation of the
references to colour in this figure legend, the reader is referred to the web version of this article.)
Table 2
Activity of compounds 1–6 against Plasmodium falciparum and L-6 cells.
Compound IC50 (P. falciparum K1) IC50 (L-6 cells)
Sanandajin (1) 2.6 ± 0.1a 9.4 ± 0.1a
Kamolonol acetate (2) 16.1 ± 0.4 7.5 ± 0.1
Fekrynol acetate (3) NAb NDc
Ethyl galbanate (4) NA ND
Methyl galbanate (5) 7.1 ± 0.1 4.3 ± 0.2
Farnesiferol B (6) NA 35.7 ± 0.3
Artemisin 0.004
Podophyllotoxin 0.02
a IC50 in lM with standard deviation.
b NA: not active (IC50 > 10 lM).
c ND: not determined.
176 D. Dastan et al. / Phytochemistry 78 (2012) 170–178selected sesquiterpene coumarin ethers, either by Horeau esterifi-
cation, or by chemical degradation to compounds of known abso-
lute stereochemistry (Hofer et al., 1983; Hofer and Greger, 1984).
Earlier CD studies with non-derivatized sesquiterpene coumarin
ethers to solely a CE in the 200 nm region into consideration seem
questionable in conclusions (Miseeva et al., 1978).
Coumarins possess a broad range of biological activities, but
data on antiplasmodial activity of coumarins are scarce
(Argotte-Ramos et al., 2006; Lee et al., 2003; Muthaura et al.,
2011; Oketch-Rabah et al., 2000). The reported in vitro activities
so far showed moderate inhibition for these compounds (Ma12et al., 2006; Ross et al., 2008; Subeki et al., 2005; Yenjai et al.,
2000). Thus, compound 1 is among the most potent non-
phototoxic coumarins.4. Experimental
4.1. General experimental procedures
Melting points were determined on an Electrothermal melting
point apparatus. Optical rotations were measured on a Perkin-El-
mer 341 polarimeter. UV spectra were recorded on a Shimadzu
UV-PC 2501 spectrometer. IR spectra were recorded on a Bruker
Tensor 27 FT-IR spectrometer. ECD spectra of compounds 1–4were
recorded in MeCN on a AVIV CD spectrometer model 62ADS and
analyzed with the AVIV 60DS V4.1 software. NMR spectra were
measured on a Bruker DRX-500 spectrometer. HR-ESIMS spectra
were acquired on a Bruker MicroTOF ESI-MS system. GPC separa-
tions were performed with a Knauer apparatus (Smartline pumps
including a 50 mL pump (EA4301 V4), UV and RI detector). The col-
umn was Nucleogel 100-5 (300  7.7 mm; Macherey Nagel). CHCl3
was used as eluent, and the flow rate was 1 mL/min. Semi-prepara-
tive HPLC was carried out with an Eurospher 100-7 RP C18
(250  20 mm; Macherey Nagel) column with a MeOH-H2O
gradient. Silica gel (70–230 and 230–400 mesh, Merck) and RP
C18 (230–400 mesh, Fluka) were used for column chromatography.
Silica TLC was performed on Merck F254 silica gel plates
(10  10 cm).8
D. Dastan et al. / Phytochemistry 78 (2012) 170–178 1774.2. Plant material
Roots of F. pseudalliacea were collected from Sanandaj (Sena-
dezh) mountains, Kurdistan Province, Iran, in September 2008 at
an altitude of 1500 m, and identified. A voucher specimen (MPH-
1197) is deposited in the Herbarium of the Medicinal Plants and
Drugs Research Institute, Shahid Beheshti University, Iran.
4.3. Extraction and isolation
The roots (1 kg) F. pseudalliacea were crushed and extracted
with n-hexane (3  4 L, rt for 24 h). Evaporation of solvent at
reduced pressure afforded 28 g of a light brown gum. A portion
(25 g) was fractionated on a silica gel column eluted with
n-hexane–CHCl3–EtOAc mixtures of increasing polarity (100:0:0,
8:2:0, 5:5:0, 0:100:0, 0:9:1, 0:3:7, respectively) to give fractions
1–11. Fraction 4 (5 g) was further purified on a silica gel column
[n-hexane–EtOAc (19:1) to EtOAc], to afford nine fractions
(4.1–4.9). Silica gel chromatography [n-hexane–CHCl3–EtOAc
(12:7:1–2:9: 9)] of fraction 4.5 afforded five fractions (4.5.1–
4.5.5). GPC of fraction 4.5.1 gave 1 (12 mg). Silica gel chromatogra-
phy [n-hexane–CHCl3–EtOAc (8:11:1–4:8:8)] of fraction 4.5.3 gave
four fractions (4.5.3.1–4.5.3.4) together with aristolone (Rucker et
al., 1984) (7, 8 mg). Methyl galbanate (Iranshahi et al., 2007) (5,
23 mg) was isolated from fraction 4.5.3.1 on a reversed-phase
(C18) column [C3H6O–H2O (8:2)]. Fraction 4.8 was separated over
a silica gel column [n-hexane–EtOAc (8:2–2:8)], to afford a mixture
of fekrynol acetate and ethyl galbanate (3 and 4, 13 mg). Silica gel
chromatography [n-hexane–EtOAc (7:3–4:6)] of fraction 8 (2.0 g)
afforded five fractions (8.1–8.5). Farnesiferol B (Iranshahi et al.,
2007) (6, 15 mg) was obtained from fraction 8.1 on a silica gel col-
umn [n-hexane–EtOAc (19:1–1:1)] and semi-preparative RP-HPLC
(MeOH in H2O (80–100% MeOH). Compound 2 (30 mg) was puri-
fied from fraction 8.4 on a silica gel column [n-hexane–CHCl3
(8:2–1:9)].
4.4. Spectroscopic data of new compounds
4.4.1. Sanandajin (1)
Colorless gum; ½a25D : +20.0 (c = 0.5, CHCl3); UV (CHCl3) kmax (log
e) 324 (3.89), 238 (3.59) nm; IR (KBr) mmax 2924, 2854, 1735, 1616,
1456, 1153–1069 cm1; 1H NMR (CDCl3, 500 MHz) and 13C NMR
(CDCl3, 125 MHz), see Table 1; CD (MeCN, c = 0.183 mM, 0.1 cm
patch length): [h]233 = 10,396, [h]258 = 7053, [h]325 = 20,414;
HR-ESIMS m/z 623.3722 [M+Na]+ (calcd for C39H52O5Na,
623.3712).
4.4.2. Kamolonol acetate (2)
Colorless crystals (CHCl3); mp 217–219 C; ½a25D : 8.0 (c = 1,
CHCl3); UV (CHCl3) kmax (log e) 323 (4.01), 238 (3.5) nm; IR (KBr)
mmax 2924, 1726, 1612, 1510, 1426, 1236 cm1 H NMR (CDCl3,
500 MHz) and 13C NMR (CDCl3, 125 MHz), see Table 1; CD (MeCN,
c = 0.9 mM, 0.1 cm patch length): [h]215 = 2040, [h]290 = 5602,
[h]322 = 5112; HR-ESIMS m/z 463.2061 [M+Na]+ (calcd for
C26H32O6 Na, 463.2097).
4.5. X-ray crystal structure analysis of kamolonol acetate (2)
The X-ray diffraction measurements were made on a STOE IPDS
2T diffractometer with graphite-monochromated Mo Ka radiation.
For data collection, a colorless block crystal with dimensions of
0.40  0.25  0.23 mm was chosen and mounted on a glass fiber.
Cell constants and an orientation matrix for data collection were
obtained by least-squares refinement of diffraction data from
4804 unique reflections. Data were collected at a temperature of
298(2) K to a maximum 2h value of 58.60 for 2 and in a series of129x scans in 1 oscillations and integrated using the Stoe X-AREA
(Stoe and Cie, 2009) software package. The structures were solved
by direct methods and subsequent difference Fourier maps, and re-
fined on F2 by a full-matrix least-squares procedure using aniso-
tropic displacement parameters (Sheldrick, 1997). The compound
crystallize in P212121 space group of orthorhombic system with
cell constants of a = 8.8921(18), b = 15.765(3) and c = 16.792(3).
All hydrogen atoms were located in ideal positions and then re-
fined isotropically. Subsequent refinement was converged with
R1 = 0.0577 [I > 2.00r(I)] and wR2 = 0.1168. All refinements were
performed using the X-STEP32 crystallographic software package
(Stoe and Cie, 2000). Crystallographic data have been deposited
with the Cambridge Crystallographic Data Center under CCDC
823135. These data can be obtained free of charge via www.ccdc.
cam.ac.uk/deposit (or from the CCDC, 12Union Road, Cambridge
CB2 1EZ, UK; fax: +44 1223 336033; deposit@ccdc.cam.ac.uk).
4.6. Conformational analysis, geometrical optimization, and ECD
calculation
Conformational analysis of compounds 1, 2, 3, and 4 were per-
formed with Schrödinger MacroModel 9.1 software using the OPLS
2005 (Optimized Potential for Liquid Simulations) force field in
H2O. Conformers occurring within a 2 kcal/mol energy window
from the global minimum were chosen for geometrical optimiza-
tion and energy calculation using density function theory (DFT)
with the B3LYP functional and the 6-31G⁄ basis-set in the gas-
phase with the Gaussian 09 program (Frisch et al., 2009). Vibra-
tional analysis was done at the same level to confirm minima.
TD-DFT/B3LYP/6-31G⁄ in the gas phase and in MeCN using the
SCRF (self-consistent reaction field) method with the CPCM (Con-
ductor-like polarizable continuum) model, was employed to calcu-
late excitation energy (denoted by wavelength in nm) and
rotatory strength R in dipole velocity (Rvel) and dipole length (Rvel)
forms. ECD curves were calculated based on rotatory strengths
using a half bandwidth of 0.3 eV with conformers of 1, 2, 3, and
4 using Gausssum 2.2 software (O’Boyle et al., 2009). The spectra
were combined after Boltzmann weighting according to their pop-
ulation contribution.
4.7. Antiplasmodial assays
Tests of extracts and pure substances were done as previously
described (Adams et al., 2009b). IC50 values were calculated from
sigmoidal concentration inhibitions curves. Assays were run in
two independent experiments in duplicate.Acknowledgment
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 Figure S1. Calculated ECD spectra MeCN (CPCM) of each minimized conformer (DFT/B3LYP/6-31G*) of 1 
occurring within an energy range of 2 kcal/mol from the global minimum. 
153
 Figure S2. Calculated ECD spectra MeCN (CPCM) of each minimized conformer (DFT/B3LYP/6-31G*) of 2 
occurring within an energy range of 2 kcal/mol from the global minimum. 
154
 Figure S3. Calculated ECD spectra MeCN (CPCM) of each minimized conformer (DFT/B3LYP/6-31G*) of 3 
occurring within an energy range of 2 kcal/mol from the global minimum. 
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Figure S4. Calculated ECD spectra MeCN (CPCM) of each minimized conformer (DFT/B3LYP/6-31G*) of 4 
occurring within an energy range of 2 kcal/mol from the global minimum. 
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3.4. Hydrangenone, a new isoprenoid with an unprecedented skeleton from 
Salvia hydrangea 
Mehdi Moridi Farimani, Salman Taheri, Samad Nejad Ebrahimi, M. Babak Bahadori, Hamid 
Reza Khavasi, Stefanie Zimmermann, Reto Brun, and Matthias Hamburger 
Org. Lett., 14, No. 1, 2012, 166-169, doi: 10.1021/ol202953b 
 
 
 
Hydrangenone, a new heptacyclic isoprenoid with a 6/7/6/5/5 membered carbon ring skeleton, 
was isolated from the aerial parts of Salvia hydrangea. The structure was established by 
extensive NMR spectroscopic methods. The relative and absolute configuration of 1 was 
assigned by NOESY and X-ray crystallographic analysis and by comparison of experimental and 
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ABSTRACT
Hydrangenone, a new heptacyclic isoprenoid with a 6/7/6/5/5 membered carbon ring skeleton, was isolated from the aerial parts of Salvia
hydrangea. The structure was established by extensive NMR spectroscopic methods. The relative and absolute configuration of 1 was assigned
by NOESY and X-ray crystallographic analysis and by comparison of experimental and calculated electronic circular dichroism (ECD) spectra.
Compound 1 showed in vitro antiplasmodial activity, with an IC50 value of 1.4 μM against P. falciparum. A plausible biosynthetic pathway of 1 was
also proposed.
The genus Salvia is a rich source of structurally diverse
terpenoids.1Oneof themost distinguishing features ofSalvia
species is their ability to synthesize isoprenoids with un-
usual scaffolds.2 In a project directed at structurally inter-
esting bioactive metabolites from Iranian Lamiaceae, we
studied Salvia hydrangea. This species is popularly known
in Persian as “Gol-e Arooneh”. It grows widely in Iran,
Anatolia, and Transcaucasia,3 and its flowers are used
in popular Iranian medicine as an anthelmintic and
antileishmanial.4 We recently identified two new antiplas-
modial isoprenoids, perovskone B and salvadione C, from
this plant.5 Further examination of the n-hexane extract of
†Department of Phytochemistry, Shahid Beheshti University.
‡Chemistry and Chemical Engineering Research Center of Iran.
§University of Basel.
)Department of Chemistry, Shahid Beheshti University.
^Swiss Tropical and Public Health Institute.
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S. hydrangea led to the isolation of hydrangenone (1), an
isoprenoid with an unprecedented skeleton which is char-
acterized by an unusual arrangement of 6/7/6/5/5 mem-
bered carbon rings fused with two tetrahydrofuran rings.
The aerial parts of S. hydrangea DC. ex Benth. were
collected from the Koohin region in Qazvin province, Iran,
inMay2009.Thedriedplantmaterial (4.5 kg) was extracted
with n-hexane (3  25 L). Fractionation of the n-hexane
extract (107 g) by column chromatography on silica gel
(n-hexane/EtOAc step gradient) afforded 30 fractions.
Fraction 20 (1.1 g) was separated on a silica gel column
[CHCl3/Me2CO (97:3)] into 10 fractions (20a20j). Frac-
tion 20b was further purified by preparative TLC on silica
gel [CH2Cl2/Me2CO (97:3)] to afford 1 (6 mg, Rf = 0.45).
Hydrangenone (1) was obtained as colorless needles
(CHCl3).
6 A molecular formula of C30H42O5 was estab-
lished from its HR-ESIMS (m/z 505.2902 [MþNa]þ, calcd
505.2924). The molecular formula accounted for 10 de-
grees of unsaturation. Absorption bands at 3440, 1707,
and 1611 cm1 in the IR spectrum implied the presence of
OH, carbonyl, and olefinic functionalities, respectively.
The 13CNMR spectrum showed resonances of 30 carbons
attributable by the DEPT spectrum to seven methyl, eight
methylene, four methine, and 11 quaternary carbons
(Table 1). Thus, 41 hydrogen atoms could be accounted
for, while the remaining one was likely from a hydroxyl
group. 13C NMR resonances at δC 202.1 (C), 123.3 (C),
and 172.5 (C) suggested the presence of anR,β-unsaturated
ketonemoiety containing a trisubstituted double bond and
an oxygen substituent at the β-position. The resonance at
δC 212.0 (C) was indicative of a second carbonyl group.
Four carbon signals at δc 87.9 (C), 90.0 (C), 90.9 (C), and
93.6 (C) suggested the presence of oxygen bearing sp3
carbons. The absence of other sp or sp2 carbon signals
and the 10 degrees of unsaturation implied that 1 contained
seven rings, including two cyclic ethers. The 1H NMR
spectrum (Table 1) showed resonances of five methyl sing-
lets at δH 0.82, 0.84, 1.35, 1.66, and 2.11. Resonances of two
additionalmethyl groups atδH1.13 (d,J=7.1Hz) and1.20
(d, J = 7.1 Hz), together with a signal at δH 3.24 (sept,
J= 7.1 Hz) indicated the presence of an isopropyl moiety.
Comparison of the NMR data of 1 with those of iso-
prenoids previously isolated from S. hydrangea suggested
structural similarities with perovskone B.5 Notable differ-
ences in the NMR spectra of 1 and perovskone B were
observed, suggesting a five-membered ringD in 1 instead of
a six-membered ring as in perovskone B. Hence, structure
determination mainly focused on confirmation of ring D
and of its connectivity to rings B, C, and E.
Unambiguous assignment of NMR data was achieved
by a combination of COSY, HSQC, and HMBC experi-
ments inCDCl3 andC6D6.HMBCdata (correlations from
H-20β toC-9,C-8, andC-23, and fromH-24β toC-23,C-9,
and C-25) revealed the connectivity between C20C9
C23C24C25 (Figure 1). Correlations of H-7β and
H-21β with C-8, C-9, and C-14, respectively, indicated
that the tertiary carbonC-8was a bridgehead betweenC-7,
C-9, C-14, and C-21. HMBC correlations of H-22 with
C-21, C-23, and C-29, and of H-21β with C-8, C-9, C-14,
C-22, and C-23, respectively, confirmed the presence of a
five-membered ring D. The acetyl group was located at
C-22 according to the HMBC cross peaks of H-22 and
H-21R with C-29, and also of H-30 with C-29 and C-22.
HMBC correlations of H-25 with C-11, C-12, and C-26
confirmed the nature of ring E.
The relative configuration of 1 was deduced from a
NOESY spectrum (Figure 1). NOESY correlations be-
tween H-5, H-1R, H-6R, and H-20R, as well as between
Me-19, H-2β, and H-6β corroborated the linkage of rings
A and B. Diagnostic cross peaks between H-22, H-21β,
and H-24β were observed and confirmed their cofacial
orientation. Equally, an NOESY cross-peak between
Figure 1. (A) Key HMBC and (B) NOESY correlations of 1.
(6) Hydrangenone (1): Colorless crystal; [R]20D þ51.9 (c 0.27, CHCl3);
IR (KBr) νmax 3440, 2937, 1707, 1611, 1457, 1370, 1230, 1110 cm
1; for 1H
and 13C NMR data, see Table 1; CD (MeOH, c= 1.0  106 M, 0.1 cm
path length): [θ]202 þ4797, [θ]243 29336, [θ]266 33773, [θ]318 þ 27521;
C30H42O5 was established from its HR-ESIMS (m/z 505.2902 [MþNa]þ,
calcd 505.2924).
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H-25 andH-20β confirmed their location on the same face
of themolecule.However, wewere not able to establish the
relative configuration atC-23. A single-crystalX-ray study
of 1 clarified the R-orientation of OH-23 and unambigu-
ously confirmed the structure of 1 (Figure 2).7
Electronic circular dichroism (ECD) is a powerful chir-
optical tool for determination of the absolute configura-
tion in natural products.8 The absolute configuration of 1
was established bymeasurement of the ECD spectrum and
comparison with calculated ECD data. A conformational
search based on the X-ray relative configuration revealed
seven conformers within a 3 kcal/mol energywindow from
the particular global minimum. These conformers were
subjected to geometrical optimization and energy calcula-
tion using density function theory (DFT) with the B3LYP
function and 6-31G* in the gas phase combined with
calculation of vibrational modes to confirm these minima.
No imaginary frequencies were found. Conformational
analysis using relative free energies indicated the presence
of one predominant conformer (100%) in the gas phase.
Theoretical calculation of ECD spectra of this conformer
was performed by the time-dependent density function
theory (TDDFT) method at B3LYP/6-31G* in MeOH
using the SCRF (Self-consistent reaction field) method
with the CPCM (Conductor-like polarizable continuum)
model. The overall pattern of calculated ECD spectra was
in good agreement with the experimental data (Figure 3).
In particular, two negative Cotton effects (CE) were ob-
served at 225, 279 nm, alongwith positive effect at 320 nm.
Thus, the absolute configuration of 1 was established as
5S, 8R, 9R, 10S, 11R, 22R, 23R, 25R.
Table 1. 1H and 13C NMR Data of Compound 1a
CDCl3 Benzene-d6
Position δH (J in Hz) δC δH (J in Hz) δC
1R 1.12b 42.7, t 1.17, dt (3.0, 13.5) 42.3, t
1β 1.37, br d (12.6) 1.39b
2R 1.46b 20.1, t 1.48b 19.8, t
2β 1.60b 1.88, tq (3.5, 13.5)
3R 1.64b 43.0, t 1.58b 42.5, t
3β 1.68b 1.70b
4 34.5, s 33.9, s
5 1.01, m 53.6, d 0.88,b dd (4.5, 12.5) 53.0, d
6R 1.70b 22.8, t 1.65b 22.5, t
6β 1.33b 1.40b
7R 1.75, br t (14.0) 44.1, t 1.67,b dd (11.5, 14.0) 44.1, t
7β 2.13,b dd (7.8, 14.5) 2.05,b dd (8.0, 14.0)
8 66.3, s 66.1, s
9 55.4, s 54.8, s
10 90.0, s 89.3, s
11 93.6, s 93.1, s
12 172.5, s 170.9, s
13 123.3, s 122.8, s
14 202.1, s 200.6, s
15 3.24, sept (7.1) 24.6, d 3.70, sept (7.0) 24.7, d
16 1.20, d (7.1) 20.7, q 1.50, d (7.0)b 20.5, q
17 1.13,b d (7.1) 20.3, q 1.45,b d (7.0) 20.1, q
18 0.84, s 32.3, q 0.85,b s 31.8, q
19 0.82, s 21.6, q 1.01, s 21.3, q
20R 2.38, d (14.0) 43.1, t 2.08, d (14.0) 42.8, t
20β 2.18, d (14.0) 2.45, d (14.0)
21R 2.00, dd (11.7, 13.8) 44.3, t 2.02,b dd (11.5, 14.0) 43.8, t
21β 2.63, dd (5.8, 11.7) 2.80, dd (5.0, 11.5)
22 2.35b 62.7, d 2.42, dd (5.0, 14.0) 62.2, d
23 87.9, s 87.4, s
24R 1.47b 34.8, t 1.41b 34.5, t
24β 2.35b 2.62, dd (8.0, 12.5)
25 2.77, dd (8.0, 11.5) 56.9, d 2.52, dd (8.0, 11.5) 56.5, d
26 90.9, s 89.7, s
27 1.35,b s 24.7, q 1.11, s 23.8, q
28 1.66,b s 27.4, q 1.57,b s 26.7, q
29 212.0, s 210.2, s
30 2.11,b s 30.8, q 1.72,b s 29.5, q
23-OH 3.86, s 6.36, s
a Spectra were recorded at 500 MHz for 1H and 125 MHz for 13C.
bOverlapping signals.
Figure 2. Single-crystal X-ray struture of 1.
Figure 3. ECD spectra of 1: experimental ECD (blue) and
calculated ECD in MeOH(black).
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Hydrangenone (1) was tested for in vitro antiplas-
modial activity against the Plasmodium falciparum
K1 strain. The compound showed a moderate activity
and selectivity index (IC50 1.4 μM, SI= 6, cytotoxicity in
rat myoblast (L6) cells). The positive control, artesunate,
had an IC50 of 0.1 μM.
Hydrangenone (1) represents the first example of a new
6/7/6/5/5 membered carbon ring framework. A plausible
biogenetic pathway toward this new skeleton bears close
similarities to the proposed formation of some other rare
isoprenoids in Salvia species (Scheme 1).2c2d,5,9 However,
while these previously described isoprenoids could be
explained by a DielsAlder reaction between a monoter-
pene and a diterpenoid, hydrangenone (1) is probably
formed via a [3 þ 2] cycloaddition type reaction be-
tween a putative icetexone precursor (2) and trans-β-
ocimene (3) to assemble the five-membered ring D. An
intramolecular ene-type reaction10 would then form the
key C(11)C(25) bond of carbocyclic ring E, and
successive formation of the two tetrahydrofuran rings
would complete the heptacyclic scaffold. Finally, two
oxidation steps on C-23 and C-29 would lead to hy-
drangenone (1). The complex fusion of rings BG
confers a high degree of rigidity to the molecule.
Acknowledgment. Financial support by the Shahid
Beheshti University Research Council is gratefully
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Supporting Information Available. Experimental proce-
dure, 1D and 2D NMR spectra, and X-ray data (CIF file)
of hydrangenone (1). This material is available free of charge
via the Internet at http://pubs.acs.org.
Scheme 1. Plausible Biogenetic Pathway of 1
(7) Crystallographicdata for1:C30H42O5,MW=482.64, orthorhombic,
space groupP212121, a=8.3674(5) A˚, b=10.8816(10) A˚, c= 28.719(2) A˚,
V = 2614.9(3) A˚3, Z = 4, Dc = 1.229 g/cm3, crystal dimensions 0.40 
0.17  0.16 mm3 were used for measurements on an STOE-IPDSII with a
graphitemonochromator (ω-scans, 2θmax=56.36),MoKR radiation. The
total number of reflections measured was 12011, of which 6886 were unique.
Final indices: Rf=0.0691, Rw=0.1090 for reflections with I>2σ(I). The
crystal structure (1) was solved by direct methods using SHELX-97
(Sheldrich, G. M. University of Gottingen: Gottingen, Germany, 1990) and
expanded using difference Fourier techniques, refined by SHELX-97 (Sheldrich,
G.M. 1997). Crystallographic data for the structure of 1 have been deposited in the
Cambridge Crystallographic Data Centre (deposition number: CCDC851279).
Copies of these data can be obtained free of charge via the Internet at www.ccdc.
cam.ac.uk/conts/retrieving.html (or from the Cambridge Crystallographic Data
Centre, 12 Union Road, Cambridge CB21EZ, UK; fax (þ44) 1223-336-033; or
deposit@ccdc.cam.ac.uk).
(8) Li, X. C.; Ferreira, D.; Ding, Y. Q. Curr. Org. Chem. 2010, 14,
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Ali, Z.Nat. Prod. Sci. 2000, 6, 66–69. (b) Parvez, A.; Choudhary, M. I.;
Akhter, F.; Noorwala,M.;Mohammad, F. V.;Hasan,N.M.; Zamir, T.;
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S1. General experimental procedures. Optical rotations were measured using a Perkin-Elmer 341 
polarimeter. IR spectra were recorded on a Bruker Tensor 27 spectrometer. NMR spectra were 
recorded on Bruker DRX 500 and Avance III 500 spectrometers, using the residual CDCl3 (δH 
7.27/δC 77.0) and benzene-d6 (δH 7.16/δC 128.0) signals as references. The 2D NMR experiments 
(1H-1H COSY, HMQC, HMBC, NOESY) were performed using standard Bruker software. HR-
ESIMS spectra were acquired on a Bruker micrOTOF ESI-MS system. ECD spectra of compound 1 
were recorded in MeOH (400 µg/ml) on an AVIV CD spectrometer model 62ADS and analyzed with 
the AVIV 60DS V4.1 software. Silica gel (70-230 and 230-400 mesh, Merck) were used for column 
chromatography. Preparative TLC was performed on silica gel 60 GF254 (Merck). Bands were 
detected on TLC under UV or by heating after spraying with 5% phosphomolybdic acid in EtOH.  
 
S2. Conformational analysis, geometrical optimization, and ECD calculation 
Conformational analysis of 1 was performed with Schrödinger MacroModel 9.1 software using the 
OPLS 2005 (Optimized Potential for Liquid Simulations) force field in H2O. Conformers occurring 
within a 3 kcal/mol energy window from the global minimum were chosen for geometrical 
optimization and energy calculation using density function theory (DFT) with the B3LYP functional 
and the 6-31G* basis-set in the gas-phase with the Gaussian 03 program package.1 Vibrational 
analysis was done at the same level to confirm minima. TD-DFT/B3LYP/6-31G* (in the gas phase 
and in MeOH using the SCRF (self-consistent reaction field) method with the CPCM (Conductor-
like polarizable continuum) model, was employed to calculate excitation energy (denoted by 
wavelength in nm) and rotatory strength R in dipole velocity (Rvel) and dipole length (Rvel) forms. 
ECD curves were calculated based on rotatory strengths using a half bandwidth of 0.2 eV with 
conformers of 1. The spectra were combined after Boltzmann weighting according to their 
population contribution.  
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S3. Antiplasmodial and antitrypanosomal assay. Tests of extracts and pure substances were done 
as previously described.2 IC50 values were calculated from sigmoidal concentration inhibition curves. 
Assays were run in two independent experiments in duplicate. 
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1H NMR spectrum of Hydrangenone in C6D6 S6.  
Expanded 1H NMR spectrum of Hydrangdione C in C6D6 S7.
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Expanded 1H NMR spectrum of Hydrangenone in C6D6 S8.
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Expanded 13C NMR spectrum of Hydrangenone in C6D6 S10.
Expanded 13C NMR spectrum of Hydrangenone in C6D6 S11.
169
9 
S12. DEPT135 spectrum of Hydrangenone in C6D6  
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S16. HMQC spectrum of Hydrangenone in C6D6  
 S17. Expanded HMQC spectrum of Hydrangenone in C6D6
172
12 
HMBC spectrum of Hydrangenone in C6D6 S18.  
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S22. 1H NMR spectrum of Hydrangenone in CDCl3  
Expanded 1H NMR spectrum of Hydrangenone in CDCl3 S23.
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Expanded 1H NMR spectrum of Hydrangenone in CDCl3 S24.
13C NMR spectrum of Hydrangenone in CDCl3 S25.
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Expanded 13C NMR spectrum of Hydrangenone in CDCl3 S26.
Expanded 13C NMR spectrum of Hydrangenone in CDCl3 S27.
177
17 
DEPT135 spectrum of Hydrangenone in CDCl3 S28.  
Expanded DEPT135 spectrum of Hydrangenone in CDCl3 S29.  
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HMQC spectrum of Hydrangenone in CDCl3 S30.
Expanded HMQC spectrum of Hydrangenone in CDCl3 S31.
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HMBC spectrum of Hydrangenone in CDCl3 S32.
Expanded HMBC spectrum of Hydrangenone in CDCl3 S33.
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3.5. Triterpenoids with rare carbon skeletons from Salvia hydrangea: 
antiprotozoal activity and absolute configurations 
Mehdi Moridi Farimani, M. Babak Bahadori, Salman Taheri, Samad Nejad Ebrahimi, Stefanie 
Zimmermann, Reto Brun, Gholamreza Amin , and Matthias Hamburger  
J. Nat. Prod., 2011, 74 (10), pp 2200–2205   DOI: 10.1021/np200559c 
Salvadione C (1) and perovskone B (2), two new triterpenoids with rare carbon skeletons, were 
isolated from n-hexane extract of Salvia hydrangea. The absolute configuration was determined 
by comparison of experimental and calculated electronic circular dichroism (ECD) spectra. In 
vitro activity against Plasmodium falciparum K1 strain, Trypanosoma brucei rhodesiense STIB 
900 strain, and cytotoxicity in rat myoblast (L6) cells were determined. Compounds 1 and 2 
showed in vitro antiplasmodial activity, with IC50 values of 1.43 and 0.18 μM and selectivity 
indices (SI) of 86.2 and 69.6, respectively. IC50 values against T. brucei rhodesiense were found 
to be 4.33 and 15.92 μM, respectively. 
Extraction of plant material, isolation, recording, and interpretation of analytical data for 
structure elucidation (mass spectrometry, microprobe NMR, optical rotation) were done by Dr. 
Mehdi Moridi. Experimental and quantum-chemical calculations of ECD spectra, contributing to 
writing of the manuscript, and preparation of some figures were my part to this publication. 
Antiprotozoal tests were done by Stefanie Zimmermann.  
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ABSTRACT: Salvadione C (1) and perovskone B (2), two new triterpenoids with rare carbon
skeletons, were isolated from an antiplasmodial n-hexane extract of Salvia hydrangea. The
absolute configuration was determined by comparison of experimental and calculated
electronic circular dichroism (ECD) spectra. In vitro activity against Plasmodium falciparum K1
strain, Trypanosoma brucei rhodesiense STIB 900 strain, and cytotoxicity in rat myoblast (L6)
cells were determined. Compounds 1 and 2 showed in vitro antiplasmodial activity, with IC50
values of 1.43 and 0.18 μM and selectivity indices (SI) of 86.2 and 69.6, respectively. IC50
values against T. brucei rhodesiense were found to be 4.33 and 15.92 μM, respectively.
The genus Salvia comprises over 1000 species, being thelargest genus of the Lamiaceae family. Several Salvia
species, such as S. officinalis, S. triloba, S. miltiorrhiza, S.
hispanica, and S. sclarea, are cultivated as medicinal plants,
spices, and sources of essential oils for the perfume industry.1
From a phytochemical viewpoint, the genus is characterized by
the widespread occurrence of diterpenoids and triterpenoids.
Rare classes of terpenoids in Salvia include sesterterpenoids2,3
and some di- and triterpenoids with highly unusual carbon
skeletons.4−7
In Iran, the genus Salvia consists of 58 annual and perennial
species, 17 of which are endemic.8 S. hydrangea DC. ex Benth. is
a conspicuous aromatic plant that grows widely in Iran,
Anatolia, and Transcaucasia.8 Its common name in Persian is
“Gol-e Arooneh”, and the aerial parts of the plant have been
used in Iranian folk medicine as anti-inflammatory, antispas-
modic, carminative, and sedative compounds.9 Infusions
prepared from flowers serve as an anthelmintic and
antileishmanial, especially in the Pars province of Iran.10
Abietane-type diterpenoids have been reported from the roots
of the plant. A moderate in vitro antiplasmodial effect of the
flower extracts was attributed to a high content in pentacyclic
triterpenes, mainly oleanolic acid.11 S. hydrangea is taxonomi-
cally close to S. bucharica,8 from which triterpenoids with novel
carbon skeletons have been discovered.6,7,12,13 This prompted
us to investigate S. hydrangea. As part of an ongoing screening
for new antiparasitic natural products,14−17 an n-hexane extract
of S. hydrangea was found active against P. falciparum and T. b.
rhodesiense, with IC50 values of 3.2 and 18 μg/mL, respectively.
Herein, we report the isolation and structure elucidation of
two active compounds, salvadione C (1) and perovskone B (2),
including the determination of their absolute configuration by
chiroptical methods.
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■ RESULTS AND DISCUSSION
Salvadione C (1) was isolated as a white, amorphous solid. The
molecular formula of C30H40O5 was deduced from HR-ESIMS
at m/z 481.2949 [M + H]+ (calcd 481.2965). The IR spectrum
showed absorptions of hydroxy (3475 cm−1), carbonyl (1713
cm−1), and olefinic (1610 cm−1) functionalities. The molecular
formula accounted for 11 degrees of unsaturation. The 13C
NMR spectrum (Table 1) showed 30 carbon signals, which
were resolved through a DEPT experiment into 5 methyl, 9
methylene, 6 methine, and 10 quaternary carbons. Thus, 39
hydrogen atoms could be accounted for, while the remaining
atom was likely from a hydroxy group. 13C NMR data (Table
1) showed signals for a monosubstituted double bond (δ c
112.9, 138.5), a trisubstituted double bond (δ c 131.2, 135.9),
and two carbonyl carbons (δ c 203.6, 209.1). Four carbon
signals at δ c 75.3 (CH2), 76.8 (C), 92.0 (C), and 108.1 (C)
indicated the presence of oxygen-bearing sp3 carbons. The
absence of other sp or sp2 carbon signals implied that the
structure of 1 contained seven rings, including two cyclic ethers,
which is compatible with the molecular formula of C30H40O5.
The 1H NMR spectrum (Table 1) showed resonances of three
methyl singlets at δH 0.89, 1.04, and 1.31. Resonances of two
additional methyl groups at δH 1.11 (d, J = 6.9 Hz) and 1.27 (d,
J = 6.9 Hz), together with a signal at δH 2.29 (sept, J = 6.9 Hz)
indicating the presence of an isopropyl moiety. Signals at δH
6.34 (dd, J = 17.5, 10.8 Hz), 5.23 (d, J = 17.5 Hz), and 5.05 (d,
J = 10.8 Hz) were indicative of a vinyl group. Another olefinic
methine signal appeared as a doublet at δH 5.68 (J = 6.1 Hz).
Comparison of the NMR data of 1 with those of triterpenoids
previously isolated from S. bucharica indicated that 1 likely had
the same carbon skeleton as salvadiol.7 Notable differences in
the 13C NMR spectra of 1 and salvadiol were observed, such as
the resonance of an oxygen-bearing methylene carbon at δC
75.3 (C-28) replacing a methyl group at δC 29.8 in salvadiol.
The chemical shifts of C-11, C-26, and C-27 in 1 were observed
at δC 108.1, 54.9, and 76.8 and thus appeared downfield by ca.
8, 9, and 2 ppm, respectively. In contrast, C-25 in 1 was shifted
upfield by ca. 15 ppm and appeared at δ C 38.4. In the
1H NMR
spectrum, the methyl group at δH 1.24 (H-28) in salviadiol was
replaced in 1 by an AB system (δH 3.85 and 3.74, 1H each,
both d, Jgem = 14.7 Hz), reminiscent of an oxymethylene group
attached to a quaternary sp3 carbon. Along with the additional
degree of unsaturation, these spectroscopic data suggested the
presence of an oxepane ring through an oxygen bridge between
C-11 and C-28. HMBC correlations (Figure 1) confirmed the
carbon skeleton of 1, and the heterocycle was corroborated by
connectivities between H-28 (δH 3.85 and 3.74) and the C-11
and C-27 carbons (δ C 108.1 and 76.8, respectively).
Unambiguous assignment of 1H and 13C NMR data was
achieved by a combination of HMQC, COSY, and HMBC
experiments. The relative configuration of 1 was determined
from a NOESY spectrum and NOE difference experiments
(Figure 2) and was in accord with that of salvadiol, with
exception of the newly formed heterocyclic ring.
The absolute configuration of 1 was established by
measurement of the ECD spectrum and comparison with
calculated ECD data. A conformational search based on the
above established relative configuration revealed three con-
formers within a 3 kcal/mol energy window from the particular
global minimum. These conformers were subjected to geo-
metrical optimization and energy calculation using density
functional theory (DFT) with the B3LYP function and 6-31G*
in the gas phase combined with calculation of vibrational modes
to confirm these minima. No imaginary frequencies were found.
Conformation analysis using relative free energies indicated the
presence of the two conformers 1a (98.2%) and 1b (1.8%)
(Figure 3) in the gas phase. Theoretical calculation of ECD
spectra of conformers was performed by the time-dependent
density function theory (TDDFT) method at B3LYP/6-31G*
in MeOH using the SCRF (self-consistent reaction field)
Table 1. 1H and 13C NMR Data of Compounds 1 and 2
(CDCl3, 500 MHz for δH, 125 MHz for δ C)
a
1 2
position δH (J, Hz) δ C position δH (J, Hz) δ C
1 1.49b 41.7 1 α 1.18b 42.9
2.00, br d
(12.6)
1 β 1.40c
2 1.28c 20.1 2 1.45c 20.9
1.45b 1.69d
3 1.47b 42.4 3 1.63d 42.2
1.92d 1.81e
4 36.4 4 34.1
5 1.27c 50.5 5 0.92, dd (3.3,
11.5)
53.7
6 1.88d 21.2 6 1.37c 19.9
1.50c
7 1.20c 42.0 7 α 2.60, dd (8.5,
15.5)
34.7
1.88d 7 β 1.77e
8 53.0 8 60.2
9 51.3 9 54.6
10 92.0 10 90.1
11 108.1 11 96.3
12 209.1 12 170.2
13 71.1 13 122.0
14 203.6 14 195.5
15 2.29, sept (6.9) 27.3 15 3.11, sept
(7.0)
24.6
16 1.27, d (6.9)c 20.3 16 1.15, d (7.0)b 20.8
17 1.11, d (6.9) 18.8 17 1.08, d (7.0) 20.0
18 0.89, s 33.1 18 0.90, s 32.3
19 1.04, s 22.1 19 0.84, s 22.1
20 α 1.86d 42.0 20 α 1.74, d (13.7) 55.8
20 β 1.20c 20 β 2.64, d (13.7)
21 5.05, d (10.8) 112.9 21 196.0
5.23, d (17.5)
22 6.34, dd (10.8,
17.5)
138.5 22 5.88, s 125.8
23 135.9 23 156.5
24 5.68, d (6.1) 131.2 24 2.74, br t
(10.0)
49.7
25 3.76e 38.4 25 α 1.37c 34.2
25 β 2.31, dt (7.4,
12.5)
12.5)
26 2.22, s 54.9 26 2.46, dd (7.0,
12.5)
54.8
27 76.8 27 90.3
28 α 3.85, d (14.7) 75.3 28 1.43, s 24.8
28 β 3.74, d (14.7)e
29 1.31, s 26.7 29 1.72, s 27.4
30 α 2.44, d (17.0) 28.1 30 1.79, s 21.9
30 β 2.60, d (17.0)
aδ values were established from HMBC, COSY, and HMQC
experiments. b,c,d,eOverlapping signals.
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method with the CPCM (conductor-like polarizable continu-
um) model. The overall pattern of calculated ECD spectra was
in good agreement with the experimental data (Figure 4). In
particular, two negative Cotton effects (CE) were observed at
239 and 279 nm, along with positive effects at 205 and 325 nm.
Thus, the absolute configuration of 1 was established as
5S,8R,9S,10S,11R,13R,25R,26R,27S. Salvadione C (1) is a new
natural product with the same carbon skeleton as salvadiol.
Perovskone B (2) was isolated as an amorphous colorless
powder. A molecular formula of C30H40O4 was established from
its HR-ESIMS (m/z 465.3040 [M + H]+, calcd 465.3005). The
IR spectrum showed absorption bands at 1673 and 1110 cm−1
indicative of α,β-unsaturated carbonyl and ether functionalities,
respectively. The molecular formula accounted for 11 degrees
of unsaturation. The 13C NMR spectrum showed 30 carbon
signals which originated, according to the DEPT spectrum,
from 7 methyl, 7 methylene, 5 methine, and 11 quaternary
carbons (Table 1). 13C NMR resonances at δ C 195.5 (C),
122.0 (C), and 170.2 (C) indicated the presence of an α,β-
unsaturated carbonyl containing a trisubstituted double bond. A
second α,β-unsaturated carbonyl moiety was characterized by
resonances at δC 196.0 (C), 125.8 (CH), and 156.5 (C). Three
oxygen-bearing quaternary carbons appeared at δ C 90.1, 90.3,
and 96.3. In the DEPT spectrum, all 40 hydrogens could be
accounted for; therefore, the molecule did not contain free
hydroxy groups. According to the degree of unsaturation, the
structure of 2 was heptacyclic. In the 1H NMR spectrum (Table
1), signals for a proton at δH 3.11 (sept, J = 7.0 Hz) and two
methyl groups at δH 1.08 (d, J = 7.0 Hz) and 1.15 (d, J = 7.0
Hz) showed the presence of a vinylic isopropyl group. Five
additional methyl groups appeared as singlets, among these a
vinylic methyl resonating at δ C 1.79. Only one olefinic proton
was observed at δH 5.88 (s). The
1H and 13C NMR data
strongly resembled those of perovskone, a triterpenoid from
Perovskia abrotanoides,18 indicating that the two compounds
were structurally related. Inspection of the 13C NMR spectra
showed the lack of the C-21 methylene group in compound 2
but the presence of an additional carbonyl group (δ C 196.0).
This suggested that the methylene was replaced by a carbonyl
group. Indeed, the signals of C-22 (δ C 125.8) and C-23 (δ C
156.5) were paramagnetically shifted (Δδ = +5.6 and +20.2
ppm, respectively) in comparison to those of perovskone. Also
the resonances of neighboring H-23 (δ H 5.88), H-30 (δH 1.79),
and H-24 (δH 2.73) were shifted (Δδ = +0.56, +0.29, and
+0.31 ppm, respectively). In comparison to perovskone, the C-
14 resonance was shifted upfield by ca. 6 ppm and appeared at
δ C 195.5, while the signal of C-8 underwent a downfield shift of
ca. 12 ppm (δ C 60.2). These differences were in agreement
with a 1,3-dicarbonyl moiety and suggested that the additional
carbonyl group had to be located at C-21. HMBC correlations
between H-22 (δH 5.88, s), H-30 (δ H 1.79, s), H-7α (δH 2.60,
dd), and H-7β (δH 1.77, m) and C-21, and between H-22 and
C-8 (Figure 5) confirmed the location of the carbonyl group.
Unambiguous assignments of NMR data were achieved by a
combination of COSY, HMQC, and HMBC experiments, and
the relative configuration was deduced from a NOESY
spectrum (Figure 6). Diagnostic cross peaks between H-24,
H-26, Me-30, H-25β, and H-20α were observed and confirmed
their cofacial orientation. In addition, cross peaks between H-5,
Figure 1. Key HMBC correlations of 1.
Figure 2. Key NOE correlations of 1.
Figure 3. Minimized conformers of 1 and 2 in the gas phase using
DFT at the B3LYP/6-31G* level: (A) compound 1, showing the two
conformers 1a,b within a 3 kcal/mol range from the global minimum,
differing only with respect to the orientation of the vinyl group: (B)
compound 2, showing the two major conformers 2a,b, which
according to Boltzmann weighing accounted for the total population
and only differed in the orientation of the isopropyl moiety.
Journal of Natural Products Article
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H-20α and H-20β, and Me-18 corroborated the linkage of rings
A and B and, hence, the same relative configuration is
established as for perovskone.
The absolute configuration of 2 was established by
comparison of experimental and calculated ECD spectra. The
conformational analysis gave two conformers within a 3 kcal/
mol energy window from the particular global minimum. They
differed only in the orientation of the isopropyl group attached
at C-13 (Figure 3). Conformers were subjected to geometrical
optimization and energy calculation using the DFT-B3LYP 6-
31G* theoretical level in the gas phase combined with
calculation of vibrational modes to confirm these minima. No
imaginary frequencies were found. Conformers 2a,b con-
tributed to 51.5 and 48.5% of the total, respectively. Calculation
of the ECD spectra of the conformers was performed as
described above. The weighted ECD spectrum in MeOH is
shown in Figure 4. The overall patterns of experimental and
calculated ECD spectra were in good agreement. Two positive
Cotton effects (CE) at 215 and 238 nm along with two
negative CEs around 266 nm and in the region 300−350 nm
were also found in the calculated spectrum (Figure 4).
Differences between calculated and experimental spectra
presumably resulted from an overestimation of the UV
absorbance in the calculations or may be due to minor
differences between calculated and solution conformers.19,20
Thus, the absolute configuration of compound 2 was
established as 5R,8R,9R,10R,11S,12R,26S. This new natural
product was named perovskone B.
Salvadione C (1) and perovskone B (2) were tested for in
vitro antiplasmodial activity against P. falciparum K1 strain. The
compounds showed fairly potent activity (IC50 values of 1.43
and 0.18 μM, respectively) and good selectivity indices (SI) of
86.2 and 69.6 (Table 2). Against T. brucei rhodesiense STIB 900,
they exhibited moderate potency (IC50 values of 4.33 and 15.92
μM, respectively).
Salvadione C and perovskone B both possess rare carbon
skeletons that can be rationalized by a Diels−Alder type
addition of an acyclic monoterpene (myrcene for salvadione C
and trans-β-ocimene for perovskone B) to a diterpenoid7,18
(Figure 7). The carbon skeletons found in 1 and 2 have been
reported once from S. bucharica (salvadiol) and Perovskia
abrotanoides (perovskone), but the scaffold of 1 is new and
Figure 4. Experimental (blue) and calculated (red) ECD spectra of 1
(A) and 2 (B). Calculated spectra were obtained by using TDDFT at
the B3LYP/6-31G* level in MeOH.
Figure 5. Key HMBC correlations of 2.
Figure 6. Key NOESY correlations of 2.
Table 2. Activity (IC50 in μM with Standard Deviations (SD)
and Selectivity Indices (SI)) against Plasmodium falciparum
K1, Trypanosoma brucei rhodesiense STIB 900, and L6 Cells
compd P. falciparum SI
T. b.
rhodesiense SIa L6 cells
1 1.43 ± 0.18 86.6 4.33 ± 0.24 43.2 >90.0
2 0.18 ± 0.002 69.6 15.92 ± 0.72 0.78 5.77 ± 0.41
aSelectivity index = IC50 of the L6 cells (cytotoxicity) divided by IC50
of the parasite.
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differs in the additional oxepane ring, which confers a high
degree of rigidity to the molecule.
In conclusion, fractionation of the antiparasitic n-hexane
extract of the aerial parts of S. hydrangea led to isolation of two
new triterpenoids with rare skeletons. Perovskone B (2)
showed in vitro antiplasmodial activity at submicromolar
concentrations and good selectivity. Its druglike physicochem-
ical properties warrant preliminary in vivo testing for
exploration of the compound’s potential for further inves-
tigation.
■ EXPERIMENTAL SECTION
General Experimental Procedures. Optical rotations were
measured using a Perkin-Elmer 341 polarimeter. IR spectra were
recorded on a Bruker Tensor 27 spectrometer. NMR spectra were
recorded on Bruker DRX 500 and Avance III 500 spectrometers, using
the residual CDCl3 signal (δH 7.27/δ C 77.0) as reference. The 2D
NMR experiments (1H−1H COSY, HMQC, HMBC, NOESY) were
performed using standard Bruker software. HR-ESIMS spectra were
acquired on a Bruker micrOTOF ESI-MS system. ECD spectra of
compounds 1 and 2 were recorded in MeOH (40 μg/mL) on an AVIV
Model 62ADS CD spectrometer and analyzed with the AVIV 60DS
V4.1 software. Silica gel (70−230 and 230−400 mesh, Merck) was
used for column chromatography. Preparative TLC was performed on
silica gel 60 GF254 (Merck). Bands were detected on TLC under UV
or by heating after spraying with 5% phosphomolybdic acid in EtOH.
Plant Material. The aerial parts of S. hydrangea DC. ex Benth.
were collected from the Koohin region in Qazvin province, Iran, in
May 2009 and identified by Dr. G. R. Amin. A voucher specimen
(6719-TEH) has been deposited at the herbarium of the Faculty of
Pharmacy, Tehran University of Medical Sciences.
Extraction and Isolation. The air-dried, powdered aerial parts of
S. hydrangea (4.5 kg) were extracted successively with n-hexane (3 ×
25 L), EtOAc (3 × 25 L), and MeOH (3 × 25 L) by maceration at
room temperature. Extracts were concentrated in vacuo, to afford dark
gummy residues of n-hexane (107 g), EtOAc (110 g), and MeOH
(280 g) extracts. The n-hexane extract was separated on a silica gel
column (230−400 mesh, 900 g) with a gradient of n-hexane−EtOAc
(100/0 to 0/100) as eluent, followed by increasing concentrations of
MeOH (up to 5%) in EtOAc. On the basis of TLC analysis, fractions
with similar composition were pooled to yield 30 combined fractions.
The less polar fractions contained waxes and carotenoids compounds
and were not further investigated. Fraction 16 (4.5 g) was separated on
a silica gel column with CH2Cl2-Me2CO (98:2), to afford seven
fractions (16a−16g). Fraction 16d was further purified by preparative
TLC (CH2Cl2−Me2CO (100/3.5)) to afford 1 (11 mg, Rf = 0.72).
Fraction 17 (2.2 g) was separated on a silica gel column with CHCl3−
Me2CO (97/3) as eluent into seven fractions (17a−17g). Fraction 17a
was recrystallized from CHCl3−MeOH to yield 5-hydroxy-4′,7-
dimethoxyflavone (6 mg). Fraction 18 (1.3 g) was separated over a
silica gel column with CHCl3−Me2CO (97/3) as eluent, to afford
oleanolic acid (25 mg). Fraction 19 (8.5 g) was triturated with Me2CO
and MeOH to give β-sitosterol (1 g). Fraction 21 (1.1 g) was
separated on a silica gel column (CHCl3−Me2CO (97/3)) into 10
fractions (21a−21j). Fraction 21a was further purified by preparative
TLC (CH2Cl2−Me2CO (100/3.5)) to afford 2 (8 mg, Rf = 0.64).
Fraction 22 (1.7 g) was triturated with Me2CO, and the insoluble solid
was recrystallized from Me2CO to afford salvigenin (120 mg).
Salvadione C (1): white amorphous powder; [α]20D = +53° (c 1.0,
CHCl3); IR (KBr) νmax 3475, 2940, 1713, 1610, 1460, 1375, 1225,
1137, 1064 cm−1; 1H and 13C NMR data, see Table 1; CD (MeOH, c
= 8.3 × 10−8 M, 1.0 cm path length) [θ]202 +31 128, [θ]216 +3592,
[θ]229 +6677, [θ]239 −30 634, [θ]262 −12 305, [θ]279 −19 987, [θ]322
+22 008; positive HR-ESIMS m/z 481.2949 [M + H]+ (calcd for
C30H41O5 481.2965).
Perovskone B (2): white amorphous powder; [α]20D = +147° (c
0.9, CHCl3); IR (KBr) νmax 2935, 1673, 1455, 1372, 1233, 1110 cm
−1;
1H and 13C NMR data, see Table 1; CD (MeOH, c = 8.7 × 10−8 M,
1.0 cm path length): [θ]216 +24 711, [θ]239 +29 541, [θ]264 −5769,
[θ]324 −2430; HR-ESIMS m/z 465.3040 [M + H]+ (calcd for
C30H41O4 465.3005).
Conformational Analysis, Geometrical Optimization, and
ECD Calculation. Conformational analysis of 1 and 2 was performed
with Schrödinger MacroModel 9.1 software using the OPLS 2005
(optimized potential for liquid simulations) force field in H2O.
Conformers occurring within a 3 kcal/mol energy window from the
global minimum were chosen for geometrical optimization and energy
calculation using density functional theory (DFT) with the B3LYP
functional and the 6-31G* basis set in the gas phase with the Gaussian
03 program package.21 Vibrational analysis was done at the same level
to confirm minima. TD-DFT/B3LYP/6-31G*, in the gas phase and in
MeOH using the SCRF (self-consistent reaction field) method with
the CPCM (conductor-like polarizable continuum) model, was
employed to calculate excitation energy (denoted by wavelength in
nm) and rotatory strength R in dipole velocity (Rvel) and dipole length
(Rvel) forms. ECD curves were calculated on the basis of rotatory
strengths using a half-bandwidth of 0.18 eV with conformers of 1 and
2. The spectra were combined after Boltzmann weighting according to
their population contribution.
Antiplasmodial and Antitrypanosomal Assay. Tests of
extracts and pure substances were done as previously described.16
IC50 values were calculated from sigmoidal concentration inhibition
curves. Assays were run in two independent experiments in duplicate.
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3. Conclusions and outlook 
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Iran has a highly diverse flora, and a high number of endemic plant species which are to be 
considered as a potentially rich source for novel phytochemicals. We investigated anti-parasitic 
activity against P. falciparum of selected Iranian medicinal plants. Several plant extracts mainly 
from species belonging to the Lamiaceae and Asteraceae families exhibited noticeable in vitro 
activity. Bioactivity guided phytochemical investigation of the extracts resulted in purification of 
several antiprotozoal compounds. A great number of the isolated compounds (almost 50%) had 
new structures, and we discovered several novel natural product scaffolds. This indicates that the 
diverse and unique flora of Iran has a great potential as a source of new natural compounds with 
sometimes unique skeletons. Although numerous plants of Iran have been phytochemically 
investigated, they have remained uninvestigated with respect to their bioactivity. Hence, they are 
a vast natural source for discovery of leads structure with new scaffold for a given target.  
Moreover, establishment of an in-house extract library from Iranian plants will accelerate 
discovery of new bioactive molecules through high-throughput screening campaigns. We suggest 
that the plant collection be carried out based on ethnobotanical and taxonomical considerations.  
Importance of sterochemical relevance on biological activity has made determination of the 
absolute configurations critical to understanding the behavior and interaction of chiral drugs with 
the biological environments. It is always a challenge for chemist to establish AC of chiral 
molecules by straightforward, nondestructive, and reliable methods. During the last decade 
quantum chemical calculations of chiroptical properties such as ECD, OR, and VCD have been 
established as reliable approaches for determination of the absolute configuration of optically 
active compounds. The interest in CD spectroscopy for determination of the AC of natural 
products has been steadily increasing (Figure 24). CD spectroscopy plays a significant role in the 
determination of ACs when their 3D structures cannot be elucidated by classical methods. 
 
 
Figure 24: The number of annual published ECD related papers, the keyword was “circular dichroism + DFT”. Source: 
SciFinder® database 
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In the course of this study, the AC of a wide range of new natural products was determined by 
calculation of ECD spectra and comparison with experimental data. We successfully applied this 
methodology to a diverse spectrum of conformationally rigid or flexible natural products,  
including abruquinones, acetylated furanocoumarins, terpenoids of various types, such as 
myrcene type monoterpenoids, bisabololoxide sesquiterpene diesters, abietane and labdane 
diterpenoids, manoloxide sesterterpenoids, ursane triterpenoids, as well as cardenolide 
glycosides, sesquiterpene coumarins, and complex isoprenoids with novel scaffolds. These 
compounds possess one to several stereogenic centers.  
Undoubtedly, the application of quantum-chemically calculated chiroptical properties such as 
ECD, VCD, and OR, in combination with experimental data, has become an accepted means for 
fast, straightforward, and nondestructive assignment of AC in chiral compounds. By this 
approach the AC of compounds can be established within reasonable time. ECD is highly 
sensitive, but possesses low signal resolution. It works perfectly with rigid structures, but flexible 
molecules pose difficulties due to the simultaneous presence of several conformers with different 
population and optical contribution. Therefore, a careful conformational analysis is a very critical 
step in the prediction of ECD spectra.  
A case in point of highly flexible bisaboloxides (5–9) (chapter 3.2), the relative stereochemistry 
of the entire molecule could not be established by NMR experiments due to a freely rotating 
bond between two discrete portions of the molecules. We demonstrated here that the absolute 
configuration could be established with the aid of ECD calculation in cases where relative 
stereochemical correlation of two portions of a molecule was not known. The assignment of AC 
was achieved through a careful conformational analysis of all relevant stereoisomers, followed 
by simulation of ECD spectra. 
In some molecules the differences between ECD spectra of stereoisomers are not distinct enough 
to establish their AC. In these cases ECD data have to be combined with additional methods, 
such as calculation of optical rotation. In the case of the abietane diterpene sahandone (4) 
(chapter 3.1), for example, the AC was revised by calculation and comparison of the optical 
rotation values rather than ECD calculation.  
Comparison of simulated ECD spectra with experimental data of a broad spectrum of new 
natural products revealed that TDB3LYP/6-31g** is a reliable approach for calculation of 
excitation states. Assignment of the AC of a compound is based on the comparison between 
calculated and experimental ECD spectra: the better they match, the more reliable conclusions 
can be drawn. However, conclusions for unambiguous configurational assignments can be drawn 
even if the calculated ECD spectra do not perfectly match with the experimental data. 
Comparison of ECD curves obtained for individual conformers of a compound showed that even 
subtle conformational differences may lead to substantial changes of the chiroptical properties. 
Consequently, the quality of predicted ECD data critically depends on a careful conformational 
analysis, and on the computational method used for prediction of CD spectra. 
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There are several examples in literature concerning revision of previously reported stereo 
structures. Consequently, ACs of some NP in the literature needs re-establishment by quantum 
chemical calculations of chiroptical properties. 
Application of ECD spectra in establishing an AC requires existing of at least one UV-vis-NIR 
range chromophore, which enables correlation between 3D structure and the sign of spectrum. In 
case of lacking appropriate chromophore, VCD technique can be used as an alternative 
chiroptical tool for determination of molecular structure of chiral compounds (such as 
sanandajin, chapter 3.3). Also, in case of high conformational flexibility in solution, the novel 
solid-state CD method should be considered as an important tool for the determination of AC. 
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